+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

List of PDF Full Texts available from EurekaMag Chapter 54836

Chapter 54836 contains a list of PDF Full Texts available from EurekaMag.

Ondrejka, S.L.; Jegalian, A.G.; Kim, A.S.; Chabot-Richards, D.S.; Giltnane, J.; Czuchlewski, D.R.; Shetty, S.; Sekeres, M.A.; Yenamandra, A.; Head, D.; Jagasia, M.; Hsi, E.D., 2015:
PDGFRB-rearranged T-lymphoblastic leukemia/lymphoma occurring with myeloid neoplasms: the missing link supporting a stem cell origin

Chang, H.Moon.; Ryu, M-Hee.; Lee, H.; Jang, S.Jin.; Lee, J-Lyun.; Kim, T.Won.; Yook, J.Hwan.; Oh, S.Tae.; Kim, B.Sik.; Lee, J.Shin.; Kang, Y-Koo., 2008:
PDGFRalpha gene mutation and protein expression in gastrointestinal stromal tumors

Tamai, K.; Yamazaki, T.; Chino, T.; Ishii, M.; Otsuru, S.; Kikuchi, Y.; Iinuma, S.; Saga, K.; Nimura, K.; Shimbo, T.; Umegaki, N.; Katayama, I.; Miyazaki, J-ichi.; Takeda, J.; McGrath, J.A.; Uitto, J.; Kaneda, Y., 2011:
PDGFRalpha-positive cells in bone marrow are mobilized by high mobility group box 1 (HMGB1) to regenerate injured epithelia

Wehler, T.C.; Frerichs, K.; Graf, C.; Drescher, D.; Schimanski, K.; Biesterfeld, S.; Berger, M.R.; Kanzler, S.; Junginger, T.; Galle, P.R.; Moehler, M.; Gockel, I.; Schimanski, C.C., 2008:
PDGFRalpha/beta expression correlates with the metastatic behavior of human colorectal cancer: a possible rationale for a molecular targeting strategy

Oseini, A.M.; Roberts, L.R., 2009:
PDGFRalpha: a new therapeutic target in the treatment of hepatocellular carcinoma?

Kimura, Y.; Inoue, K.; Abe, M.; Nearman, J.; Baranowska-Kortylewicz, J., 2007:
PDGFRbeta and HIF-1alpha inhibition with imatinib and radioimmunotherapy of experimental prostate cancer

Pinho, S.; Lacombe, J.; Hanoun, M.; Mizoguchi, T.; Bruns, I.; Kunisaki, Y.; Frenette, P.S., 2013:
PDGFRα and CD51 mark human nestin+ sphere-forming mesenchymal stem cells capable of hematopoietic progenitor cell expansion

Chojnacki, A.; Mak, G.; Weiss, S., 2011:
PDGFRα expression distinguishes GFAP-expressing neural stem cells from PDGF-responsive neural precursors in the adult periventricular area

Clement, D.L.; Mally, S.; Stock, C.; Lethan, M.; Satir, P.; Schwab, A.; Pedersen, S.F.; Christensen, Søren.T., 2013:
PDGFRα signaling in the primary cilium regulates NHE1-dependent fibroblast migration via coordinated differential activity of MEK1/2-ERK1/2-p90RSK and AKT signaling pathways

Sabbatino, F.; Wang, Y.; Wang, X.; Flaherty, K.T.; Yu, L.; Pepin, D.; Scognamiglio, G.; Pepe, S.; Kirkwood, J.M.; Cooper, Z.A.; Frederick, D.T.; Wargo, J.A.; Ferrone, S.; Ferrone, C.R., 2015:
PDGFRα up-regulation mediated by sonic hedgehog pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation

Estevez-Garcia, P.; Castaño, A.; Martin, A.C.; Lopez-Rios, F.; Iglesias, J.; Muñoz-Galván, S.; Lopez-Calderero, I.; Molina-Pinelo, S.; Pastor, M.D.; Carnero, A.; Paz-Ares, L.; Garcia-Carbonero, R., 2013:
PDGFRα/β and VEGFR2 polymorphisms in colorectal cancer: incidence and implications in clinical outcome

Plantamura, I.; Casalini, P.; Dugnani, E.; Sasso, M.; D'Ippolito, E.; Tortoreto, M.; Cacciatore, M.; Guarnotta, C.; Ghirelli, C.; Barajon, I.; Bianchi, F.; Triulzi, T.; Agresti, R.; Balsari, A.; Campiglio, M.; Tripodo, C.; Iorio, M.V.; Tagliabue, E., 2015:
PDGFRβ and FGFR2 mediate endothelial cell differentiation capability of triple negative breast carcinoma cells

Hewitt, K.J.; Shamis, Y.; Knight, E.; Smith, A.; Maione, A.; Alt-Holland, A.; Sheridan, S.D.; Haggarty, S.J.; Garlick, J.A., 2012:
PDGFRβ expression and function in fibroblasts derived from pluripotent cells is linked to DNA demethylation

Aslam, M.Imran.; Abraham, J.; Mansoor, A.; Druker, B.J.; Tyner, J.W.; Keller, C., 2014:
PDGFRβ reverses EphB4 signaling in alveolar rhabdomyosarcoma

Guo, S.; Yu, L.; Cheng, Y.; Li, C.; Zhang, J.; An, J.; Wang, H.; Yan, B.; Zhan, T.; Cao, Y.; Zheng, H.; Li, Z., 2013:
PDGFRβ triggered by bFGF promotes the proliferation and migration of endothelial progenitor cells via p-ERK signalling

Wu, N.; Iwamoto, T.; Sugawara, Y.; Futaki, M.; Yoshizaki, K.; Yamamoto, S.; Yamada, A.; Nakamura, T.; Nonaka, K.; Fukumoto, S., 2010:
PDGFs regulate tooth germ proliferation and ameloblast differentiation

Quintana, E.; Mayr, J.A.; García Silva, M.T.; Font, A.; Tortoledo, M.A.; Moliner, S.; Ozaez, L.; Lluch, M.; Cabello, A.; Ricoy, J.R.; Koch, J.; Ribes, A.; Sperl, W.; Briones, P., 2013:
PDH E1β deficiency with novel mutations in two patients with Leigh syndrome

Kim, S.; Shin, E-Jin.; Hahm, J-Hoon.; Park, P-Jong.; Hwang, J-Eun.; Paik, Y-Ki., 2013:
PDHK-2 deficiency is associated with attenuation of lipase-mediated fat consumption for the increased survival of Caenorhabditis elegans dauers

Sakono, M.; Seko, A.; Takeda, Y.; Ito, Y., 2014:
PDI family protein ERp29 forms 1:1 complex with lectin chaperone calreticulin

Houston, J.P.; Kroenke, K.; Davidson, J.R.; Adler, L.A.; Faries, D.E.; Ahl, J.; Swindle, R.; Trzepacz, P.T., 2011:
PDI-4A: an augmented provisional screening instrument assessing 5 additional common anxiety-related diagnoses in adult primary care patients

Klaile, E.; Kukalev, A.; Obrink, Börn.; Müller, M.M., 2008:
PDIP38 is a novel mitotic spindle-associated protein that affects spindle organization and chromosome segregation

Wong, A.; Zhang, S.; Mordue, D.; Wu, J.M.; Zhang, Z.; Darzynkiewicz, Z.; Lee, E.Y.C.; Lee, M.Y.W.T., 2014:
PDIP38 is translocated to the spliceosomes/nuclear speckles in response to UV-induced DNA damage and is required for UV-induced alternative splicing of MDM2

Fu, X.; Wang, P.; Fukui, M.; Long, C.; Yin, L.; Choi, H.Joung.; Zhu, B.Ting., 2012:
PDIp is a major intracellular oestrogen-storage protein that modulates tissue levels of oestrogen in the pancreas

Iskandar, K.; Cao, Y.; Hayashi, Y.; Nakata, M.; Takano, E.; Yada, T.; Zhang, C.; Ogawa, W.; Oki, M.; Chua, S.; Itoh, H.; Noda, T.; Kasuga, M.; Nakae, J., 2010:
PDK-1/FoxO1 pathway in POMC neurons regulates Pomc expression and food intake

Wang, Y.; Amdam, G.V.; Rueppell, O.; Wallrichs, M.A.; Fondrk, M.Kim.; Kaftanoglu, O.; Page, R.E., 2009:
PDK1 and HR46 gene homologs tie social behavior to ovary signals

Ito, K.; Akazawa, H.; Tamagawa, M.; Furukawa, K.; Ogawa, W.; Yasuda, N.; Kudo, Y.; Liao, C-hui.; Yamamoto, R.; Sato, T.; Molkentin, J.D.; Kasuga, M.; Noda, T.; Nakaya, H.; Komuro, I., 2009:
PDK1 coordinates survival pathways and beta-adrenergic response in the heart

Mashukova, A.; Forteza, R.; Wald, F.A.; Salas, P.J., 2012:
PDK1 in apical signaling endosomes participates in the rescue of the polarity complex atypical PKC by intermediate filaments in intestinal epithelia

Barile, E.; De, S.K.; Pellecchia, M., 2014:
PDK1 inhibitors

Di, R-min.; Feng, Q-ting.; Chang, Z.; Luan, Q.; Zhang, Y-yang.; Huang, J.; Li, X-Li.; Yang, Z-zhou., 2011:
PDK1 plays a critical role in regulating cardiac function in mice and human

Seong, H-A.; Jung, H.; Manoharan, R.; Ha, H., 2012:
PDK1 protein phosphorylation at Thr354 by murine protein serine-threonine kinase 38 contributes to negative regulation of PDK1 protein activity

Shen, X.; Xi, G.; Radhakrishnan, Y.; Clemmons, D.R., 2010:
PDK1 recruitment to the SHPS-1 signaling complex enhances insulin-like growth factor-i-stimulated AKT activation and vascular smooth muscle cell survival

Baracho, G.V.; Cato, M.H.; Zhu, Z.; Jaren, O.R.; Hobeika, E.; Reth, M.; Rickert, R.C., 2014:
PDK1 regulates B cell differentiation and homeostasis

Nakamura, K.; Sakaue, H.; Nishizawa, A.; Matsuki, Y.; Gomi, H.; Watanabe, E.; Hiramatsua, R.; Tamamori-Adachi, M.; Kitajima, S.; Noda, T.; Ogawa, W.; Kasuga, M., 2008:
PDK1 regulates cell proliferation and cell cycle progression through control of cyclin D1 and p27Kip1 expression

Yagi, M.; Kantarci, A.; Iwata, T.; Omori, K.; Ayilavarapu, S.; Ito, K.; Hasturk, H.; Van Dyke, T.E., 2009:
PDK1 regulates chemotaxis in human neutrophils

Feng, Q.; Di, R.; Tao, F.; Chang, Z.; Lu, S.; Fan, W.; Shan, C.; Li, X.; Yang, Z., 2010:
PDK1 regulates vascular remodeling and promotes epithelial-mesenchymal transition in cardiac development

Dangelmaier, C.; Manne, B.K.; Liverani, E.; Jin, J.; Bray, P.; Kunapuli, S.P., 2014:
PDK1 selectively phosphorylates Thr(308) on Akt and contributes to human platelet functional responses

Reddy, P.; Adhikari, D.; Zheng, W.; Liang, S.; Hämäläinen, T.; Tohonen, V.; Ogawa, W.; Noda, T.; Volarevic, S.; Huhtaniemi, I.; Liu, K., 2009:
PDK1 signaling in oocytes controls reproductive aging and lifespan by manipulating the survival of primordial follicles

Tan, J.; Li, Z.; Lee, P.Leng.; Guan, P.; Aau, M.Yee.; Lee, S.Theng.; Feng, M.; Lim, C.Zihui.; Lee, E.Yong.Jing.; Wee, Z.Ning.; Lim, Y.Chyn.; Karuturi, R.K.Murthy.; Yu, Q., 2014:
PDK1 signaling toward PLK1-MYC activation confers oncogenic transformation, tumor-initiating cell activation, and resistance to mTOR-targeted therapy

Cao, Y.; Nakata, M.; Okamoto, S.; Takano, E.; Yada, T.; Minokoshi, Y.; Hirata, Y.; Nakajima, K.; Iskandar, K.; Hayashi, Y.; Ogawa, W.; Barsh, G.S.; Hosoda, H.; Kangawa, K.; Itoh, H.; Noda, T.; Kasuga, M.; Nakae, J., 2011:
PDK1-Foxo1 in agouti-related peptide neurons regulates energy homeostasis by modulating food intake and energy expenditure

Tan, J.; Yu, Q., 2011:
PDK1-driven Myc signaling regulates cellular response to mTOR inhibitors

Gagliardi, P.Armando.; di Blasio, L.; Puliafito, A.; Seano, G.; Sessa, R.; Chianale, F.; Leung, T.; Bussolino, F.; Primo, L., 2014:
PDK1-mediated activation of MRCKα regulates directional cell migration and lamellipodia retraction

Velpula, K.Kumar.; Tsung, A.J., 2015:
PDK1: a new therapeutic target for glioblastoma?

Bayascas, Jé.Ramón., 2011:
PDK1: the major transducer of PI 3-kinase actions

Liu, Z.; Chen, X.; Wang, Y.; Peng, H.; Wang, Y.; Jing, Y.; Zhang, H., 2015:
PDK4 protein promotes tumorigenesis through activation of cAMP-response element-binding protein (CREB)-Ras homolog enriched in brain (RHEB)-mTORC1 signaling cascade

Boasso, A.; Hardy, A.W.; Landay, A.L.; Martinson, J.L.; Anderson, S.A.; Dolan, M.J.; Clerici, M.; Shearer, G.M., 2008:
PDL-1 upregulation on monocytes and T cells by HIV via type I interferon: restricted expression of type I interferon receptor by CCR5-expressing leukocytes

Woo, J.; Vierboom, M.P.M.; Kwon, H.; Chao, D.; Ye, S.; Li, J.; Lin, K.; Tang, I.; Belmar, N.A.; Hartman, T.; Breedveld, E.; Vexler, V.; 't Hart, B.A.; Law, D.A.; Starling, G.C., 2014:
PDL241, a novel humanized monoclonal antibody, reveals CD319 as a therapeutic target for rheumatoid arthritis

Goldberg, J.S., 2014:
PDLA a potential new potent topical analgesic: a case report

Wright, L.D.; McKeon-Fischer, K.D.; Cui, Z.; Nair, L.S.; Freeman, J.W., 2015:
PDLA/PLLA and PDLA/PCL nanofibers with a chitosan-based hydrogel in composite scaffolds for tissue engineered cartilage

Bowe, R.A.; Cox, O.T.; Ayllón, Vónica.; Tresse, E.; Healy, N.C.; Edmunds, S.J.; Huigsloot, M.; O'Connor, R. , 2014:
PDLIM2 regulates transcription factor activity in epithelial-to-mesenchymal transition via the COP9 signalosome

Yan, P.; Fu, J.; Qu, Z.; Li, S.; Tanaka, T.; Grusby, M.J.; Xiao, G., 2009:
PDLIM2 suppresses human T-cell leukemia virus type I Tax-mediated tumorigenesis by targeting Tax into the nuclear matrix for proteasomal degradation

Vanaja, D.Krishna.; Grossmann, M.E.; Cheville, J.C.; Gazi, M.H.; Gong, A.; Zhang, J.San.; Ajtai, K.; Burghardt, T.P.; Young, C.Y.F., 2009:
PDLIM4, an actin binding protein, suppresses prostate cancer cell growth

Liu, Z.; Zhu, F.; Yao, L.; Yang, C.; Xiao, L.; Zhu, J.; Wang, H.; Wang, G.; Liu, W.; Xiao, Z., 2013:
PDLIM5 gene polymorphisms and short term antidepressant response in Chinese major depressive disorders

Qiu, T.; Yin, Y.; Li, B.; Xie, L.; Yan, Q.; Dai, H.; Wang, X.; Li, S., 2015:
PDLLA/PRGD/β-TCP conduits build the neurotrophin-rich microenvironment suppressing the oxidative stress and promoting the sciatic nerve regeneration

Xu, H.; Yan, Y.; Li, S., 2011:
PDLLA/chondroitin sulfate/chitosan/NGF conduits for peripheral nerve regeneration

Schäffler, E., 2011:
PDLer talks clear text about the upcoming end of civil service: "We are left alone with many questions"

Jiang, H-Y.; Yan, L-S.; Ye, J.; Pan, W.; Luo, B.; Yao, X.Steve., 2012:
PDM RZ-to-NRZ and NRZ-to-PRZ format conversions using a variable DGD element inside a polarization-diversified loop

Boffi, P.; Martelli, P.; Cirigliano, M.; Magarini, M.; Martinelli, M.; Bertolini, M.; Pepe, M.; Di Mola, D.; Gavioli, G., 2011:
PDM-16QAM transmission performance over uncompensated fiber links

Bertran-Pardo, O.; Renaudier, Jérémie.; Charlet, G.; Salsi, M.; Bertolini, M.; Mardoyan, Hïk.; Tran, P.; Koebele, C.; Bigo, Sébastien., 2010:
PDM-QPSK: on the system benefits arising from temporally interleaving polarization tributaries at 100Gb/s

Serena, P.; Rossi, N.; Bononi, A., 2012:
PDM-iRZ-QPSK vs. PS-QPSK at 100 Gbit/s over dispersion-managed links

Majewski, A.P.; Stahlschmidt, U.; Jérôme, Vérie.; Freitag, R.; Müller, A.H.E.; Schmalz, H., 2014:
PDMAEMA-grafted core-shell-corona particles for nonviral gene delivery and magnetic cell separation

Kuncová-Kallio, J.; Kallio, P.J., 2007:
PDMS and its suitability for analytical microfluidic devices

Li, G.; Parmar, M.; Kim, D.; Lee, J-Bong.J.B.; Lee, D-Weon., 2013:
PDMS based coplanar microfluidic channels for the surface reduction of oxidized Galinstan

Ibarlucea, B.; Díez-Gil, César.; Ratera, I.; Veciana, J.; Caballero, A.; Zapata, F.; Tárraga, A.; Molina, P.; Demming, S.; Büttgenbach, S.; Fernández-Sánchez, César.; Llobera, A., 2013:
PDMS based photonic lab-on-a-chip for the selective optical detection of heavy metal ions

Kim, M.; Song, K.Hoon.; Doh, J., 2014:
PDMS bonding to a bio-friendly photoresist via self-polymerized poly(dopamine) adhesive for complex protein micropatterning inside microfluidic channels

Kotz, K.; Cheng, X.; Toner, M., 2008:
PDMS device fabrication and surface modification

Mahadevan, G.; Sheardown, H.; Selvaganapathy, P., 2013:
PDMS embedded microneedles as a controlled release system for the eye

Suter, J.D.; Sun, Y.; Howard, D.J.; Viator, J.A.; Fan, X., 2008:
PDMS embedded opto-fluidic microring resonator lasers

da Silva, D.S.; Brenner, C.G.B.; Mayer, F.M.; Montipó, S.; Martins, A.F., 2013:
PDMS extraction bars for the determination of volatile aromatic hydrocarbons in water and wastewater

Köhler, S.; Weilbeer, C.; Howitz, S.; Becker, H.; Beushausen, V.; Belder, D., 2010:
PDMS free-flow electrophoresis chips with integrated partitioning bars for bubble segregation

Comina, Gán.; Suska, A.; Filippini, D., 2013:
PDMS lab-on-a-chip fabrication using 3D printed templates

Jiang, S.; Bae, S.Chul.; Granick, S., 2007:
PDMS melts on mica studied by confocal Raman scattering

Pla-Roca, M.; Juncker, D., 2011:
PDMS microfluidic capillary systems for patterning proteins on surfaces and performing miniaturized immunoassays

Yi, P.; Awang, R.A.; Rowe, W.S.T.; Kalantar-zadeh, K.; Khoshmanesh, K., 2014:
PDMS nanocomposites for heat transfer enhancement in microfluidic platforms

Hu, Y.; Ge, J.; Yin, Y., 2009:
PDMS rubber as a single-source precursor for templated growth of silica nanotubes

Zbik, M.S.; Frost, R.L., 2010:
PDMS spreading morphological patterns on substrates of different hydrophilicity in air vacuum and water

Bailey, B.M.; Fei, R.; Munoz-Pinto, D.; Hahn, M.S.; Grunlan, M.A., 2013:
PDMS(star)-PEG hydrogels prepared via solvent-induced phase separation (SIPS) and their potential utility as tissue engineering scaffolds

Guo, L.; Deweerth, S.P., 2010:
PDMS-based conformable microelectrode arrays with selectable novel 3-D microelectrode geometries for surface stimulation and recording

Xu, Q.; Bi, L.; Zheng, H.; Fan, D.; Wang, W., 2012:
PDMS-based gold electrode for sensing ascorbic acid

Fernández, M.R.; Casabona, M.G.; Anupama, V.N.; Krishnakumar, B.; Curutchet, G.A.; Bernik, D.L., 2011:
PDMS-based porous particles as support beds for cell immobilization: bacterial biofilm formation as a function of porosity and polymer composition

Ko, Y.Hwan.; Nagaraju, G.; Lee, S.Hyun.; Yu, J.Su., 2014:
PDMS-based triboelectric and transparent nanogenerators with ZnO nanorod arrays

Guo, J.; Li, C.Ming.; Kang, Y., 2015:
PDMS-film coated on PCB for AC impedance sensing of biological cells

Beh, C.Weijie.; Zhou, W.; Wang, T-Huei., 2013:
PDMS-glass bonding using grafted polymeric adhesive--alternative process flow for compatibility with patterned biological molecules

SadAbadi, H.; Badilescu, S.; Packirisamy, M.; Wüthrich, R., 2012:
PDMS-gold nanocomposite platforms with enhanced sensing properties

Francioso, L.; De Pascali, C.; Bartali, R.; Morganti, E.; Lorenzelli, L.; Siciliano, P.; Laidani, N., 2013:
PDMS/Kapton interface plasma treatment effects on the polymeric package for a wearable thermoelectric generator

Pompon, D.; Laisné, A., 2007:
PDNA as building blocks for membrane-guided self-assemblies

Anonymous, 2008:
PDP drug costs are higher than employer plans

Anonymous, 2008:
PDP drug restrictions block comparison shopping

Cline, R.R.; Worley, M.M.; Schondelmeyer, S.W.; Schommer, J.C.; Larson, T.A.; Uden, D.L.; Hadsall, R.S., 2010:
PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25

Narasimhan, S.Devi.; Yen, K.; Bansal, A.; Kwon, E-Soo.; Padmanabhan, S.; Tissenbaum, H.A., 2011:
PDP-1 links the TGF-β and IIS pathways to regulate longevity, development, and metabolism

Li, Z.; Jiang, J.; Chen, Y.; You, L.; Huang, Y.; Tan, A.; Li, Z.; Jiang, J.; Niu, B.; Meng, Z., 2014:
PDP1 regulates energy metabolism through the IIS-TOR pathway in the red flour beetle, Tribolium castaneum

Anonymous, 2009:
PDPs see increases in cost-sharing amounts

Jiménez, A.R.; Seco, F.; Zampella, F.; Prieto, Jé.C.; Guevara, J., 2012:
PDR with a foot-mounted IMU and ramp detection

Kang, J.; Hwang, J-Ung.; Lee, M.; Kim, Y-Young.; Assmann, S.M.; Martinoia, E.; Lee, Y., 2010:
PDR-type ABC transporter mediates cellular uptake of the phytohormone abscisic acid

Jiang, L.; Luo, X.; Shi, J.; Sun, H.; Sun, Q.; Sheikh, M.Saeed.; Huang, Y., 2011:
PDRG1, a novel tumor marker for multiple malignancies that is selectively regulated by genotoxic stress

Foudree, A.; Aluru, M.; Rodermel, S., 2011:
PDS activity acts as a rheostat of retrograde signaling during early chloroplast biogenesis

Put, N.; Van Roosbroeck, K.; Vande Broek, I.; Michaux, L.; Vandenberghe, P., 2012:
PDS5A, a novel translocation partner of MLL in acute myeloid leukemia

Anonymous, 2011:
PDSA assesses 'the true state of our pet nation'

Anonymous, 2014:
PDSA presents posthumous gold medal to New Zealand police dog

Hooker, R., 2014:
PDSA to expand its charitable objects

Pan, H.; Ma, X.; Chen, J.; Jiang, H., 2009:
PDT combined with Intravesical BCG instillation would form an autovaccine for bladder cancer?

Rizvi, I.; Anbil, S.; Alagic, N.; Celli, J.; Celli, J.P.; Zheng, L.Zak.; Palanisami, A.; Glidden, M.D.; Pogue, B.W.; Hasan, T., 2014:
PDT dose parameters impact tumoricidal durability and cell death pathways in a 3D ovarian cancer model

Bagnato, V.S.; Kurachi, C.; Ferreira, J.; Marcassa, L.G.; Sibata, C.H.; Allison, R.R., 2005:
PDT experience in Brazil: A regional profile

Patrice, T.; Olivier, D.; Krika, Y.; Bourre, L., 2005:
PDT for Barrett's esophagus: Status and unsolved problems

Allison, R.R.; Sibata, C.; Gay, H., 2009:
PDT for cancers of the head and neck

Allison, R.R., 2009:
PDT frontiers

Moghissi, K., 2010:
PDT in Laser Europe 2010 (6-8th May 2010)

Moghissi, K., 2009:
PDT in Laser Florence 2007

Freitag, L., 2007:
PDT in early central lung cancer

Noro Filho, G.A.; Casarin, R.C.V.; Casati, Márcio.Z.; Giovani, E.M., 2012:
PDT in non-surgical treatment of periodontitis in HIV patients: a split-mouth, randomized clinical trial

Zwiebel, S.; Baron, E., 2012:
PDT in squamous cell carcinoma of the skin

Basset-Seguin, N., 2014:
PDT panoramic view. Principle, photosensitizers, light sources and validated indications in dermatology

Rück, A.; Böhmler, A.; Steiner, R., 2005:
PDT with TOOKAD(®) studied in the chorioallantoic membrane of fertilized eggs

Linch, M.; Hayes, A.J., 2015:
PDT with a glucose-conjugated chlorin for GIST--letter

Kataoka, H.; Tanaka, M., 2015:
PDT with a glucose-conjugated chlorin for GIST--response

Wu, Y.; Li, Z.; Ma, W.; Huang, Y.; Huo, L.; Guo, X.; Zhang, M.; Ade, H.; Hou, J., 2013:
PDT-S-T: a new polymer with optimized molecular conformation for controlled aggregation and π-π stacking and its application in efficient photovoltaic devices

Demyanenko, S.V.; Uzdensky, A.B.; Sharifulina, S.A.; Lapteva, T.O.; Polyakova, L.P., 2014:
PDT-induced epigenetic changes in the mouse cerebral cortex: a protein microarray study

Firczuk, Młgorzata.; Nowis, D.; Gołąb, J., 2011:
PDT-induced inflammatory and host responses

Moghissi, K., 2007:
PDT: The plight

Nuutinen, U.; Simelius, N.; Ropponen, A.; Eeva, J.; Mättö, M.; Eray, M.; Pellinen, R.; Wahlfors, J.; Pelkonen, J., 2008:
PDTC enables type I TRAIL signaling in type II follicular lymphoma cells

Carroll, J., 2007:
PDUFA Faces Rough Reauthorization

Hennessy, S.; Strom, B.L., 2007:
PDUFA reauthorization--drug safety's golden moment of opportunity?

Liu, S.; Ballian, N.; Belaguli, N.S.; Patel, S.; Li, M.; Templeton, N.Smyth.; Gingras, M-Claude.; Gibbs, R.; Fisher, W.; Brunicardi, F.Charles., 2008:
PDX-1 acts as a potential molecular target for treatment of human pancreatic cancer

Kaneto, H.; Miyatsuka, T.; Kawamori, D.; Yamamoto, K.; Kato, K.; Shiraiwa, T.; Katakami, N.; Yamasaki, Y.; Matsuhisa, M.; Matsuoka, T-Aki., 2007:
PDX-1 and MafA play a crucial role in pancreatic beta-cell differentiation and maintenance of mature beta-cell function

Liu, T.; Wang, C-You.; Gou, S-Miao.; Wu, H-Shui.; Xiong, J-Xin.; Zhou, J., 2007:
PDX-1 expression and proliferation of duct epithelial cells after partial pancreatectomy in rats

Wang, H-lan.; Pan, M-xin.; Zhang, H-ying.; An, J.; Gao, Y., 2007:
PDX-1 gene transfection and expression in bone marrow stromal cells-derived nestin-positive cells

Burkhardt, B.R.; Cook, J.R.; Young, R.A.; Wolf, B.A., 2008:
PDX-1 interaction and regulation of the Pancreatic Derived Factor (PANDER, FAM3B) promoter

Liu, S-He.; Rao, D.D.; Nemunaitis, J.; Senzer, N.; Zhou, G.; Dawson, D.; Gingras, M-Claude.; Wang, Z.; Gibbs, R.; Norman, M.; Templeton, N.S.; Demayo, F.J.; O'Malley, B.; Sanchez, R.; Fisher, W.E.; Brunicardi, F.Charles., 2013:
PDX-1 is a therapeutic target for pancreatic cancer, insulinoma and islet neoplasia using a novel RNA interference platform

Guo, X.Rong.; Wang, X.Li.; Li, M.Chol.; Yuan, Y.Hong.; Chen, Y.; Zou, D.Dan.; Bian, L.Jiao.; Li, D.Sheng., 2016:
PDX-1 mRNA-induced reprogramming of mouse pancreas-derived mesenchymal stem cells into insulin-producing cells in vitro

Chan, E.S.; Alexander, J.; Swanson, P.E.; Jain, D.; Yeh, M.M., 2012:
PDX-1, CDX-2, TTF-1, and CK7: a reliable immunohistochemical panel for pancreatic neuroendocrine neoplasms

Marzioni, M.; Saccomanno, S.; Agostinelli, L.; Rychlicki, C.; De Minicis, S.; Pierantonelli, I.; Trauner, M.; Fickert, P.; Müller, T.; Shanmukhappa, K.; Trozzi, L.; Candelaresi, C.; Baroni, G.Svegliati.; Benedetti, A., 2014:
PDX-1/Hes-1 interactions determine cholangiocyte proliferative response to injury in rodents: possible implications for sclerosing cholangitis

Liu, S-He.; Patel, S.; Gingras, M-Claude.; Nemunaitis, J.; Zhou, G.; Chen, C.; Li, M.; Fisher, W.; Gibbs, R.; Brunicardi, F.Charles., 2011:
PDX-1: demonstration of oncogenic properties in pancreatic cancer

Gauthier, B.R.; Wiederkehr, A.; Baquié, M.; Dai, C.; Powers, A.C.; Kerr-Conte, J.; Pattou, Fçois.; MacDonald, R.J.; Ferrer, J.; Wollheim, C.B., 2009:
PDX1 deficiency causes mitochondrial dysfunction and defective insulin secretion through TFAM suppression

Guo, L.; Inada, A.; Aguayo-Mazzucato, C.; Hollister-Lock, J.; Fujitani, Y.; Weir, G.C.; Wright, C.V.E.; Sharma, A.; Bonner-Weir, S., 2013:
PDX1 in ducts is not required for postnatal formation of β-cells but is necessary for their subsequent maturation

Limbert, C.; Päth, Günter.; Ebert, R.; Rothhammer, V.; Kassem, M.; Jakob, F.; Seufert, J., 2012:
PDX1- and NGN3-mediated in vitro reprogramming of human bone marrow-derived mesenchymal stromal cells into pancreatic endocrine lineages

Preuss, U.W.; Winham, S.J.; Biernacka, J.M.; Geske, J.R.; Bakalkin, G.; Koller, G.; Zill, P.; Soyka, M.; Karpyak, V.M., 2014:
PDYN rs2281285 variant association with drinking to avoid emotional or somatic discomfort

Henriksson, R.; Bäckman, C.M.; Harvey, B.K.; Kadyrova, H.; Bazov, I.; Shippenberg, T.S.; Bakalkin, G., 2015:
PDYN, a gene implicated in brain/mental disorders, is targeted by REST in the adult human brain

Sugiura, T.; Shimizu, T.; Kijima, A.; Minakata, S.; Kato, Y., 2011:
PDZ adaptors: their regulation of epithelial transporters and involvement in human diseases

Walkup, W.G.; Kennedy, M.B., 2014:
PDZ affinity chromatography: a general method for affinity purification of proteins based on PDZ domains and their ligands

He, Y.; Liwo, A.; Weinstein, H.; Scheraga, H.A., 2011:
PDZ binding to the BAR domain of PICK1 is elucidated by coarse-grained molecular dynamics

Mendes, K.; Kodadek, T., 2011:
PDZ dimerization brings proteins together

Śmietana, K.; Mateja, A.; Krężel, A.; Otlewski, J., 2011:
PDZ domain from Dishevelled -- a specificity study

Gardiner, J.; Overall, R.; Marc, J., 2012 :
PDZ domain proteins: 'dark matter' of the plant proteome?

Shy, D.; Gillet, L.; Ogrodnik, J.; Albesa, M.; Verkerk, A.O.; Wolswinkel, R.; Rougier, J-Sébastien.; Barc, J.; Essers, M.C.; Syam, N.; Marsman, R.F.; van Mil, A.M.; Rotman, S.; Redon, R.; Bezzina, C.R.; Remme, C.Ann.; Abriel, H., 2014:
PDZ domain-binding motif regulates cardiomyocyte compartment-specific NaV1.5 channel expression and function

Kim, J.Kuk.; Kwon, O.; Kim, J.; Kim, E-Kyun.; Park, H.Kyung.; Lee, J.Eun.; Kim, K.Lock.; Choi, J.Woong.; Lim, S.; Seok, H.; Lee-Kwon, W.; Choi, J.Hyun.; Kang, B.Heon.; Kim, S.; Ryu, S.Ho.; Suh, P-Ghill., 2012:
PDZ domain-containing 1 (PDZK1) protein regulates phospholipase C-β3 (PLC-β3)-specific activation of somatostatin by forming a ternary complex with PLC-β3 and somatostatin receptors

Møller, T.C.; Wirth, V.F.; Roberts, N.I.; Bender, J.; Bach, A.; Jacky, B.P.S.; Strømgaard, K.; Deussing, J.M.; Schwartz, T.W.; Martinez, K.L., 2014:
PDZ domain-mediated interactions of G protein-coupled receptors with postsynaptic density protein 95: quantitative characterization of interactions

Khan, Z.; Lafon, M., 2015:
PDZ domain-mediated protein interactions: therapeutic targets in neurological disorders

Lee, H-Jin.; Zheng, J.J., 2010:
PDZ domains and their binding partners: structure, specificity, and modification

Nagasaka, K.; Kawana, K.; Osuga, Y.; Fujii, T., 2014:
PDZ domains and viral infection: versatile potentials of HPV-PDZ interactions in relation to malignancy

Tao, Y-Xiang.; Johns, R.A., 2008:
PDZ domains at excitatory synapses: potential molecular targets for persistent pain treatment

Subbaiah, V.Krishna.; Kranjec, C.; Thomas, M.; Banks, L., 2011:
PDZ domains: the building blocks regulating tumorigenesis

Garbett, D.; Bretscher, A., 2012:
PDZ interactions regulate rapid turnover of the scaffolding protein EBP50 in microvilli

Xue, L.; Zhang, F.; Chen, X.; Lin, J.; Shi, J., 2010:
PDZ protein mediated activity-dependent LTP/LTD developmental switch at rat retinocollicular synapses

Mikelis, C.M.; Palmby, T.R.; Simaan, M.; Li, W.; Szabo, R.; Lyons, R.; Martin, D.; Yagi, H.; Fukuhara, S.; Chikumi, H.; Galisteo, R.; Mukouyama, Y-Suke.; Bugge, T.H.; Gutkind, J.Silvio., 2013:
PDZ-RhoGEF and LARG are essential for embryonic development and provide a link between thrombin and LPA receptors and Rho activation

Struckhoff, A.P.; Rana, M.K.; Kher, S.S.; Burow, M.E.; Hagan, J.L.; Del Valle, L.; Worthylake, R.A., 2014:
PDZ-RhoGEF is essential for CXCR4-driven breast tumor cell motility through spatial regulation of RhoA

Lin, M-Yao.; Lin, Y-Min.; Kao, T-chan.; Chuang, H-Hao.; Chen, R-Hwa., 2011:
PDZ-RhoGEF ubiquitination by Cullin3-KLHL20 controls neurotrophin-induced neurite outgrowth

Gee, H.Yung.; Park, H.Woo.; Kim, K.Hwan.; Lee, M.Goo., 2010:
PDZ-based adaptor proteins in epithelial anion transport and VIP receptor regulation

Gardiol, D., 2012:
PDZ-containing proteins as targets in human pathologies

Leung, K.Keung.; Suen, P.Man.; Lau, T.Kin.; Ko, W.Hung.; Yao, K.Ming.; Leung, P.Sing., 2008:
PDZ-domain containing-2 (PDZD2) drives the maturity of human fetal pancreatic progenitor-derived islet-like cell clusters with functional responsiveness against membrane depolarization

Stenzel, N.; Fetzer, C.P.; Heumann, R.; Erdmann, K.S., 2009:
PDZ-domain-directed basolateral targeting of the peripheral membrane protein FRMPD2 in epithelial cells

Mo, J.; Choi, S.; Ahn, P.Gi.; Sun, W.; Lee, H.Woo.; Kim, H., 2012:
PDZ-scaffold protein, Tamalin promotes dendritic outgrowth and arborization in rat hippocampal neuron

Ebermann, I.; Phillips, J.B.; Liebau, M.C.; Koenekoop, R.K.; Schermer, B.; Lopez, I.; Schäfer, E.; Roux, A-Francoise.; Dafinger, C.; Bernd, A.; Zrenner, E.; Claustres, M.; Blanco, B.; Nürnberg, G.; Nürnberg, P.; Ruland, R.; Westerfield, M.; Benzing, T.; Bolz, H.J., 2010:
PDZD7 is a modifier of retinal disease and a contributor to digenic Usher syndrome

Henning, M.S.; Morham, S.G.; Goff, S.P.; Naghavi, M.H., 2010:
PDZD8 is a novel Gag-interacting factor that promotes retroviral infection

Henning, M.S.; Stiedl, P.; Barry, D.S.; McMahon, R.; Morham, S.G.; Walsh, D.; Naghavi, M.H., 2011:
PDZD8 is a novel moesin-interacting cytoskeletal regulatory protein that suppresses infection by herpes simplex virus type 1

Zheng, J.; Chan, T.; Cheung, F.Shin.Gee.; Zhu, L.; Murray, M.; Zhou, F., 2015:
PDZK1 and NHERF1 regulate the function of human organic anion transporting polypeptide 1A2 (OATP1A2) by modulating its subcellular trafficking and stability

Choi, J.H.; Murray, J.W.; Wolkoff, A.W., 2011:
PDZK1 binding and serine phosphorylation regulate subcellular trafficking of organic anion transport protein 1a1

Kim, H.; Abd Elmageed, Z.Y.; Ju, J.; Naura, A.S.; Abdel-Mageed, A.B.; Varughese, S.; Paul, D.; Alahari, S.; Catling, A.; Kim, J.G.; Boulares, A.Hamid., 2013:
PDZK1 is a novel factor in breast cancer that is indirectly regulated by estrogen through IGF-1R and promotes estrogen-mediated growth

Sugiura, T.; Otake, T.; Shimizu, T.; Wakayama, T.; Silver, D.L.; Utsumi, R.; Nishimura, T.; Iseki, S.; Nakamichi, N.; Kubo, Y.; Tsuji, A.; Kato, Y., 2011:
PDZK1 regulates organic anion transporting polypeptide Oatp1a in mouse small intestine

Honda, T.; Yamamoto, H.; Ishii, A.; Inui, M., 2011:
PDZRN3 negatively regulates BMP-2-induced osteoblast differentiation through inhibition of Wnt signaling

Thomas, M.; Banks, L., 2015:
PDZRN3/LNX3 is a novel target of human papillomavirus type 16 (HPV-16) and HPV-18 E6

Yang, J.Ok.; Kim, W-Yeon.; Jeong, S-Young.; Oh, J-Hwa.; Jho, S.; Bhak, J.; Kim, N-Soon., 2010:
PDbase: a database of Parkinson's disease-related genes and genetic variation using substantia nigra ESTs

Yu, J.; Li, X.; Wang, Y.; Li, B.; Li, H.; Li, Y.; Zhou, W.; Zhang, C.; Wang, Y.; Rao, Z.; Bartlam, M.; Cao, Y., 2011:
PDlim2 selectively interacts with the PDZ binding motif of highly pathogenic avian H5N1 influenza A virus NS1

Argani, H.; Ossareh, S.; Tabiban, S.; Ganji, M.Reza.; Nafar, M.; Abdi, E.; Alipour Abedi, B., 2009:
PDpoietin in comparison with Eprex in treatment of anemic patients on hemodialysis

Bateman, C., 2012:
PE eye department carves up cataract surgery record book

Tischler, A.; McCaughtry, N., 2011:
PE is not for me: when boys' masculinities are threatened

Susman, J.L., 2009:
PE recognized too late

Toprak, C.; Avci, A.; Ozturkeri, B.; Tabakci, M.Mustafa.; Kahveci, G., 2015:
PE with ST-segment elevation in leads V1-3 and AVR treated successfully by catheter directed high-dose bolus thrombolytic therapy during CPR

Lorenz, K.; Troger, J.; Gramlich, O.; Grus, F.; Hattmannstorfer, R.; Fischer-Colbrie, R.; Joachim, S.; Schmid, E.; Teuchner, B.; Haas, G.; Bechrakis, N., 2011:
PE-11, a peptide derived from chromogranin B, in the rat eye

Ariyaratne, P.Nuwantha.; Sung, W-Kin., 2011:
PE-Assembler: de novo assembler using short paired-end reads

Liu, C-Chuan.; Lo, S-Chung.Ben.; Freedman, M.T.; Lasser, M.E.; Kula, J.; Sarcone, A.; Wang, Y., 2010:
PE-CMOS based C-scan ultrasound for foreign object detection in soft tissue

Park, C.Gyu.; Rodriguez, A.; Steinman, R.M., 2012:
PE-Cy5.5 conjugates bind to the cells expressing mouse DEC205/CD205

Martin, M.W.; Martin, S.; Rosengard, P., 2010:
PE2GO: program evaluation of a physical activity program in elementary schools

Gao, J.; Kou, G.; Wang, H.; Chen, H.; Li, B.; Lu, Y.; Zhang, D.; Wang, S.; Hou, S.; Qian, W.; Dai, J.; Zhao, J.; Zhong, Y.; Guo, Y., 2008:
PE38KDEL-loaded anti-HER2 nanoparticles inhibit breast tumor progression with reduced toxicity and immunogenicity

Bartholomeusz, C.; Rosen, D.; Wei, C.; Kazansky, A.; Yamasaki, F.; Takahashi, T.; Itamochi, H.; Kondo, S.; Liu, J.; Ueno, N.T., 2008:
PEA-15 induces autophagy in human ovarian cancer cells and is associated with prolonged overall survival

Bartholomeusz, C.; Gonzalez-Angulo, A.M.; Kazansky, A.; Krishnamurthy, S.; Liu, P.; Yuan, L.X.H.; Yamasaki, F.; Liu, S.; Hayashi, N.; Zhang, D.; Esteva, F.J.; Hortobagyi, G.N.; Ueno, N.T., 2010:
PEA-15 inhibits tumorigenesis in an MDA-MB-468 triple-negative breast cancer xenograft model through increased cytoplasmic localization of activated extracellular signal-regulated kinase

Nagarajan, A.; Dogra, S.Kumar.; Liu, A.Y.; Green, M.R.; Wajapeyee, N., 2014:
PEA15 regulates the DNA damage-induced cell cycle checkpoint and oncogene-directed transformation

Lichtenberg, M.; Kolks, O.; Hailer, B.; Stahlhoff, W-Friedrich.; Tiefenbacher, C.; Nolte-Ernsting, C.; Arjumand, J.; Wittenberg, G., 2015:
PEACE I all-comers registry: patency evaluation after implantation of the 4-French Pulsar-18 self-expanding nitinol stent in femoropopliteal lesions

Rao, D.M.; Moler, J.C.; Ozden, M.; Zhang, Y.; Liang, C.; Karro, J.E., 2010:
PEACE: Parallel Environment for Assembly and Clustering of Gene Expression

Luo, J.; Fang, D.; Qiu, W.; Xiao, B.; Fan, Y.; Ye, J.; Han, L.; Zhang, H.; Yu, Y.; Liang, L.; Gu, X., 2018:
Clinical phenotypes and genetic study of 2 cases with 22q13 deletion syndrome

Anonymous, 1946:
PEAK YEAR for marriages, 1946

Kelber, J.A.; Klemke, R.L., 2011:
PEAK1, a novel kinase target in the fight against cancer

Schwartzberg, L.S.; Rivera, F.; Karthaus, M.; Fasola, G.; Canon, J-Luc.; Hecht, J.Randolph.; Yu, H.; Oliner, K.S.; Go, W.Y., 2014:
PEAK: a randomized, multicenter phase II study of panitumumab plus modified fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) or bevacizumab plus mFOLFOX6 in patients with previously untreated, unresectable, wild-type KRAS exon 2 metastatic colorectal cancer

Zhang, J.; Xin, L.; Shan, B.; Chen, W.; Xie, M.; Yuen, D.; Zhang, W.; Zhang, Z.; Lajoie, G.A.; Ma, B., 2012:
PEAKS DB: de novo sequencing assisted database search for sensitive and accurate peptide identification

Sinyavsky, N.; Dolinenkov, P.; Maćkowiak, M., 2012:
PEANUT experiment in NQR spectroscopy for I=3/2

Dossey, L., 2007:
PEAR lab and nonlocal mind: why they matter

Moore, R.C.; Harmell, A.L.; Chattillion, E.; Ancoli-Israel, S.; Grant, I.; Mausbach, B.T., 2014:
PEAR model and sleep outcomes in dementia caregivers: influence of activity restriction and pleasant events on sleep disturbances

Zhang, J.; Kobert, K.; Flouri, Táš.; Stamatakis, A., 2014:
PEAR: a fast and accurate Illumina Paired-End reAd mergeR

Buysse, J.M.; Huang, I-Zu.; Pitt, B., 2012:
PEARL-HF: prevention of hyperkalemia in patients with heart failure using a novel polymeric potassium binder, RLY5016

Ciechanowski, P.; Chaytor, N.; Miller, J.; Fraser, R.; Russo, J.; Unutzer, J.; Gilliam, F., 2011:
PEARLS depression treatment for individuals with epilepsy: a randomized controlled trial

McAvoy, B.R., 2013:
PEARLS: practical evidence about real life situations

Moreno, M.A.; Kota, R.; McIntosh, G.C.; Frohna, J.G., 2014:
PEARLs of Wisdom: Impact of a New Block Conference on Pediatrics Resident Attendance, Satisfaction, and Learning

Bliss-Holtz, J., 2008:
PEARS and RRTS: perfect together?

Xu, S.; Gupta, S.; Jin, L., 2011:
PEAS V1.0: a package for elementary analysis of SNP data

Xu, Y-Feng.; Yi, Y.; Qiu, S-Jian.; Gao, Q.; Li, Y-Wei.; Dai, C-Xin.; Cai, M-Yan.; Ju, M-Jie.; Zhou, J.; Zhang, B-Heng.; Fan, J., 2011:
PEBP1 downregulation is associated to poor prognosis in HCC related to hepatitis B infection

Wee, H-Jun.; Voon, D.Chih-Cheng.; Bae, S-Chul.; Ito, Y., 2008 :
PEBP2-beta/CBF-beta-dependent phosphorylation of RUNX1 and p300 by HIPK2: implications for leukemogenesis

Martin, D., 2007:
PEC proposals promise equality for clinicians and managers

Teo, G.; Vogel, C.; Ghosh, D.; Kim, S.; Choi, H., 2014:
PECA: a novel statistical tool for deconvoluting time-dependent gene expression regulation

Fang, F.; Zhang, W.; Yang, L.; Wang, Z.; Liu, D-ge., 2013:
PECAM-1 and E-selectin expression in vulnerable plague and their relationships to myocardial Leu125Val polymorphism of PECAM-1 and Ser128Arg polymorphism of E-selectin in patients with acute coronary syndrome

Noel, J.; Wang, H.; Hong, N.; Tao, J-Qin.; Yu, K.; Sorokina, E.M.; Debolt, K.; Heayn, M.; Rizzo, V.; Delisser, H.; Fisher, A.B.; Chatterjee, S., 2014:
PECAM-1 and caveolae form the mechanosensing complex necessary for NOX2 activation and angiogenic signaling with stopped flow in pulmonary endothelium

Jones, C.I.; Garner, S.F.; Moraes, L.A.; Kaiser, W.J.; Rankin, A.; Ouwehand, W.H.; Goodall, A.H.; Gibbins, J.M., 2010:
PECAM-1 expression and activity negatively regulate multiple platelet signaling pathways

Crockett, J.; Newman, D.K.; Newman, P.J., 2010:
PECAM-1 functions as a negative regulator of laminin-induced platelet activation

Pamuk, O.Nuri.; Tozkir, H.; Uyanik, M.Sevki.; Gurkan, H.; Saritas, F.; Duymaz, J.; Donmez, S.; Yazar, M.; Pamuk, G.Emel., 2015:
PECAM-1 gene polymorphisms and soluble PECAM-1 level in rheumatoid arthritis and systemic lupus erythematosus patients: any link with clinical atherosclerotic events?

Stevens, H.Y.; Melchior, Bît.; Bell, K.S.; Yun, S.; Yeh, J-Chern.; Frangos, J.A., 2008:
PECAM-1 is a critical mediator of atherosclerosis

Wu, N.; Kurosu, T.; Oshikawa, G.; Nagao, T.; Miura, O., 2014:
PECAM-1 is involved in BCR/ABL signaling and may downregulate imatinib-induced apoptosis of Philadelphia chromosome-positive leukemia cells

Tiwari, R.; Sullivan, J.; Czuprynski, C.J., 2009:
PECAM-1 is involved in neutrophil transmigration across Histophilus somni treated bovine brain endothelial cells

Chen, Z.; Tzima, E., 2009:
PECAM-1 is necessary for flow-induced vascular remodeling

Moriguchi, T.; Sumpio, B.E., 2015:
PECAM-1 phosphorylation and tissue factor expression in HUVECs exposed to uniform and disturbed pulsatile flow and chemical stimuli

Park, S.; DiMaio, T.A.; Scheef, E.A.; Sorenson, C.M.; Sheibani, N., 2011:
PECAM-1 regulates proangiogenic properties of endothelial cells through modulation of cell-cell and cell-matrix interactions

Saragih, H.; Zilian, E.; Jaimes, Yúa.; Paine, A.; Figueiredo, C.; Eiz-Vesper, B.; Blasczyk, R.; Larmann, J.; Theilmeier, G.; Burg-Roderfeld, M.; Andrei-Selmer, L-Cornelia.; Becker, J.Ulrich.; Santoso, S.; Immenschuh, S., 2015:
PECAM-1-dependent heme oxygenase-1 regulation via an Nrf2-mediated pathway in endothelial cells

Listì, F.; Caruso, C.; Balistreri, C.Rita.; Grimaldi, M.Paola.; Caruso, M.; Caimi, G.; Hoffmann, E.; Lio, D.; Candore, G., 2007:
PECAM-1/CD31 in infarction and longevity

Privratsky, J.R.; Newman, D.K.; Newman, P.J., 2010:
PECAM-1: conflicts of interest in inflammation

Privratsky, J.R.; Newman, P.J., 2015:
PECAM-1: regulator of endothelial junctional integrity

Seidman, M.A.; Chew, T.W.; Schenkel, A.R.; Muller, W.A., 2009:
PECAM-independent thioglycollate peritonitis is associated with a locus on murine chromosome 2

Shuvaev, V.V.; Han, J.; Yu, K.J.; Huang, S.; Hawkins, B.J.; Madesh, M.; Nakada, M.; Muzykantov, V.R., 2011:
PECAM-targeted delivery of SOD inhibits endothelial inflammatory response

Etich, J.; Bergmeier, V.; Frie, C.; Kreft, S.; Bengestrate, L.; Eming, S.; Mauch, C.; Eckes, B.; Ulus, H.; Lund, F.E.; Rappl, G.; Abken, H.; Paulsson, M.; Brachvogel, B., 2013:
PECAM1(+)/Sca1(+)/CD38(+) vascular cells transform into myofibroblast-like cells in skin wound repair

Lindberg, D.M.; Berger, R.P.; Lane, W.Gwirtzman., 2015:
PECARN abdominal injury rule should exclude potentially abused children

Zhang, K.; Xu, Y.; Chen, G., 2008:
PECB: prediction of enzyme catalytic residues based on Naive Bayes classification

Lindström, E.; Tuninger, E.; Levander, S., 2012:
PECC--factor structure and findings in three longitudinal cohorts of patients with schizophrenia

Anonymous, 1947:
PECKHAM health experiment starts again

Zhang, J.; Sun, P.; Zhao, X.; Ma, Z., 2015:
PECM: prediction of extracellular matrix proteins using the concept of Chou's pseudo amino acid composition

Tsai, E.A.; Berman, M.A.; Conlin, L.K.; Rehm, H.L.; Francey, L.J.; Deardorff, M.A.; Holst, J.; Kaur, M.; Gallant, E.; Clark, D.M.; Glessner, J.T.; Jensen, S.T.; Grant, S.F.A.; Gruber, P.J.; Hakonarson, H.; Spinner, N.B.; Krantz, I.D., 2014:
PECONPI: a novel software for uncovering pathogenic copy number variations in non-syndromic sensorineural hearing loss and other genetically heterogeneous disorders

Silva, E., 2010:
PECOS may cost you some pesos

Salazar, J.L., 2010:
PECSH/MNA win arbitration related to pension changes

Jiang, J.; Yao, L.; Yu, Y.; Lv, M.; Miao, Y.; Cao, J., 2015:
PECTATE LYASE-LIKE10 is associated with pollen wall development in Brassica campestris

Sharma, S.K.; Barthwal, S.; Singh, V.; Kumar, A.; Dwivedi, P.K.; Prasad, B.; Kumar, D., 2012:
PECVD based silicon oxynitride thin films for nano photonic on chip interconnects applications

Sen, S.; Senturk, E.; Kuman, N.Kanlioglu.; Pabuscu, E.; Kacar, F., 2010:
PEComa (clear cell "sugar" tumor) of the lung: a benign tumor that presented with thrombocytosis

Perrone, T., 2009:
PEComa Versus EGIST

Uddin, Z.; Qureshi, A.; Fatima, S.; Kayani, N., 2010:
PEComa in a 12-year-old boy

Bléchet, C.; Arbeille, B.; de Muret, A.; Berhouet, J.; Bonnard, C.; de Pinieux, G., 2008:
PEComa of soft tissue: report of an articular case

Guglielmetti, G.; De Angelis, P.; Mondino, P.; Terrone, C.; Volpe, A., 2014:
PEComa of soft tissues can mimic lymph node relapse in patients with history of testicular seminoma

Scheppach, W.; Reissmann, N.; Sprinz, T.; Schippers, E.; Schoettker, B.; Mueller, J.G., 2013:
PEComa of the colon resistant to sirolimus but responsive to doxorubicin/ifosfamide

Doyle, L.A.; Hornick, J.L.; Fletcher, C.D.M., 2014:
PEComa of the gastrointestinal tract: clinicopathologic study of 35 cases with evaluation of prognostic parameters

Vijayabhaskar, R.; Mehta, S.S.; Deodhar, K.K.; Pramesh, C.S.; Mistry, R.C., 2010:
PEComa of the lung

Bocciolini, C.; Fornelli, A.; Casadei, G.Piero.; Cattani, M.Grazia.; Dall'Olio, D., 2014:
PEComa of the nasal cavity with worrisome histologic features and benign behavior: a case report

Panelos, J.; Gallo, O.; Scala, I.; Franchi, A., 2009:
PEComa of the nasal septum

Afrogheh, A.; Schneider, J.; Bezuidenhout, A.Fourie.; Hille, J., 2014:
PEComa of the nose: report of a case with immunohistochemical and ultrustructural studies and a review of the literature

Shin, J-Shik.; Spillane, A.; Wills, E.; Cooper, W.A., 2007:
PEComa of the retroperitoneum

Shringarpure, S.S.; Thachil, J.V.; Maya, M., 2012:
PEComa of the urinary bladder

Sikora-Szcześniak, Dława.L., 2013:
PEComa of the uterus--a case report

Yamashita, K.; Fletcher, C.D.M., 2010:
PEComa presenting in bone: clinicopathologic analysis of 6 cases and literature review

Liu, J.; Fiel-Gan, M.; Mandavilli, S.; Vignati, P.; Ludwig, M., 2007:
PEComa, a not so rare tumor that can cause clinical and pathologic diagnostic confusion: a case report

Cuevas Herreros, Óscar.; Escobar Lezcano, L.; Rodriguez Blaco, M.; Artigas Raventós, V., 2017:
PEComa, a rare epithelioid cell tumor

Khaja, F.; Carilli, A.; Baidas, S.; Sriharan, A.; Norford, S., 2014:
PEComa: A Perivascular Epithelioid Cell Tumor in the Liver-A Case Report and Review of the Literature

Righi, A.; Dimosthenous, K.; Rosai, J., 2008:
PEComa: another member of the MiT tumor family?

Walsh, S.N.; Sangüeza, O.P., 2010:
PEComas: a review with emphasis on cutaneous lesions

Houlle, S.; Lemoine, F.; Francois, A.; Michot, C.; Sabourin, J-Christophe., 2011:
PEComas: report of five abdominopelvic cases

Sharma, S.; Kotru, M.; Gupta, R., 2009:
PEComata: highly melanotic multiple perivascular epithelioid cell tumors (PEComa) of the uterus

Fijten, M., 2008:
PED (permanent veterinary education) via the portal

Zanca, C.; Cozzolino, F.; Quintavalle, C.; Di Costanzo, S.; Ricci-Vitiani, L.; Santoriello, M.; Monti, M.; Pucci, P.; Condorelli, G., 2010:
PED interacts with Rac1 and regulates cell migration/invasion processes in human non-small cell lung cancer cells

Cima, G., 2015:
PED virus reinfecting U.S. herds. Virus estimated to have killed 7 million-plus pigs

Buonomo, R.; Giacco, F.; Vasaturo, A.; Caserta, S.; Guido, S.; Pagliara, V.; Garbi, C.; Mansueto, G.; Cassese, A.; Perruolo, G.; Oriente, F.; Miele, C.; Beguinot, F.; Formisano, P., 2012:
PED/PEA-15 controls fibroblast motility and wound closure by ERK1/2-dependent mechanisms

Formisano, P.; Ragno, P.; Pesapane, A.; Alfano, D.; Alberobello, A.Teresa.; Rea, V.Elena.Anna.; Giusto, R.; Rossi, F.W.; Beguinot, F.; Rossi, G.; Montuori, N., 2012:
PED/PEA-15 interacts with the 67 kD laminin receptor and regulates cell adhesion, migration, proliferation and apoptosis

Botta, G.; Perruolo, G.; Libertini, S.; Cassese, A.; Abagnale, A.; Beguinot, F.; Formisano, P.; Portella, G., 2010:
PED/PEA-15 modulates coxsackievirus-adenovirus receptor expression and adenoviral infectivity via ERK-mediated signals in glioma cells

Walter, M.C.; Rattei, T.; Arnold, R.; Güldener, U.; Münsterkötter, M.; Nenova, K.; Kastenmüller, G.; Tischler, P.; Wölling, A.; Volz, A.; Pongratz, N.; Jost, R.; Mewes, H-Werner.; Frishman, D., 2009:
PEDANT covers all complete RefSeq genomes

Fitchev, P.; Chung, C.; Plunkett, B.A.; Brendler, C.B.; Crawford, S.E., 2015:
PEDF & stem cells: niche vs. nurture

Minkevich, N.I.; Lipkin, V.M.; Kostanyan, I.A., 2010:
PEDF - A Noninhibitory Serpin with Neurotrophic Activity

Reinoso, M.A.; Mukherjee, P.; Marcheselli, V.; Bergsma, D.; Hesse, R.; Bazan, N., 2008:
PEDF Promotes Biosynthesis of a Novel Anti-inflammatory and Anti-apoptotic Mediator NPD1 in Retinal Pigment Epithelial Cells

Volpert, K.N.; Tombran-Tink, J.; Barnstable, C.; Layer, P.G., 2010:
PEDF and GDNF are key regulators of photoreceptor development and retinal neurogenesis in reaggregates from chick embryonic retina

Machalińska, A.; Safranow, K.; Mozolewska-Piotrowska, K.; Dziedziejko, V.; Karczewicz, D., 2013:
PEDF and VEGF plasma level alterations in patients with dry form of age-related degeneration--a possible link to the development of the disease

Falk, T.; Congrove, N.R.; Zhang, S.; McCourt, A.D.; Sherman, S.J.; McKay, B.S., 2012:
PEDF and VEGF-A output from human retinal pigment epithelial cells grown on novel microcarriers

Nakamura, T.; Yamagishi, S-I., 2010:
PEDF and septic shock

Murray, A.R.; Ma, J-xing., 2011:
PEDF as a treatment for cervical cancer

Dass, C.R.; Ek, E.T.H.; Choong, P.F.M., 2009:
PEDF as an emerging therapeutic candidate for osteosarcoma

Jeng, K-Shyang.; Sheen, I-Shyan.; Jeng, W-Juei.; Su, J-Chih., 2012:
PEDF effectively decreases VEGF to PEDF messenger RNA ratio of the inner edge of rat hepatocellular carcinoma induced by diethyl nitrosamine - an "in vivo" study

Zhou, Y.; Xu, F.; Deng, H.; Bi, Y.; Sun, W.; Zhao, Y.; Chen, Z.; Weng, J., 2014:
PEDF expression is inhibited by insulin treatment in adipose tissue via suppressing 11β-HSD1

Shin, E.Seok.; Sorenson, C.M.; Sheibani, N., 2014:
PEDF expression regulates the proangiogenic and proinflammatory phenotype of the lung endothelium

Sarojini, H.; Estrada, R.; Lu, H.; Dekova, S.; Lee, M-Jer.; Gray, R.D.; Wang, E., 2008:
PEDF from mouse mesenchymal stem cell secretome attracts fibroblasts

He, Y.; Leung, K.Wah.; Ren, Y.; Pei, J.; Ge, J.; Tombran-Tink, J., 2014:
PEDF improves mitochondrial function in RPE cells during oxidative stress

Tombran-Tink, J., 2010:
PEDF in angiogenic eye diseases

Zhu, X-feng.; Zou, H-dong., 2012:
PEDF in diabetic retinopathy: a protective effect of oxidative stress

Elayappan, B.; Ravinarayannan, H.; Pasha, S.Pran.Babu.Sardar.; Lee, K-jin.; Gurunathan, S., 2010:
PEDF inhibits VEGF- and EPO- induced angiogenesis in retinal endothelial cells through interruption of PI3K/Akt phosphorylation

Guo, T.; Gu, C.; Li, B., 2013:
PEDF inhibits growth and invasiveness of endometrial cancer cells in vitro

Yang, H.; Cheng, R.; Liu, G.; Zhong, Q.; Li, C.; Cai, W.; Yang, Z.; Ma, J.; Yang, X.; Gao, G., 2010:
PEDF inhibits growth of retinoblastoma by anti-angiogenic activity

Sohn, J.; Selvaraj, V.; Wakayama, K.; Orosco, L.; Lee, E.; Crawford, S.E.; Guo, F.; Lang, J.; Horiuchi, M.; Zarbalis, K.; Itoh, T.; Deng, W.; Pleasure, D., 2012:
PEDF is a novel oligodendrogenic morphogen acting on the adult SVZ and corpus callosum

Banumathi, E.; Sheikpranbabu, S.; Haribalaganesh, R.; Gurunathan, S., 2010:
PEDF prevents reactive oxygen species generation and retinal endothelial cell damage at high glucose levels

De Marzo, A.; Aruta, C.; Marigo, V., 2011:
PEDF promotes retinal neurosphere formation and expansion in vitro

Akiyama, T.; Dass, C.R.; Shinoda, Y.; Kawano, H.; Tanaka, S.; Choong, P.F.M., 2010:
PEDF regulates osteoclasts via osteoprotegerin and RANKL

Cai, J.; Wu, L.; Qi, X.; Li Calzi, S.; Caballero, S.; Shaw, L.; Ruan, Q.; Grant, M.B.; Boulton, M.E., 2011:
PEDF regulates vascular permeability by a γ-secretase-mediated pathway

Gaetano, C.; Colussi, C.; Capogrossi, M.C., 2007:
PEDF, PPAR-gamma, p53: deadly circuits arise when worlds collide

Huang, Q.; Wang, S.; Sorenson, C.M.; Sheibani, N., 2008:
PEDF-deficient mice exhibit an enhanced rate of retinal vascular expansion and are more sensitive to hyperoxia-mediated vessel obliteration

Swaiman, K.F., 2009:

Anonymous, 1949:
PEDIATRICS as a specialty

Frost, C.M.; Wei, B.; Baghmanli, Z.; Cederna, P.S.; Urbanchek, M.G., 2012:
PEDOT electrochemical polymerization improves electrode fidelity and sensitivity

Mathiyarasu, J.; Senthilkumar, S.; Phani, K.L.N.; Yegnaraman, V., 2007:
PEDOT-Au nanocomposite films for electrochemical sensing of dopamine and uric acid

Gerwig, R.; Fuchsberger, K.; Schroeppel, B.; Link, G.Steve.; Heusel, G.; Kraushaar, U.; Schuhmann, W.; Stett, A.; Stelzle, M., 2012:
PEDOT-CNT Composite Microelectrodes for Recording and Electrostimulation Applications: Fabrication, Morphology, and Electrical Properties

Castagnola, E.; Maiolo, L.; Maggiolini, E.; Minotti, A.; Marrani, M.; Maita, F.; Pecora, A.; Angotzi, G.Nicola.; Ansaldo, A.; Boffini, M.; Fadiga, L.; Fortunato, G.; Ricci, D., 2016:
PEDOT-CNT-Coated Low-Impedance, Ultra-Flexible, and Brain-Conformable Micro-ECoG Arrays

Trifigny, N.; Kelly, F.M.; Cochrane, Cédric.; Boussu, Fçois.; Koncar, V.; Soulat, D., 2014:
PEDOT:PSS-based piezo-resistive sensors applied to reinforcement glass fibres for in situ measurement during the composite material weaving process

Sices, L.; Stancin, T.; Kirchner, L.; Bauchner, H., 2009:
PEDS and ASQ developmental screening tests may not identify the same children

Brothers, K.B.; Glascoe, F.Page.; Robertshaw, N.S., 2007:
PEDS: developmental milestones--an accurate brief tool for surveillance and screening

Forrest, C.B.; Margolis, P.A.; Bailey, L.Charles.; Marsolo, K.; Del Beccaro, M.A.; Finkelstein, J.A.; Milov, D.E.; Vieland, V.J.; Wolf, B.A.; Yu, F.B.; Kahn, M.G., 2014:
PEDSnet: a National Pediatric Learning Health System

Forrest, C.B.; Margolis, P.; Seid, M.; Colletti, R.B., 2016:
PEDSnet: how a prototype pediatric learning health system is being expanded into a national network

Moseley, A.M.; Herbert, R.; Maher, C.G.; Sherrington, C.; Elkins, M.R., 2008:
PEDro scale can only rate what papers report

Bleakley, C.M., 2008:
PEDro scores were based on information in the paper

Michaleff, Z.A.; Kamper, S.J., 2014:
PEDro systematic review update: the effectiveness of physiotherapy exercises in subacromical impingement syndrome

da Costa, B.R.; Hilfiker, R.; Egger, M., 2013:
PEDro's bias: summary quality scores should not be used in meta-analysis

Giglia, E., 2008:
PEDro: this well-known, unknown. Physiotherapy Evidence Database

Xin, H.; Shepherd, D.; Dearn, K., 2012:
PEEK (Polyether-ether-ketone) Based Cervical Total Disc Arthroplasty: Contact Stress and Lubrication Analysis

Schimmel, J.J.P.; Poeschmann, M.S.; Horsting, P.P.; Schönfeld, D.H.W.; van Limbeek, J.; Pavlov, P.W., 2012:
PEEK Cages in Lumbar Fusion: Mid-term Clinical Outcome and Radiological Fusion

Pelletier, M.Henry.; Cordaro, N.; Punjabi, V.M.; Waites, M.; Lau, A.; Walsh, W.R., 2016:
PEEK Versus Ti Interbody Fusion Devices: Resultant Fusion, Bone Apposition, Initial and 26-Week Biomechanics

Mondorf, Y.; Gaab, M.R.; Oertel, J.M.K., 2010:
PEEK cage cervical ventral fusion in spondylodiscitis

Walter, J.; Kuhn, S.Antje.; Reichart, R.; Kalff, R.; Ewald, C., 2011:
PEEK cages as a potential alternative in the treatment of cervical spondylodiscitis: a preliminary report on a patient series

Klingler, J-Helge.; Krüger, M.T.; Sircar, R.; Kogias, E.; Scholz, C.; Volz, F.; Scheiwe, C.; Hubbe, U., 2015:
PEEK cages versus PMMA spacers in anterior cervical discectomy: comparison of fusion, subsidence, sagittal alignment, and clinical outcome with a minimum 1-year follow-up

Foletti, J-M.; Lari, N.; Dumas, P.; Compes, P.; Guyot, L., 2013:
PEEK customized implant for skull esthetic reconstruction

Schwitalla, A.; Müller, W-Dieter., 2014:
PEEK dental implants: a review of the literature

Mavrogenis, A.F.; Vottis, C.; Triantafyllopoulos, G.; Papagelopoulos, P.J.; Pneumaticos, S.G., 2015:
PEEK rod systems for the spine

Stawarczyk, B.; Jordan, P.; Schmidlin, P.R.; Roos, M.; Eichberger, M.; Gernet, W.; Keul, C., 2016:
PEEK surface treatment effects on tensile bond strength to veneering resins

Bernard, G.R., 2008:
PEEP guided by esophageal pressure--any added value?

Chen, G.; Ma, G-xuan., 2007:
PEEP in massive whole lung lavage

Gentile, M.A.; Knudsen, N.W., 2007:
PEEP in the morning, PEEP at night

Young, P.; Wyncoll, D., 2009:
PEEP is protective against pulmonary microaspiration

Vargas, M.; Sutherasan, Y.; Gregoretti, C.; Pelosi, P., 2014:
PEEP role in ICU and operating room: from pathophysiology to clinical practice

Zhao, Z.; Steinmann, D.; Frerichs, Iéz.; Guttmann, J.; Möller, K., 2010:
PEEP titration guided by ventilation homogeneity: a feasibility study using electrical impedance tomography

Keenan, J.C.; Dries, D.J., 2014:
PEEP titration: new horizons

Dellamonica, J.; Lerolle, N.; Sargentini, C.; Beduneau, G.; Di Marco, F.; Mercat, A.; Richard, J.C.M.; Diehl, J.L.; Mancebo, J.; Rouby, J.J.; Lu, Q.; Bernardin, G.; Brochard, L., 2012:
PEEP-induced changes in lung volume in acute respiratory distress syndrome. Two methods to estimate alveolar recruitment

West, J.C., 2014:
PEER REVIEW: statements made during peer review activity may not be defamatory. Davis v. Hildyard

Anonymous, 1946:
PEET-Grady method [insecticide testing

Moore, V.C.; Jaakkola, M.S.; Burge, C.B.S.G.; Pantin, C.F.; Robertson, A.S.; Vellore, A.Dev.; Burge, P.Sherwood., 2011:
PEF analysis requiring shorter records for occupational asthma diagnosis

Kolate, A.; Baradia, D.; Patil, S.; Vhora, I.; Kore, G.; Misra, A., 2015:
PEG - a versatile conjugating ligand for drugs and drug delivery systems

Craxì, A., 2009:
PEG IFN alfa-2a vs. alfa-2b: and the winner is ...?

Pawłowska, Młgorzata.; Halota, W., 2007:
PEG IFN alpha-2a in the treatment of chronic hepatitis C in patients with treatment failure

Rendenbach, U.; Kaulbach, T., 2007:
PEG also without consent of the patient? No, that is bodily injury!

Eze, N.; Jefford, J.M.; Wolf, D.; Williamson, P.; Neild, P., 2007:
PEG and RIG tube feeding in Head and Neck patients: a retrospective review of complications and outcome

Froehlich, E.; Mandeville, J.S.; Arnold, D.; Kreplak, L.; Tajmir-Riahi, H.A., 2011:
PEG and mPEG-anthracene induce DNA condensation and particle formation

Huang, Q.; Li, D.; Kang, A.; An, W.; Fan, B.; Ma, X.; Ma, G.; Su, Z.; Hu, T., 2014:
PEG as a spacer arm markedly increases the immunogenicity of meningococcal group Y polysaccharide conjugate vaccine

Zhang, W-Wen.; Meng, J-Xin.; Cao, L-Wei.; Liu, Y-Liang., 2008 :
PEG assisted hydrothermal synthesis of LaPO4 : Eu3+ nanoparticles

Hamamura, K.; Weng, Y.; Zhao, J.; Yokota, H.; Xie, D., 2008:
PEG attachment to osteoblasts enhances mechanosensitivity

Cao, H.; Dong, Y.; O'Rorke, S.; Wang, W.; Pandit, A., 2011:
PEG based hyperbranched polymeric hollow nanospheres

Prencipe, G.; Tabakman, S.M.; Welsher, K.; Liu, Z.; Goodwin, A.P.; Zhang, L.; Henry, J.; Dai, H., 2009:
PEG branched polymer for functionalization of nanomaterials with ultralong blood circulation

Füessl, H.S.; Stiefelhagen, P., 2013:
PEG catheter in patients with advanced dementia. How should I counsel family caregivers?

Issa, B.; Qadri, S.; Obaidat, I.M.; Bowtell, R.W.; Haik, Y., 2012:
PEG coating reduces NMR relaxivity of Mn(0.5)Zn(0.5)Gd(0.02)Fe(1.98)O4 hyperthermia nanoparticles

Qu, G.; Yao, Z.; Zhang, C.; Wu, X.; Ping, Q., 2009:
PEG conjugated N-octyl-O-sulfate chitosan micelles for delivery of paclitaxel: in vitro characterization and in vivo evaluation

Pasut, G.; Veronese, F.M., 2010:
PEG conjugates in clinical development or use as anticancer agents: an overview

Okuda, T.; Kobayashi, Y.; Yanamoto, S.; Okamoto, H., 2013:
PEG conjugation of a near-infrared fluorescent probe for noninvasive dual imaging of lung deposition and gene expression by pulmonary gene delivery

Snyder, M.A.; Ng, P.; Mekosh, H.; Gagnon, P., 2010:
PEG enhances viral clearance on ceramic hydroxyapatite

Leeds, J.S.; McAlindon, M.E.; Sanders, D.S., 2008:
PEG feeding and dementia-results need to be interpreted with caution. Is this the time for a randomized controlled study?

Haywood, S., 2012:
PEG feeding tube placement and aftercare

Lukovich, Péter.; Dudás, I.; Tari, K.; Jónás, A.; Herczeg, Görgy., 2013:
PEG fixation of an upside-down stomach using a flexible endoscope: case report and review of the literature

Reid, B.; Gibson, M.; Singh, A.; Taube, J.; Furlong, C.; Murcia, M.; Elisseeff, J., 2015:
PEG hydrogel degradation and the role of the surrounding tissue environment

Lin, C-Chi.; Anseth, K.S., 2009:
PEG hydrogels for the controlled release of biomolecules in regenerative medicine

Lin, C-Chi.; Raza, A.; Shih, H., 2012:
PEG hydrogels formed by thiol-ene photo-click chemistry and their effect on the formation and recovery of insulin-secreting cell spheroids

Yoshizawa, Y.; Kono, Y.; Ogawara, K-ichi.; Kimura, T.; Higaki, K., 2011:
PEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacy

Jadhav, S.Y.; Bhosale, R.B.; Shirame, S.P.; Patil, S.B.; Kulkarni, S.D., 2015:
PEG mediated synthesis and biological evaluation of asymmetrical pyrazole curcumin analogues as potential analgesic, anti-inflammatory and antioxidant agents

Jadhav, S.Y.; Shirame, S.P.; Kulkarni, S.D.; Patil, S.B.; Pasale, S.K.; Bhosale, R.B., 2013:
PEG mediated synthesis and pharmacological evaluation of some fluoro substituted pyrazoline derivatives as antiinflammatory and analgesic agents

Hu, W.; Metselaar, J.; Ben, L-Hong.; Cravens, P.D.; Singh, M.P.; Frohman, E.M.; Eagar, T.N.; Racke, M.K.; Kieseier, B.C.; Stüve, O., 2009:
PEG minocycline-liposomes ameliorate CNS autoimmune disease

Zeng, S.; Tsang, M-Kiu.; Chan, C-Fai.; Wong, K-Leung.; Hao, J., 2013:
PEG modified BaGdF₅:Yb/Er nanoprobes for multi-modal upconversion fluorescent, in vivo X-ray computed tomography and biomagnetic imaging

Fuhrmann, K.; Schulz, J.D.; Gauthier, M.A.; Leroux, J-Christophe., 2012:
PEG nanocages as non-sheddable stabilizers for drug nanocrystals

Fyock, C.J.; Kethu, S.R., 2008:
PEG placement causing liver perforation

Kelly, N., 2014:
PEG placement for patients with oropharyngeal/oeosphageal cancers

Brouette, N.; Sferrazza, M., 2013:
PEG polymer brushes via the Langmuir-Schaefer technique: the transfer ratio

Zhao, Y.; Kang, L.; Gao, S.; Gao, X.; Xin, W.; Wang, J., 2013:
PEG precipitation coupled with chromatography is a new and sufficient method for the purification of botulinum neurotoxin type B [corrected

Martins, B.Costa.; Takada, J.; Kawaguti, Fábio.Shiguehissa.; Ribeiro, Jão.Paulo.Aguiar.; Hondo, Fábio.Yuji.; de Lima, M.Simas.; Neves, C.Zanellatto.; Nahas, C.Sérgio.R.; Marques, C.Frederico.Sparapan.; Sakai, P.; Maluf-Filho, F., 2012:
PEG rescue with gastropexy after early tube withdrawal: an application of natural orifice transluminal endoscopic surgery (with video)

Jamous, M.; Tamma, M.L.; Gourni, E.; Waser, B.; Reubi, J.C.; Maecke, H.R.; Mansi, R., 2015:
PEG spacers of different length influence the biological profile of bombesin-based radiolabeled antagonists

Friginal-Ruiz, A.Belén.; Lucendo, A.J., 2012:
PEG tube feeding in dementia patients: beyond the evidence

Senadhi, V.; Emuron, D.; Singh, R.; Dutta, S., 2012:
PEG tube placement in morbidly obese patients

Marks, J.M.; Ponsky, J.L.; Pearl, J.P.; McGee, M.F., 2007:
PEG "Rescue": a practical NOTES technique

Wen, Y.; Pan, S.; Luo, X.; Zhang, W.; Shen, Y.; Feng, M., 2010:
PEG- and PDMAEG-graft-modified branched PEI as novel gene vector: synthesis, characterization and gene transfection

Tyagi, S.; Spörlein, B.; Tyagi, A.K.; Herrmann, R.G.; Koop, H.U., 1989:
PEG- and electroporation-induced transformation in Nicotiana tabacum: influence of genotype on transformation frequencies

Markova, A.A.; Mihm, U.; Schlaphoff, V.; Lunemann, S.; Filmann, N.; Bremer, B.; Berg, T.; Sarrazin, C.; Zeuzem, S.; Manns, M.P.; Cornberg, M.; Herrmann, E.; Wedemeyer, H., 2015:
PEG-IFN alpha but not ribavirin alters NK cell phenotype and function in patients with chronic hepatitis C

Morisco, F.; Amoruso, D.; Stroffolini, T.; Caporaso, N., 2008:
PEG-IFN and ribavirin re-treatment of HCV-1b cirrhosis non responder to conventional combination therapy

Highleyman, L., 2007:
PEG-IFN, RBV dosing during chronic HCV re-treatment

Ianotto, J-Christophe.; Kiladjian, J-Jacques.; Demory, J-Louis.; Roy, L.; Boyer, Fçoise.; Rey, Jôme.; Dupriez, B.; Berthou, C.; Abgrall, J-François., 2009:
PEG-IFN-alpha-2a therapy in patients with myelofibrosis: a study of the French Groupe d'Etudes des Myelofibroses (GEM) and France Intergroupe des syndromes Myéloprolifératifs (FIM)

Yada, N.; Kudo, M.; Chung, H.; Hayaishi, S.; Takita, M.; Ueda, T.; Tatsumi, C.; Hatanaka, K.; Kitai, S.; Ishikawa, E.; Inoue, T.; Hagiwara, S.; Ueshima, K., 2010:
PEG-IFNalpha/RBV combination therapy for chronic hepatitis C patients increases serum ferritin level while it improves sustained viral response rate

Khonkarn, R.; Mankhetkorn, S.; Hennink, W.E.; Okonogi, S., 2012:
PEG-OCL micelles for quercetin solubilization and inhibition of cancer cell growth

Yu, D.; Wang, A.; Huang, H.; Chen, Y., 2008:
PEG-PBLG nanoparticle-mediated HSV-TK/GCV gene therapy for oral squamous cell carcinoma

Wang, Y.; Chen, L.; Tan, L.; Zhao, Q.; Luo, F.; Wei, Y.; Qian, Z., 2015:
PEG-PCL based micelle hydrogels as oral docetaxel delivery systems for breast cancer therapy

Ge, X.; Zhang, Q.; Cai, Y.; Duan, S.; Chen, S.; Lv, N.; Jin, T.; Chen, Y.; Yuan, W., 2015:
PEG-PCL-DEX polymersome-protamine vector as an efficient gene delivery system via PEG-guided self-assembly

Ping, X.; Jiang, K.; Lee, S-Young.; Cheng, J-Xing.; Jin, X., 2015:
PEG-PDLLA micelle treatment improves axonal function of the corpus callosum following traumatic brain injury

Musacchio, T.; Laquintana, V.; Latrofa, A.; Trapani, G.; Torchilin, V.P., 2009:
PEG-PE micelles loaded with paclitaxel and surface-modified by a PBR-ligand: synergistic anticancer effect

Sarisozen, C.; Vural, I.; Levchenko, T.; Hincal, A.Atilla.; Torchilin, V.P., 2013:
PEG-PE-based micelles co-loaded with paclitaxel and cyclosporine A or loaded with paclitaxel and targeted by anticancer antibody overcome drug resistance in cancer cells

Lutz, G.J.; Sirsi, S.R.; Williams, J.H., 2008:
PEG-PEI copolymers for oligonucleotide delivery to cells and tissues

Pandian, S.Ram.Kumar.; Deepak, V.; Nellaiah, H.; Sundar, K., 2016:
PEG-PHB-glutaminase nanoparticle inhibits cancer cell proliferation in vitro through glutamine deprivation

Fustier, C.; Chang, T.M.S., 2013:
PEG-PLA Nanocapsules Containing a Nanobiotechnological Complex of Polyhemoglobin-Tyrosinase for the Depletion of Tyrosine in Melanoma: Preparation and In Vitro Characterisation

Li, Y.; Qi, X.Rong.; Maitani, Y.; Nagai, T., 2009:
PEG-PLA diblock copolymer micelle-like nanoparticles as all-trans-retinoic acid carrier: in vitro and in vivo characterizations

Rafat, M.; Cléroux, C.A.; Fong, W.Gin.; Baker, A.N.; Leonard, B.C.; O'Connor, M.D.; Tsilfidis, C., 2010:
PEG-PLA microparticles for encapsulation and delivery of Tat-EGFP to retinal cells

Gu, G.; Hu, Q.; Feng, X.; Gao, X.; Menglin, J.; Kang, T.; Jiang, D.; Song, Q.; Chen, H.; Chen, J., 2015:
PEG-PLA nanoparticles modified with APTEDB peptide for enhanced anti-angiogenic and anti-glioma therapy

Jain, A.K.; Goyal, A.K.; Mishra, N.; Vaidya, B.; Mangal, S.; Vyas, S.P., 2010:
PEG-PLA-PEG block copolymeric nanoparticles for oral immunization against hepatitis B

Patel, B.; Gupta, V.; Ahsan, F., 2013:
PEG-PLGA based large porous particles for pulmonary delivery of a highly soluble drug, low molecular weight heparin

Zhang, K.; Tang, X.; Zhang, J.; Lu, W.; Lin, X.; Zhang, Y.; Tian, B.; Yang, H.; He, H., 2014:
PEG-PLGA copolymers: their structure and structure-influenced drug delivery applications

Hiemstra, C.; Zhong, Z.Y.; Jiang, X.; Hennink, W.E.; Dijkstra, P.J.; Feijen, J., 2007:
PEG-PLLA and PEG-PDLA multiblock copolymers: synthesis and in situ hydrogel formation by stereocomplexation

Wang, F.; Phonthammachai, N.; Mya, K.Yi.; Tjiu, W.Weei.; He, C., 2010:
PEG-POSS assisted facile preparation of amphiphilic gold nanoparticles and interface formation of Janus nanoparticles

Zhang, Y.; Yin, Q.; Lu, H.; Xia, H.; Lin, Y.; Cheng, J., 2013:
PEG-Polypeptide Dual Brush Block Copolymers: Synthesis and Application in Nanoparticle Surface PEGylation

Reddy, C.Bhupendra.; Kumar, K.Suresh.; Kumar, M.Anil.; Narayana Reddy, M.Veera.; Krishna, B.Satheesh.; Naveen, M.; Arunasree, M.K.; Reddy, C.Suresh.; Raju, C.Naga.; Reddy, C.Devendranath., 2012:
PEG-SO(3)H catalyzed synthesis and cytotoxicity of α-aminophosphonates

Zacchigna, M.; Cateni, F.; Drioli, S.; Procida, G.; Altieri, T., 2014:
PEG-Ursolic Acid Conjugate: Synthesis and In Vitro Release Studies

Hightower, C.Makena.; Salazar Vázquez, B.Y.; Acharya, S.A.; Subramaniam, S.; Intaglietta, M., 2012:
PEG-albumin plasma expansion increases expression of MCP-1 evidencing increased circulatory wall shear stress: an experimental study

Tao, X.; Deng, C.; Ling, J., 2014:
PEG-amine-initiated polymerization of sarcosine N-thiocarboxyanhydrides toward novel double-hydrophilic PEG-b-polysarcosine diblock copolymers

Fu, C.H.; Sakamoto, K.M., 2007:

Henriksen, L.Tram.; Harila-Saari, A.; Ruud, E.; Abrahamsson, J.; Pruunsild, K.; Vaitkeviciene, G.; Jónsson, Ólafur.Gísli.; Schmiegelow, K.; Heyman, M.; Schrøder, H.; Albertsen, B.Klug., 2015:
PEG-asparaginase allergy in children with acute lymphoblastic leukemia in the NOPHO ALL2008 protocol

Umeda, Y.; Kojima, C.; Harada, A.; Horinaka, H.; Kono, K., 2011:
PEG-attached PAMAM dendrimers encapsulating gold nanoparticles: growing gold nanoparticles in the dendrimers for improvement of their photothermal properties

Pungkham, H.; Swatdipakdi, N.; Theerasilp, M.; Karnkla, S.; Chittchang, M.; Ploypradith, P.; Nasongkla, N., 2012:
PEG-b-PCL and PEG-b-PLA polymeric micelles as nanocarrieres for lamellarin N delivery

Deng, H.; Liu, J.; Zhao, X.; Zhang, Y.; Liu, J.; Xu, S.; Deng, L.; Dong, A.; Zhang, J., 2015:
PEG-b-PCL copolymer micelles with the ability of pH-controlled negative-to-positive charge reversal for intracellular delivery of doxorubicin

Velluto, D.; Demurtas, D.; Hubbell, J.A., 2008:
PEG-b-PPS diblock copolymer aggregates for hydrophobic drug solubilization and release: cyclosporin A as an example

Velluto, D.; Thomas, S.N.; Simeoni, E.; Swartz, M.A.; Hubbell, J.A., 2012:
PEG-b-PPS-b-PEI micelles and PEG-b-PPS/PEG-b-PPS-b-PEI mixed micelles as non-viral vectors for plasmid DNA: tumor immunotoxicity in B16F10 melanoma

Yang, F.; Wang, J.; Peng, G.; Fu, S.; Zhang, S.; Liu, C., 2012:
PEG-based bioresponsive hydrogels with redox-mediated formation and degradation

Stahl, P.J.; Romano, N.H.; Wirtz, D.; Yu, S.Michael., 2011:
PEG-based hydrogels with collagen mimetic peptide-mediated and tunable physical cross-links

Qiu, Y.; Lim, J.J.; Scott, L.; Adams, R.C.; Bui, H.T.; Temenoff, J.S., 2011:
PEG-based hydrogels with tunable degradation characteristics to control delivery of marrow stromal cells for tendon overuse injuries

Badi, N.; Lutz, J-François., 2010:
PEG-based thermogels: applicability in physiological media

Licciardi, M.; Grassi, M.; Di Stefano, M.; Feruglio, L.; Giuliani, G.; Valenti, S.; Cappelli, A.; Giammona, G., 2010:
PEG-benzofulvene copolymer hydrogels for antibody delivery

Adali, T.; Bentaleb, A.; Elmarzugi, N.; Hamza, A.M., 2014:
PEG-calf thymus DNA interactions: conformational, morphological and spectroscopic thermal studies

Passuello, T.; Pedroni, M.; Piccinelli, F.; Polizzi, S.; Marzola, P.; Tambalo, S.; Conti, G.; Benati, D.; Vetrone, F.; Bettinelli, M.; Speghini, A., 2013:
PEG-capped, lanthanide doped GdF3 nanoparticles: luminescent and T2 contrast agents for optical and MRI multimodal imaging

Qu, J-Bo.; Shao, H-Hui.; Jing, G-Lun.; Huang, F., 2013:
PEG-chitosan-coated iron oxide nanoparticles with high saturated magnetization as carriers of 10-hydroxycamptothecin: preparation, characterization and cytotoxicity studies

Gu, G.; Xia, H.; Hu, Q.; Liu, Z.; Jiang, M.; Kang, T.; Miao, D.; Tu, Y.; Pang, Z.; Song, Q.; Yao, L.; Chen, H.; Gao, X.; Chen, J., 2013:
PEG-co-PCL nanoparticles modified with MMP-2/9 activatable low molecular weight protamine for enhanced targeted glioblastoma therapy

Zhang, L.; Cao, D-Y.; Wang, J.; Xiang, B.; Dun, J-N.; Fang, Y.; Xue, G-Q., 2014:
PEG-coated irinotecan cationic liposomes improve the therapeutic efficacy of breast cancer in animals

Qi, R.; Gao, Y.; Tang, Y.; He, R-Rui.; Liu, T-Le.; He, Y.; Sun, S.; Li, B-Yu.; Li, Y-Bing.; Liu, G., 2009:
PEG-conjugated PAMAM dendrimers mediate efficient intramuscular gene expression

Khandare, J.J.; Jalota-Badhwar, A.; Satavalekar, S.D.; Bhansali, S.G.; Aher, N.D.; Kharas, F.; Banerjee, S.S., 2012:
PEG-conjugated highly dispersive multifunctional magnetic multi-walled carbon nanotubes for cellular imaging

Behl, G.; Sikka, M.; Chhikara, A.; Chopra, M., 2014 :
PEG-coumarin based biocompatible self-assembled fluorescent nanoaggregates synthesized via click reactions and studies of aggregation behavior

Huang, Y.; Lu, J.; Gao, X.; Li, J.; Zhao, W.; Sun, M.; Stolz, D.Beer.; Venkataramanan, R.; Rohan, L.Cencia.; Li, S., 2013:
PEG-derivatized embelin as a dual functional carrier for the delivery of paclitaxel

Lu, J.; Huang, Y.; Zhao, W.; Marquez, R.T.; Meng, X.; Li, J.; Gao, X.; Venkataramanan, R.; Wang, Z.; Li, S., 2013:
PEG-derivatized embelin as a nanomicellar carrier for delivery of paclitaxel to breast and prostate cancers

Yuan, Z.; Huang, J.; Liu, J.; Cheng, S.; Zhuo, R.; Li, F., 2011:
PEG-detachable and acid-labile cross-linked micelles based on orthoester linked graft copolymer for paclitaxel release

Kim, H.Jin.; Oba, M.; Pittella, F.; Nomoto, T.; Cabral, H.; Matsumoto, Y.; Miyata, K.; Nishiyama, N.; Kataoka, K., 2012:
PEG-detachable cationic polyaspartamide derivatives bearing stearoyl moieties for systemic siRNA delivery toward subcutaneous BxPC3 pancreatic tumor

Du, J-bo.; Song, Y-feng.; Ye, W-liang.; Cheng, Y.; Cui, H.; Liu, D-zhou.; Liu, M.; Zhang, B-le.; Zhou, S-yuan., 2015:
PEG-detachable lipid-polymer hybrid nanoparticle for delivery of chemotherapy drugs to cancer cells

Verma, S.; Jain, S.L.; Sain, B., 2011:
PEG-embedded KBr(3): A recyclable catalyst for multicomponent coupling reaction for the efficient synthesis of functionalized piperidines

Zhang, X.; Huang, Y.; Zhao, W.; Chen, Y.; Zhang, P.; Li, J.; Venkataramanan, R.; Li, S., 2015:
PEG-farnesyl thiosalicylic acid telodendrimer micelles as an improved formulation for targeted delivery of paclitaxel

Zhang, X.; Lu, J.; Huang, Y.; Zhao, W.; Chen, Y.; Li, J.; Gao, X.; Venkataramanan, R.; Sun, M.; Stolz, D.Beer.; Zhang, L.; Li, S., 2013:
PEG-farnesylthiosalicylate conjugate as a nanomicellar carrier for delivery of paclitaxel

Li, Z.; Wang, C.; Cheng, L.; Gong, H.; Yin, S.; Gong, Q.; Li, Y.; Liu, Z., 2014:
PEG-functionalized iron oxide nanoclusters loaded with chlorin e6 for targeted, NIR light induced, photodynamic therapy

Yallapu, M.Mohan.; Foy, S.P.; Jain, T.K.; Labhasetwar, V., 2011:
PEG-functionalized magnetic nanoparticles for drug delivery and magnetic resonance imaging applications

Lautenschläger, C.; Schmidt, C.; Lehr, C-Michael.; Fischer, D.; Stallmach, A., 2014:
PEG-functionalized microparticles selectively target inflamed mucosa in inflammatory bowel disease

Jiang, G.; Sun, J.; Ding, F., 2014:
PEG-g-chitosan thermosensitive hydrogel for implant drug delivery: cytotoxicity, in vivo degradation and drug release

Zhang, X.G.; Teng, D.Y.; Wu, Z.M.; Wang, X.; Wang, Z.; Yu, D.M.; Li, C.X., 2008:
PEG-grafted chitosan nanoparticles as an injectable carrier for sustained protein release

Tocco, G.; Fais, A.; Meli, G.; Begala, M.; Podda, G.; Fadda, M.Benedetta.; Corda, M.; Attanasi, O.A.; Filippone, P.; Berretta, S., 2008:
PEG-immobilization of cardol and soluble polymer-supported synthesis of some cardol-coumarin derivatives: preliminary evaluation of their inhibitory activity on mushroom tyrosinase

Ge, L.; Guo, R.; Zhang, X., 2009:
PEG-induced lamellar-to-isotropic phase transition in the system of TX-100/n-C8H17OH/H2O

Abeles, A.M., 2015:
PEG-ing down (and preventing?) the cause of pegloticase failure

Palumbo, E., 2007:
PEG-interferon alpha-2b for acute hepatitis C: a review

Sabar, M.Farooq.; Kausar, S.; Zafar, A.Usman., 2013:
PEG-interferon conjugates: effects of length and structure of linker

Palumbo, E., 2010:
PEG-interferon in acute and chronic hepatitis C: a review

Xie, M.; Luo, K.; Huang, B-Hai.; Liu, S-Lin.; Hu, J.; Cui, D.; Zhang, Z-Ling.; Xiao, G-Fu.; Pang, D-Wen., 2011:
PEG-interspersed nitrilotriacetic acid-functionalized quantum dots for site-specific labeling of prion proteins expressed on cell surfaces

Guo, Y.; Yuan, H.; Claudio, N.M.; Kura, S.; Shakerdge, N.; Mempel, T.R.; Bacskai, B.J.; Josephson, L., 2015:
PEG-like nanoprobes: multimodal, pharmacokinetically and optically tunable nanomaterials

Yang, C.; Fu, Z-Xue., 2015:
PEG-liposomal oxaliplatin combined with nuclear factor-κB inhibitor (PDTC) induces apoptosis in human colorectal cancer cells

Yang, C.; Liu, H-Zhong.; Fu, Z-Xue., 2012:
PEG-liposomal oxaliplatin induces apoptosis in human colorectal cancer cells via Fas/FasL and caspase-8

Yang, C.; Liu, H-Zhong.; Lu, W-Dong.; Fu, Z-Xue., 2011:
PEG-liposomal oxaliplatin potentialization of antitumor efficiency in a nude mouse tumor-xenograft model of colorectal carcinoma

García, Aés.J., 2014:
PEG-maleimide hydrogels for protein and cell delivery in regenerative medicine

Piltan, M.; Moradi, L.; Salimi, H.; Zargoosh, K.; Zarei, S.Amir., 2013:
PEG-mediated catalyst-free expeditious synthesis of polysubstituted anilines and benzenes via the reaction of malononitrile and β-ketoester derivatives in the presence of activated acetylenes

Zhou, J-liang.; Zou, M-hui.; Chen, Y-chu.; Lu, C-fen.; Shi, J-wei.; Dong, N-guo., 2014:
PEG-mediated covalent binding of VEGF to decellularized aortic valves promotes adhesion and proliferation of endothelial progenitor cells

Wilson, S.M.; Thorpe, T.A.; Moloney, M.M., 1989:
PEG-mediated expression of GUS and CAT genes in protoplasts from embryogenic suspension cultures of Picea glauca

Pal, S.; Singh, V.; Das, P.; Choudhury, L.H., 2013:
PEG-mediated one-pot multicomponent reactions for the efficient synthesis of functionalized dihydropyridines and their functional group dependent DNA cleavage activity

Ji, H.; Liu, L.; Li, K.; Xie, Q.; Wang, Z.; Zhao, X.; Li, X., 2015:
PEG-mediated osmotic stress induces premature differentiation of the root apical meristem and outgrowth of lateral roots in wheat

Spörlein, B.; Streubel, M.; Dahlfeld, G.; Westhoff, P.; Koop, H.U., 1991:
PEG-mediated plastid transformation: a new system for transient gene expression assays in chloroplasts

Sun, C.; Du, K.; Fang, C.; Bhattarai, N.; Veiseh, O.; Kievit, F.; Stephen, Z.; Lee, D.; Ellenbogen, R.G.; Ratner, B.; Zhang, M., 2010:
PEG-mediated synthesis of highly dispersive multifunctional superparamagnetic nanoparticles: their physicochemical properties and function in vivo

Chao, X.; Guo, L.; Zhao, Y.; Hua, K.; Peng, M.; Chen, C.; Cui, Y., 2011:
PEG-modified GoldMag nanoparticles (PGMNs) combined with the magnetic field for local drug delivery

Bailon, P.; Won, C-Youb., 2009:
PEG-modified biopharmaceuticals

Bottini, M.; Rosato, N.; Bottini, N., 2012:
PEG-modified carbon nanotubes in biomedicine: current status and challenges ahead

Zhou, J.; Yang, X.; Wright, J.Fraser.; High, K.A.; Couto, L.; Qu, G., 2011:
PEG-modulated column chromatography for purification of recombinant adeno-associated virus serotype 9

Zheng, S.; Li, X.; Zhang, Y.; Xie, Q.; Wong, Y-Shing.; Zheng, W.; Chen, T., 2013:
PEG-nanolized ultrasmall selenium nanoparticles overcome drug resistance in hepatocellular carcinoma HepG2 cells through induction of mitochondria dysfunction

Ruiz-Hernández, E.; Hess, M.; Melen, G.J.; Theek, B.; Talelli, M.; Shi, Y.; Ozbakir, B.; Teunissen, E.A.; Ramírez, M.; Moeckel, D.; Kiessling, F.; Storm, G.; Scheeren, H.W.; Hennink, W.E.; Szalay, A.A.; Stritzker, J.; Lammers, T., 2014:
PEG-pHPMAm-based polymeric micelles loaded with doxorubicin-prodrugs in combination antitumor therapy with oncolytic vaccinia viruses

Hamley, I.W., 2015:
PEG-peptide conjugates

Ponta, A.; Bae, Y., 2011:
PEG-poly(amino acid) block copolymer micelles for tunable drug release

Quadir, M.A.; Morton, S.W.; Deng, Z.J.; Shopsowitz, K.E.; Murphy, R.P.; Epps, T.H.; Hammond, P.T., 2016:
PEG-polypeptide block copolymers as pH-responsive endosome-solubilizing drug nanocarriers

Yu, J.; Chen, W.; Wu, C.; Chen, H., 2015:
PEG-protein interaction induced contraction of NalD chains

Xu, Y.; Ke, H.; Liang, L.; Wang, X.; Pei, J.; Du, L., 2011:
PEG-rhGH therapy for small for gestational age rats and effects on their metabolic parameters

Lu, J.; Cheng, C.; Zhao, X.; Liu, Q.; Yang, P.; Wang, Y.; Luo, G., 2010:
PEG-scutellarin prodrugs: synthesis, water solubility and protective effect on cerebral ischemia/reperfusion injury

Li, J.; Ge, Z.; Liu, S., 2014:
PEG-sheddable polyplex micelles as smart gene carriers based on MMP-cleavable peptide-linked block copolymers

Akiyama, Y.; Niidome, Y.; Mori, T.; Katayama, Y.; Niidome, T., 2014:
PEG-silica-modified gold nanorods that retain their optical properties in tumor tissues

Zhang, W.; Sun, J.; Liu, Y.; Tao, M.; Ai, X.; Su, X.; Cai, C.; Tang, Y.; Feng, Z.; Yan, X.; Chen, G.; He, Z., 2015:
PEG-stabilized bilayer nanodisks as carriers for doxorubicin delivery

Rafat, M.; Li, F.; Fagerholm, P.; Lagali, N.S.; Watsky, M.A.; Munger, R.; Matsuura, T.; Griffith, M., 2008:
PEG-stabilized carbodiimide crosslinked collagen-chitosan hydrogels for corneal tissue engineering

Gillich, T.; Acikgöz, C.; Isa, L.; Schlüter, A.Dieter.; Spencer, N.D.; Textor, M., 2013:
PEG-stabilized core-shell nanoparticles: impact of linear versus dendritic polymer shell architecture on colloidal properties and the reversibility of temperature-induced aggregation

Moczko, E.; Guerreiro, A.; Piletska, E.; Piletsky, S., 2014:
PEG-stabilized core-shell surface-imprinted nanoparticles

Zetterberg, M.M.; Reijmar, K.; Pränting, M.; Engström, Åke.; Andersson, D.I.; Edwards, K., 2012:
PEG-stabilized lipid disks as carriers for amphiphilic antimicrobial peptides

Morelli, C.; Maris, P.; Sisci, D.; Perrotta, E.; Brunelli, E.; Perrotta, I.; Panno, M.Luisa.; Tagarelli, A.; Versace, C.; Casula, M.Francesca.; Testa, F.; Andò, S.; Nagy, J.B.; Pasqua, L., 2011:
PEG-templated mesoporous silica nanoparticles exclusively target cancer cells

Wahl, F.; Jäschke, A., 2012:
PEG-tethered guanosine acetal conjugates for the enzymatic synthesis of modified RNA

Kim, T.Hyung.; Jo, Y.Gi.; Jiang, H.Hua.; Lim, S.Mook.; Youn, Y.Seok.; Lee, S.; Chen, X.; Byun, Y.; Lee, K.Choon., 2013:
PEG-transferrin conjugated TRAIL (TNF-related apoptosis-inducing ligand) for therapeutic tumor targeting

Chekhonin, V.P.; Gurina, O.I.; Lokhonina, A.V.; Ryabinina, A.E.; Maksimova, M.A.; Semenova, A.V.; Shvets, V.I., 2008:
PEG-treated immunoliposomes specific for the Schwann cells of neural tissue

Sherman, M.R.; Saifer, M.G.P.; Perez-Ruiz, F., 2007:
PEG-uricase in the management of treatment-resistant gout and hyperuricemia

Lee, J.; Kim, J.; Park, E.; Jo, S.; Song, R., 2008:
PEG-ylated cationic CdSe/ZnS QDs as an efficient intracellular labeling agent

Wang, C.; Xiao, Y.; Hu, Z.; Chen, Y.; Liu, N.; Hu, G., 2008:
PEG10 directly regulated by E2Fs might have a role in the development of hepatocellular carcinoma

Tsuji, K.; Yasui, K.; Gen, Y.; Endo, M.; Dohi, O.; Zen, K.; Mitsuyoshi, H.; Minami, M.; Itoh, Y.; Taniwaki, M.; Tanaka, S.; Arii, S.; Okanoue, T.; Yoshikawa, T., 2010:
PEG10 is a probable target for the amplification at 7q21 detected in hepatocellular carcinoma

Deng, X.; Hu, Y.; Ding, Q.; Han, R.; Guo, Q.; Qin, J.; Li, J.; Xiao, R.; Tian, S.; Hu, W.; Zhang, Q.; Xiong, J., 2015:
PEG10 plays a crucial role in human lung cancer proliferation, progression, prognosis and metastasis

Xiong, J.; Qin, J.; Zheng, Y.; Peng, X.; Luo, Y.; Meng, X., 2012:
PEG10 promotes the migration of human Burkitt's lymphoma cells by up-regulating the expression of matrix metalloproteinase-2 and -9

Hu, Y.Lin.; Ma, X.Yun.; Ge, Q.; Lu, M., 2010:
PEG1000-DAIL / Toluene Temperature-dependent Biphasic System that Regulate Homogeneously Catalyzed Oxidation of Primary Alcohols to Carboxylic Acids

Wang, G.; Wang, J.; Luo, J.; Wang, L.; Chen, X.; Zhang, L.; Jiang, S., 2014:
PEG2000-DPSE-coated quercetin nanoparticles remarkably enhanced anticancer effects through induced programed cell death on C6 glioma cells

Anonymous, 2014:
PEGANONE, new antiepileptic

Nemir, S.; Hayenga, H.N.; West, J.L., 2010:
PEGDA hydrogels with patterned elasticity: Novel tools for the study of cell response to substrate rigidity

Stadler, V.; Kirmse, R.; Beyer, M.; Breitling, F.; Ludwig, T.; Bischoff, F.Ralf., 2008:
PEGMA/MMA copolymer graftings: generation, protein resistance, and a hydrophobic domain

Wang, H.; Zhang, S.; Liao, Z.; Wang, C.; Liu, Y.; Feng, S.; Jiang, X.; Chang, J., 2010:
PEGlated magnetic polymeric liposome anchored with TAT for delivery of drugs across the blood-spinal cord barrier

Wonganan, P.; Croyle, M.A., 2010:
PEGylated Adenoviruses: From Mice to Monkeys

Tan, I.; Zarafshani, Z.; Lutz, J-François.; Titirici, M-Magdalena., 2010:
PEGylated Chromatography: Efficient Bioseparation on Silica Monoliths Grafted with Smart Biocompatible Polymers

Nakamura, H.; Fang, J.; Mizukami, T.; Nunoi, H.; Maeda, H., 2012:
PEGylated D-amino acid oxidase restores bactericidal activity of neutrophils in chronic granulomatous disease via hypochlorite

Liu, Y.; Yang, K.; Cheng, L.; Zhu, J.; Ma, X.; Xu, H.; Li, Y.; Guo, L.; Gu, H.; Liu, Z., 2014:
PEGylated FePt@Fe2O3 core-shell magnetic nanoparticles: potential theranostic applications and in vivo toxicity studies

Plett, P.Artur.; Chua, H.Lin.; Sampson, C.H.; Katz, B.P.; Fam, C.M.; Anderson, L.J.; Cox, G.N.; Orschell, C.M., 2014:
PEGylated G-CSF (BBT-015), GM-CSF (BBT-007), and IL-11 (BBT-059) analogs enhance survival and hematopoietic cell recovery in a mouse model of the hematopoietic syndrome of the acute radiation syndrome

Boschi, A.; Massi, A.; Uccelli, L.; Pasquali, M.; Duatti, A., 2011:
PEGylated N-methyl-S-methyl dithiocarbazate as a new reagent for the high-yield preparation of nitrido Tc-99m and Re-188 radiopharmaceuticals

Yi, Z.; Lu, W.; Xu, Y.; Yang, J.; Deng, L.; Qian, C.; Zeng, T.; Wang, H.; Rao, L.; Liu, H.; Zeng, S., 2015:
PEGylated NaLuF4: Yb/Er upconversion nanophosphors for in vivo synergistic fluorescence/X-ray bioimaging and long-lasting, real-time tracking

Li, X.; Takashima, M.; Yuba, E.; Harada, A.; Kono, K., 2015:
PEGylated PAMAM dendrimer-doxorubicin conjugate-hybridized gold nanorod for combined photothermal-chemotherapy

Zhu, S.; Hong, M.; Zhang, L.; Tang, G.; Jiang, Y.; Pei, Y., 2010:
PEGylated PAMAM dendrimer-doxorubicin conjugates: in vitro evaluation and in vivo tumor accumulation

Jiang, Y-Yan.; Tang, G-Tao.; Zhang, L-Hong.; Kong, S-Yi.; Zhu, S-Jie.; Pei, Y-Ying., 2010:
PEGylated PAMAM dendrimers as a potential drug delivery carrier: in vitro and in vivo comparative evaluation of covalently conjugated drug and noncovalent drug inclusion complex

Huang, F-Wei.; Wang, H-Yuan.; Li, C.; Wang, H-Fen.; Sun, Y-Xia.; Feng, J.; Zhang, X-Zheng.; Zhuo, R-Xi., 2011:
PEGylated PEI-based biodegradable polymers as non-viral gene vectors

Park, J.; Fong, P.M.; Lu, J.; Russell, K.S.; Booth, C.J.; Saltzman, W.Mark.; Fahmy, T.M., 2010:
PEGylated PLGA nanoparticles for the improved delivery of doxorubicin

Gajbhiye, V.; Vijayaraj Kumar, P.; Tekade, R.Kumar.; Jain, N.K., 2008:
PEGylated PPI dendritic architectures for sustained delivery of H2 receptor antagonist

Perry, J.L.; Reuter, K.G.; Kai, M.P.; Herlihy, K.P.; Jones, S.W.; Luft, J.Chris.; Napier, M.; Bear, J.E.; DeSimone, J.M., 2013:
PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics

Hu, R.; Law, W-Cheung.; Lin, G.; Ye, L.; Liu, J.; Liu, J.; Reynolds, J.L.; Yong, K-Tye., 2012:
PEGylated Phospholipid Micelle-Encapsulated Near-Infrared PbS Quantum Dots for in vitro and in vivo Bioimaging

He, H.; Li, Y.; Jia, X-Ru.; Du, J.; Ying, X.; Lu, W-Liang.; Lou, J-Ning.; Wei, Y., 2011:
PEGylated Poly(amidoamine) dendrimer-based dual-targeting carrier for treating brain tumors

Cheng, L.; Gong, H.; Zhu, W.; Liu, J.; Wang, X.; Liu, G.; Liu, Z., 2015:
PEGylated Prussian blue nanocubes as a theranostic agent for simultaneous cancer imaging and photothermal therapy

Kim, T.Hyung.; Youn, Y.Seok.; Jiang, H.Hua.; Lee, S.; Chen, X.; Lee, K.Choon., 2012:
PEGylated TNF-related apoptosis-inducing ligand (TRAIL) analogues: pharmacokinetics and antitumor effects

Jiang, H.Hua.; Kim, T.Hyung.; Lee, S.; Chen, X.; Youn, Y.Seok.; Lee, K.Choon., 2012:
PEGylated TNF-related apoptosis-inducing ligand (TRAIL) for effective tumor combination therapy

Kim, T.Hyung.; Jiang, H.Hua.; Park, C.Woong.; Youn, Y.Seok.; Lee, S.; Chen, X.; Lee, K.Choon., 2011:
PEGylated TNF-related apoptosis-inducing ligand (TRAIL)-loaded sustained release PLGA microspheres for enhanced stability and antitumor activity

Li, X-Tao.; Zhou, Z-Yan.; Jiang, Y.; He, M-Li.; Jia, L-Qun.; Zhao, L.; Cheng, L.; Jia, T-Zhu., 2016 :
PEGylated VRB plus quinacrine cationic liposomes for treating non-small cell lung cancer

Cheng, L.; Liu, J.; Gu, X.; Gong, H.; Shi, X.; Liu, T.; Wang, C.; Wang, X.; Liu, G.; Xing, H.; Bu, W.; Sun, B.; Liu, Z., 2014:
PEGylated WS(2) nanosheets as a multifunctional theranostic agent for in vivo dual-modal CT/photoacoustic imaging guided photothermal therapy

O'Riordan, C.R.; Song, A., 2008:
PEGylated adenovirus for targeted gene therapy

Castelletto, V.; McKendrick, J.E.; Hamley, I.W.; Olsson, U.; Cenker, C., 2010:
PEGylated amyloid peptide nanocontainer delivery and release system

Mok, H.; Bae, K.Hyun.; Ahn, C-Hee.; Park, T.Gwan., 2009:
PEGylated and MMP-2 specifically dePEGylated quantum dots: comparative evaluation of cellular uptake

Tan, L.; Neoh, K.Gee.; Kang, E-Tang.; Choe, W.Seok.; Su, X., 2012:
PEGylated anti-MUC1 aptamer-doxorubicin complex for targeted drug delivery to MCF7 breast cancer cells

Liu, M.; Xu, M.; Loh, X.Jun.; Abe, H.; Tsumuraya, T.; Fujii, I.; Li, J.; Son, T.Il.; Ito, Y., 2011:
PEGylated antibody in organic media

Schmidt, P.G.; Campbell, K.M.; Hinds, K.D.; Cook, G.P., 2007:
PEGylated bioactive molecules in biodegradable polymer microparticles

Misra, H.; Lickliter, J.; Kazo, F.; Abuchowski, A., 2015:
PEGylated carboxyhemoglobin bovine (SANGUINATE): results of a phase I clinical trial

Xie, Y.; Qiao, H.; Su, Z.; Chen, M.; Ping, Q.; Sun, M., 2015:
PEGylated carboxymethyl chitosan/calcium phosphate hybrid anionic nanoparticles mediated hTERT siRNA delivery for anticancer therapy

Silva, B.F.B.; Majzoub, R.N.; Chan, C-Ling.; Li, Y.; Olsson, U.; Safinya, C.R., 2014:
PEGylated cationic liposome-DNA complexation in brine is pathway-dependent

Zhuang, Y.; Ma, Y.; Wang, C.; Hai, L.; Yan, C.; Zhang, Y.; Liu, F.; Cai, L., 2012:
PEGylated cationic liposomes robustly augment vaccine-induced immune responses: Role of lymphatic trafficking and biodistribution

Maurstad, G.; Stokke, Børn.T.; Vårum, K.M.; Strand, S.P., 2013:
PEGylated chitosan complexes DNA while improving polyplex colloidal stability and gene transfection efficiency

Hu, F-Qiang.; Meng, P.; Dai, Y-Qin.; Du, Y-Zhong.; You, J.; Wei, X-Hong.; Yuan, H., 2008:
PEGylated chitosan-based polymer micelle as an intracellular delivery carrier for anti-tumor targeting therapy

Guo, J.; Meng, F.; Li, X.; Wang, M.; Wu, Y.; Jing, X.; Huang, Y., 2012:
PEGylated click polypeptides synthesized by copper-free microwave-assisted thermal click polymerization for selective endotoxin removal from protein solutions

Godinho, B.M.D.C.; Ogier, J.R.; Quinlan, A.; Darcy, R.; Griffin, B.T.; Cryan, J.F.; O'Driscoll, C.M., 2015:
PEGylated cyclodextrins as novel siRNA nanosystems: correlations between polyethylene glycol length and nanoparticle stability

Martínez-Barbosa, M.Elisa.; Cammas-Marion, S.; Bouteiller, L.; Vauthier, C.; Ponchel, G., 2011:
PEGylated degradable composite nanoparticles based on mixtures of PEG-b-poly(γ-benzyl L-glutamate) and poly(γ-benzyl L-glutamate)

Siyad, M.A.; Vinod Kumar, G.S., 2013:
PEGylated dendrimer polystyrene support: synthesis, characterisation and evaluation of biologically active peptides

Peng, C.; Zheng, L.; Chen, Q.; Shen, M.; Guo, R.; Wang, H.; Cao, X.; Zhang, G.; Shi, X., 2012 :
PEGylated dendrimer-entrapped gold nanoparticles for in vivo blood pool and tumor imaging by computed tomography

Pan, D.; She, W.; Guo, C.; Luo, K.; Yi, Q.; Gu, Z., 2015:
PEGylated dendritic diaminocyclohexyl-platinum (II) conjugates as pH-responsive drug delivery vehicles with enhanced tumor accumulation and antitumor efficacy

Kim, Y.; Hechler, Béatrice.; Gao, Z-Guo.; Gachet, C.; Jacobson, K.A., 2011:
PEGylated dendritic unimolecular micelles as versatile carriers for ligands of G protein-coupled receptors

Omran, Z.; Kay, G.; Di Salvo, A.; Knott, R.M.; Cairns, D., 2011:
PEGylated derivatives of cystamine as enhanced treatments for nephropathic cystinosis

McDonnell, T.; Ioannou, Y.; Rahman, A., 2014:
PEGylated drugs in rheumatology--why develop them and do they work?

Jain, S.; Tiwary, A.K.; Jain, N.K., 2008:
PEGylated elastic liposomal formulation for lymphatic targeting of zidovudine

Haeri, A.; Sadeghian, S.; Rabbani, S.; Anvari, M.Sotoudeh.; Erfan, M.; Dadashzadeh, S., 2012:
PEGylated estradiol benzoate liposomes as a potential local vascular delivery system for treatment of restenosis

Ruan, S.; Wan, J.; Fu, Y.; Han, K.; Li, X.; Chen, J.; Zhang, Q.; Shen, S.; He, Q.; Gao, H., 2015:
PEGylated fluorescent carbon nanoparticles for noninvasive heart imaging

Shi, J.; Yu, X.; Wang, L.; Liu, Y.; Gao, J.; Zhang, J.; Ma, R.; Liu, R.; Zhang, Z., 2014:
PEGylated fullerene/iron oxide nanocomposites for photodynamic therapy, targeted drug delivery and MR imaging

Naicker, K.; Ariatti, M.; Singh, M., 2015:
PEGylated galactosylated cationic liposomes for hepatocytic gene delivery

Eck, W.; Craig, G.; Sigdel, A.; Ritter, G.; Old, L.J.; Tang, L.; Brennan, M.F.; Allen, P.J.; Mason, M.D., 2009:
PEGylated gold nanoparticles conjugated to monoclonal F19 antibodies as targeted labeling agents for human pancreatic carcinoma tissue

Nguyen, T.M.; Gigault, J.; Hackley, V.A., 2014:
PEGylated gold nanorod separation based on aspect ratio: characterization by asymmetric-flow field flow fractionation with UV-Vis detection

Shen, H.; Liu, M.; He, H.; Zhang, L.; Huang, J.; Chong, Y.; Dai, J.; Zhang, Z., 2013:
PEGylated graphene oxide-mediated protein delivery for cell function regulation

Chung, Y-Chen.; Wei, M-Feng.; Chang, F-Hsiung.; Young, T-Horng., 2012:
PEGylated guanidinylated polyallylamine as gene-delivery carrier

Shi, X.; Shi, Z.; Huang, H.; Zhu, H.; Zhu, H.; Ju, D.; Zhou, P., 2014:
PEGylated human catalase elicits potent therapeutic effects on H1N1 influenza-induced pneumonia in mice

Ran, R.; Liu, Y.; Gao, H.; Kuang, Q.; Zhang, Q.; Tang, J.; Fu, H.; Zhang, Z.; He, Q., 2015:
PEGylated hyaluronic acid-modified liposomal delivery system with anti-γ-glutamylcyclotransferase siRNA for drug-resistant MCF-7 breast cancer therapy

Liu, Z.; Pu, F.; Liu, J.; Jiang, L.; Yuan, Q.; Li, Z.; Ren, J.; Qu, X., 2013:
PEGylated hybrid ytterbia nanoparticles as high-performance diagnostic probes for in vivo magnetic resonance and X-ray computed tomography imaging with low systemic toxicity

Levy, D.E.; Ding, Z.; Hu, C.; Zalipsky, S., 2010:
PEGylated iminodiacetic acid zinc complex stabilizes cationic RNA-bearing nanoparticles

Karakoti, A.S.; Das, S.; Thevuthasan, S.; Seal, S., 2011 :
PEGylated inorganic nanoparticles

Caparrotta, T.M.; Evans, M., 2015:
PEGylated insulin Lispro, (LY2605541)--a new basal insulin analogue

Reuss, R., 2013:
PEGylated interferon beta-1a in the treatment of multiple sclerosis - an update

Baker, D.P.; Pepinsky, R.Blake.; Brickelmaier, M.; Gronke, R.S.; Hu, X.; Olivier, K.; Lerner, M.; Miller, L.; Crossman, M.; Nestorov, I.; Subramanyam, M.; Hitchman, S.; Glick, G.; Richman, S.; Liu, S.; Zhu, Y.; Panzara, M.A.; Davar, G., 2011:
PEGylated interferon beta-1a: meeting an unmet medical need in the treatment of relapsing multiple sclerosis

Sandrow-Feinberg, H.R.; Zhukareva, V.; Santi, L.; Miller, K.; Shumsky, J.S.; Baker, D.P.; Houle, J.D., 2010:
PEGylated interferon-beta modulates the acute inflammatory response and recovery when combined with forced exercise following cervical spinal contusion injury

Sun, G.; Lin, X.; Wang, Z.; Feng, Y.; Xu, D.; Shen, L., 2011:
PEGylated inulin as long-circulating pharmaceutical carrier

Sugiyama, A.; Sato, A.; Shimizu, H.; Ando, K.; Takeuchi, T., 2010:
PEGylated lactoferrin enhances its hepatoprotective effects on acute liver injury induced by D-galactosamine and lipopolysaccharide in rats

Hervella, P.; Alonso-Sande, M.; Ledo, F.; Lucero, M.L.; Alonso, M.J.; Garcia-Fuentes, M., 2014:
PEGylated lipid nanocapsules with improved drug encapsulation and controlled release properties

Nuytten, N.; Hakimhashemi, M.; Ysenbaert, T.; Defour, L.; Trekker, J.; Soenen, S.J.H.; Van der Meeren, P.; De Cuyper, M., 2010:
PEGylated lipids impede the lateral diffusion of adsorbed proteins at the surface of (magneto)liposomes

Papa, A-Laure.; Sidiqui, A.; Balasubramanian, S.Uma.Aisvarya.; Sarangi, S.; Luchette, M.; Sengupta, S.; Harfouche, R., 2014:
PEGylated liposomal Gemcitabine: insights into a potential breast cancer therapeutic

Shroff, K.; Kokkoli, E., 2012:
PEGylated liposomal doxorubicin targeted to α5β1-expressing MDA-MB-231 breast cancer cells

Konishi, H.; Takagi, A.; Kurita, A.; Kaneda, N.; Matsuzaki, T., 2013:
PEGylated liposome IHL-305 markedly improved the survival of ovarian cancer peritoneal metastasis in mouse

Pan, J.; Wan, D.; Gong, J., 2011:
PEGylated liposome coated QDs/mesoporous silica core-shell nanoparticles for molecular imaging

Muppidi, K.; Wang, J.; Betageri, G.; Pumerantz, A.S., 2012:
PEGylated liposome encapsulation increases the lung tissue concentration of vancomycin

He, Y.; Zhang, L.; Song, C., 2012:
PEGylated liposomes modified with LHRH analogs for tumor targeting

Yang, Y.; Yang, Y.; Xie, X.; Cai, X.; Zhang, H.; Gong, W.; Wang, Z.; Mei, X., 2014:
PEGylated liposomes with NGR ligand and heat-activable cell-penetrating peptide-doxorubicin conjugate for tumor-specific therapy

Luan, J.; Yang, X.; Chu, L.; Xi, Y.; Zhai, G., 2015:
PEGylated long circulating nanostructured lipid carriers for Amoitone B: preparation, cytotoxicity and intracellular uptake

Worlinsky, J.L.; Halepas, S.; Brückner, C., 2015:
PEGylated meso-arylporpholactone metal complexes as optical cyanide sensors in water

Jain, N.K.; Nahar, M., 2010:
PEGylated nanocarriers for systemic delivery

Karakoti, A.S.; Singh, S.; Kumar, A.; Malinska, M.; Kuchibhatla, S.V.N.T.; Wozniak, K.; Self, W.T.; Seal, S., 2009:
PEGylated nanoceria as radical scavenger with tunable redox chemistry

Liu, Z.; Robinson, J.T.; Sun, X.; Dai, H., 2008:
PEGylated nanographene oxide for delivery of water-insoluble cancer drugs

Vllasaliu, D.; Fowler, R.; Stolnik, S., 2014:
PEGylated nanomedicines: recent progress and remaining concerns

Brambilla, D.; Verpillot, R.; Le Droumaguet, B.; Nicolas, J.; Taverna, M.; Kóňa, J.; Lettiero, B.; Hashemi, S.Hossein.; De Kimpe, L.; Canovi, M.; Gobbi, M.; Nicolas, Vérie.; Scheper, W.; Moghimi, S.Moein.; Tvaroška, I.; Couvreur, P.; Andrieux, K., 2012:
PEGylated nanoparticles bind to and alter amyloid-beta peptide conformation: toward engineering of functional nanomedicines for Alzheimer's disease

Wang, L.; Luo, Q.; Lin, T.; Li, R.; Zhu, T.; Zhou, K.; Ji, Z.; Song, J.; Jia, B.; Zhang, C.; Chen, W.; Zhu, G., 2016:
PEGylated nanostructured lipid carriers (PEG-NLC) as a novel drug delivery system for biochanin A

Zhou, Z.; Wang, J.; Liu, W.; Yu, C.; Kong, B.; Sun, Y.; Yang, H.; Yang, S.; Wang, W., 2016:
PEGylated nickel carbide nanocrystals as efficient near-infrared laser induced photothermal therapy for treatment of cancer cells in vivo

Lin, T.; Fang, Q.; Peng, D.; Huang, X.; Zhu, T.; Luo, Q.; Zhou, K.; Chen, W., 2014:
PEGylated non-ionic surfactant vesicles as drug delivery systems for Gambogenic acid

Zhang, Y.; Chen, Y.; Jin, G., 2010:
PEGylated phospholipid membrane on polymer cushion and its interaction with cholesterol

Qian, Y.; Zha, Y.; Feng, B.; Pang, Z.; Zhang, B.; Sun, X.; Ren, J.; Zhang, C.; Shao, X.; Zhang, Q.; Jiang, X., 2013 :
PEGylated poly(2-(dimethylamino) ethyl methacrylate)/DNA polyplex micelles decorated with phage-displayed TGN peptide for brain-targeted gene delivery

Weber, N.D.; Merkel, O.M.; Kissel, T.; Muñoz-Fernández, Mía.Ángeles., 2012:
PEGylated poly(ethylene imine) copolymer-delivered siRNA inhibits HIV replication in vitro

Jiang, X.; Xin, H.; Sha, X.; Gu, J.; Jiang, Y.; Law, K.; Chen, Y.; Chen, L.; Wang, X.; Fang, X., 2012:
PEGylated poly(trimethylene carbonate) nanoparticles loaded with paclitaxel for the treatment of advanced glioma: in vitro and in vivo evaluation

Kong, S-yi.; Tang, G-tao.; Pei, Y-ying.; Jiang, Y-yan., 2010:
PEGylated polyamidoamine dendrimer/methotrexate complex: pharmacokinetics and anti-tumor activity in normal and tumor-bearing rodents

Yuan, Q.; Yeudall, W.Andrew.; Yang, H., 2010:
PEGylated polyamidoamine dendrimers with bis-aryl hydrazone linkages for enhanced gene delivery

Conte, C.; d'Angelo, I.; Miro, A.; Ungaro, F.; Quaglia, F., 2014:
PEGylated polyester-based nanoncologicals

Lee, H.; Sung, D.; Veerapandian, M.; Yun, K.; Seo, S-Won., 2011:
PEGylated polyethyleneimine grafted silica nanoparticles: enhanced cellular uptake and efficient siRNA delivery

Zhou, S.; Wu, Z.; Chen, X.; Jia, L.; Zhu, W., 2015:
PEGylated polyethylenimine as enhanced T₁ contrast agent for efficient magnetic resonance imaging

Ryan, G.M.; Kaminskas, L.M.; Bulitta, Jürgen.B.; McIntosh, M.P.; Owen, D.J.; Porter, C.J.H., 2014:
PEGylated polylysine dendrimers increase lymphatic exposure to doxorubicin when compared to PEGylated liposomal and solution formulations of doxorubicin

Joralemon, M.J.; McRae, S.; Emrick, T., 2010:
PEGylated polymers for medicine: from conjugation to self-assembled systems

Yoshimoto, N.; Yamamoto, S., 2012:
PEGylated protein separations: challenges and opportunities

Yu, W.; Yu, C.; Wu, L.; Fang, T.; Qiu, R.; Zhang, J.; Yu, T.; Fu, L.; Chen, W.; Hu, T., 2015:
PEGylated recombinant human interferon-ω as a long-acting antiviral agent: structure, antiviral activity and pharmacokinetics

Zhu, G.; Chen, G.; Shi, L.; Feng, J.; Wang, Y.; Ye, C.; Feng, W.; Niu, J.; Huang, Z., 2015:
PEGylated rhFGF-2 conveys long-term neuroprotection and improves neuronal function in a rat model of Parkinson's disease

Morkhade, D.M.; Nande, V.S.; Barabde, U.V.; Patil, A.T.; Joshi, S.B., 2007:
PEGylated rosin derivatives: novel microencapsulating materials for sustained drug delivery

Wu, S-Han.; Lin, C-Yuan.; Hung, Y.; Chen, W.; Chang, C.; Mou, C-Yuan., 2012:
PEGylated silica nanoparticles encapsulating multiple magnetite nanocrystals for high-performance microscopic magnetic resonance angiography

Sudeep, P.K.; Page, Z.; Emrick, T., 2008:
PEGylated silicon nanoparticles: synthesis and characterization

Uskoković, V.; Lee, P.Peng.; Walsh, L.A.; Fischer, K.E.; Desai, T.A., 2012:
PEGylated silicon nanowire coated silica microparticles for drug delivery across intestinal epithelium

Nadhman, A.; Nazir, S.; Khan, M.Ihsanullah.; Arooj, S.; Bakhtiar, M.; Shahnaz, G.; Yasinzai, M., 2015:
PEGylated silver doped zinc oxide nanoparticles as novel photosensitizers for photodynamic therapy against Leishmania

Minimol, P.F.; Paul, W.; Sharma, C.P., 2013 :
PEGylated starch acetate nanoparticles and its potential use for oral insulin delivery

Huang, Y.; Chen, J.; Chen, X.; Gao, J.; Liang, W., 2007:
PEGylated synthetic surfactant vesicles (Niosomes): novel carriers for oligonucleotides

Zhao, Y.; Fan, X.; Liu, D.; Wang, Z., 2011:
PEGylated thermo-sensitive poly(amidoamine) dendritic drug delivery systems

Dong, L.; An, D.; Gong, M.; Lu, Y.; Gao, H-Ling.; Xu, Y-Jun.; Yu, S-Hong., 2014:
PEGylated upconverting luminescent hollow nanospheres for drug delivery and in vivo imaging

Castillo, P.M.; de la Mata, M.; Casula, M.F.; Sánchez-Alcázar, Jé.A.; Zaderenko, A.P., 2014:
PEGylated versus non-PEGylated magnetic nanoparticles as camptothecin delivery system

Yang, L.; da Rocha, S.R.P., 2014:
PEGylated, NH2-terminated PAMAM dendrimers: a microscopic view from atomistic computer simulations

Simón-Yarza, T.; Formiga, F.R.; Tamayo, E.; Pelacho, B.; Prosper, F.; Blanco-Prieto, Mía.J., 2013:
PEGylated-PLGA microparticles containing VEGF for long term drug delivery

Resch, G.; Moreillon, P.; Fischetti, V.A., 2011:
PEGylating a bacteriophage endolysin inhibits its bactericidal activity

Beyerle, A.; Merkel, O.; Stoeger, T.; Kissel, T., 2009:
PEGylation affects cytotoxicity and cell-compatibility of poly(ethylene imine) for lung application: structure-function relationships

Deng, N-hua.; Wang, L.; He, Q-chuan.; Zheng, J-cun.; Meng, Y.; Meng, Y-Fa.; Zhang, C-Jie.; Shen, F-bing., 2016:
PEGylation alleviates the non-specific toxicities of Alpha-Momorcharin and preserves its antitumor efficacy in vivo

Da Pieve, C.; Blackshaw, E.; Missailidis, S.; Perkins, A.C., 2013:
PEGylation and biodistribution of an anti-MUC1 aptamer in MCF-7 tumor-bearing mice

Ginn, C.; Khalili, H.; Lever, R.; Brocchini, S., 2015:
PEGylation and its impact on the design of new protein-based medicines

Pilloni, M.; Nicolas, J.; Marsaud, Véronique.; Bouchemal, K.; Frongia, F.; Scano, A.; Ennas, G.; Dubernet, C., 2011:
PEGylation and preliminary biocompatibility evaluation of magnetite-silica nanocomposites obtained by high energy ball milling

Liu, J.; Yu, M.; Ning, X.; Zhou, C.; Yang, S.; Zheng, J., 2014:
PEGylation and zwitterionization: pros and cons in the renal clearance and tumor targeting of near-IR-emitting gold nanoparticles

Wattendorf, U.; Merkle, H.P., 2008:
PEGylation as a tool for the biomedical engineering of surface modified microparticles

Mier, W.; Krämer, S.; Zitzmann, S.; Altmann, A.; Leotta, K.; Schierbaum, U.; Schnölzer, M.; Eisenhut, M.; Haberkorn, U., 2013:
PEGylation enables the specific tumor accumulation of a peptide identified by phage display

Mezo, A.R.; Low, S.C.; Hoehn, T.; Palmieri, H., 2012:
PEGylation enhances the therapeutic potential of peptide antagonists of the neonatal Fc receptor, FcRn

André, M.; Besse, S.; Chezal, J-Michel.; Mounetou, E., 2015:
PEGylation enhances the tumor selectivity of melanoma-targeted conjugates

Batra, J.; Robinson, J.; Mehner, C.; Hockla, A.; Miller, E.; Radisky, D.C.; Radisky, E.S., 2013:
PEGylation extends circulation half-life while preserving in vitro and in vivo activity of tissue inhibitor of metalloproteinases-1 (TIMP-1)

Sun, G.; Lin, X.; Hong, Y.; Feng, Y.; Ruan, K.; Xu, D., 2012:
PEGylation for drug delivery to ischemic myocardium: pharmacokinetics and cardiac distribution of poly(ethylene glycol)s in mice with normal and ischemic myocardium

Pasut, G.; Veronese, F.M., 2010:
PEGylation for improving the effectiveness of therapeutic biomolecules

Bansal, R.; Post, E.; Proost, J.H.; de Jager-Krikken, A.; Poelstra, K.; Prakash, J., 2011:
PEGylation improves pharmacokinetic profile, liver uptake and efficacy of Interferon gamma in liver fibrosis

Youn, Y.S.; Jeon, J.E.; Chae, S.Y.; Lee, S.; Lee, K.C., 2007:
PEGylation improves the hypoglycaemic efficacy of intranasally administered glucagon-like peptide-1 in type 2 diabetic db/db mice

Fam, C.M.; Eisenberg, S.P.; Carlson, S.J.; Chlipala, E.A.; Cox, G.N.; Rosendahl, M.S., 2015:
PEGylation improves the pharmacokinetic properties and ability of interferon gamma to inhibit growth of a human tumor xenograft in athymic mice

Tagalakis, A.D.; Kenny, G.D.; Bienemann, A.S.; McCarthy, D.; Munye, M.M.; Taylor, H.; Wyatt, M.J.; Lythgoe, M.F.; White, E.A.; Hart, S.L., 2014:
PEGylation improves the receptor-mediated transfection efficiency of peptide-targeted, self-assembling, anionic nanocomplexes

Zheng, J-cun.; Lei, N.; He, Q-chuan.; Hu, W.; Jin, J-Gui.; Meng, Y.; Deng, N-hua.; Meng, Y-Fa.; Zhang, C-Jie.; Shen, F-bing., 2013:
PEGylation is effective in reducing immunogenicity, immunotoxicity, and hepatotoxicity of α-momorcharin in vivo

Wang, Y-Jue.; Hao, S-Juan.; Liu, Y-Dong.; Hu, T.; Zhang, G-Feng.; Zhang, X.; Qi, Q-Sheng.; Ma, G-Hui.; Su, Z-Guo., 2010:
PEGylation markedly enhances the in vivo potency of recombinant human non-glycosylated erythropoietin: a comparison with glycosylated erythropoietin

Free, P.; Shaw, C.P.; Lévy, Rël., 2009:
PEGylation modulates the interfacial kinetics of proteases on peptide-capped gold nanoparticles

Peng, F.; Liu, Y.; Li, X.; Sun, L.; Zhao, D.; Wang, Q.; Ma, G.; Su, Z., 2014:
PEGylation of G-CSF in organic solvent markedly increase the efficacy and reactivity through protein unfolding, hydrolysis inhibition and solvent effect

Allmeroth, M.; Moderegger, D.; Gündel, D.; Buchholz, H-Georg.; Mohr, N.; Koynov, K.; Rösch, F.; Thews, O.; Zentel, R., 2014:
PEGylation of HPMA-based block copolymers enhances tumor accumulation in vivo: a quantitative study using radiolabeling and positron emission tomography

Ingallinella, P.; Peier, A.M.; Pocai, A.; Marco, A.Di.; Desai, K.; Zytko, K.; Qian, Y.; Du, X.; Cellucci, A.; Monteagudo, E.; Laufer, R.; Bianchi, E.; Marsh, D.J.; Pessi, A., 2012:
PEGylation of Neuromedin U yields a promising candidate for the treatment of obesity and diabetes

Moret, F.; Selvestrel, F.; Lubian, E.; Mognato, M.; Celotti, L.; Mancin, F.; Reddi, E., 2015:
PEGylation of ORMOSIL nanoparticles differently modulates the in vitro toxicity toward human lung cells

Erfani-Jabarian, L.; Dinarvand, R.; Rouini, M.Reza.; Atyabi, F.; Amini, M.; Mohammadhosseini, N.; Shafiee, A.; Foroumadi, A., 2012:
PEGylation of Octreotide Using an α,β-unsaturated-β'-mono-sulfone Functionalized PEG Reagent

Hu, T.; Li, D.; Manjula, B.N.; Brenowitz, M.; Prabhakaran, M.; Acharya, S.A., 2009:
PEGylation of Val-1(alpha) destabilizes the tetrameric structure of hemoglobin

Dattelbaum, A.M.; Baker, G.A.; Fox, J.M.; Iyer, S.; Dattelbaum, J.D., 2010:
PEGylation of a maltose biosensor promotes enhanced signal response when immobilized in a silica sol-gel

Bian, X.; Shen, F.; Chen, Y.; Wang, B.; Deng, M.; Meng, Y., 2010 :
PEGylation of alpha-momorcharin: synthesis and characterization of novel anti-tumor conjugates with therapeutic potential

Ueda, T.; Kitagishi, H.; Kano, K., 2012:
PEGylation of an artificial O2 and CO receptor: synthesis, characterisation and pharmacokinetic study

Akhtar, J.; Mallaredy, V.; Dandapat, J.; Maiti, P.; Sahoo, S.K.; Singh, S., 2013:
PEGylation of an osteoclast inhibitory peptide: suitable candidate for the treatment of osteoporosis

Jevševar, S.; Kusterle, M.; Kenig, M., 2012:
PEGylation of antibody fragments for half-life extension

Koussoroplis, S.Juliette.; Paulissen, Gève.; Tyteca, D.; Goldansaz, H.; Todoroff, J.; Barilly, Céline.; Uyttenhove, C.; Van Snick, J.; Cataldo, D.; Vanbever, R., 2015:
PEGylation of antibody fragments greatly increases their local residence time following delivery to the respiratory tract

Park, J-Beom.; Kwon, Y.Min.; Lee, T-Yi.; Brim, R.; Ko, M-Chuan.; Sunahara, R.K.; Woods, J.H.; Yang, V.C., 2010:
PEGylation of bacterial cocaine esterase for protection against protease digestion and immunogenicity

Naeye, B.; Raemdonck, K.; Remaut, K.; Sproat, B.; Demeester, J.; De Smedt, S.C., 2010:
PEGylation of biodegradable dextran nanogels for siRNA delivery

Soderquist, R.G.; Milligan, E.D.; Sloane, E.M.; Harrison, J.A.; Douvas, K.K.; Potter, J.M.; Hughes, T.S.; Chavez, R.A.; Johnson, K.; Watkins, L.R.; Mahoney, M.J., 2008:
PEGylation of brain-derived neurotrophic factor for preserved biological activity and enhanced spinal cord distribution

Holmberg, V.C.; Rasch, M.R.; Korgel, B.A., 2010:
PEGylation of carboxylic acid-functionalized germanium nanowires

Ibricevic, A.; Guntsen, S.P.; Zhang, K.; Shrestha, R.; Liu, Y.; Sun, J.Yi.; Welch, M.J.; Wooley, K.L.; Brody, S.L., 2014:
PEGylation of cationic, shell-crosslinked-knedel-like nanoparticles modulates inflammation and enhances cellular uptake in the lung

Locke, A.K.; Cummins, B.M.; Abraham, A.A.; Coté, G.L., 2015:
PEGylation of concanavalin A to improve its stability for an in vivo glucose sensing assay

Zappe, H.; Snell, M.E.; Bossard, M.J., 2007:
PEGylation of cyanovirin-N, an entry inhibitor of HIV

Lei, P.; Girshick, S.L., 2014:
PEGylation of gold-decorated silica nanoparticles in the aerosol phase

Meng, F.; Manjula, B.N.; Smith, P.K.; Acharya, S.A., 2008:
PEGylation of human serum albumin: reaction of PEG-phenyl-isothiocyanate with protein

Choi, K.Young.; Min, K.Hyun.; Yoon, H.Yeol.; Kim, K.; Park, J.Hyung.; Kwon, I.Chan.; Choi, K.; Jeong, S.Young., 2011:
PEGylation of hyaluronic acid nanoparticles improves tumor targetability in vivo

Kieseier, B.C.; Calabresi, P.A., 2012:
PEGylation of interferon-β-1a: a promising strategy in multiple sclerosis

Soderquist, R.G.; Milligan, E.D.; Harrison, J.A.; Chavez, R.A.; Johnson, K.W.; Watkins, L.R.; Mahoney, M.J., 2010:
PEGylation of interleukin-10 for the mitigation of enhanced pain states

Mattos, A.; de Jager-Krikken, A.; de Haan, M.; Beljaars, L.; Poelstra, K., 2013:
PEGylation of interleukin-10 improves the pharmacokinetic profile and enhances the antifibrotic effectivity in CCl₄-induced fibrogenesis in mice

Zhang, C.; Desai, R.; Perez-Luna, V.; Karuri, N., 2015:
PEGylation of lysine residues improves the proteolytic stability of fibronectin while retaining biological activity

Kucerova, J.; Svobodova, Z.; Knotek, P.; Palarcik, J.; Vlcek, M.; Kincl, M.; Horak, D.; Autebert, J.; Viovy, J-Louis.; Bilkova, Z., 2015:
PEGylation of magnetic poly(glycidyl methacrylate) microparticles for microfluidic bioassays

Busch, A.P.; Neebe, M.; Hampp, N., 2013:
PEGylation of membrane proteins like bacteriorhodopsin as a tool to increase their stability toward ethanol

Pochechueva, T.; Chinarev, A.; Bovin, N.; Fedier, Aé.; Jacob, F.; Heinzelmann-Schwarz, V., 2015:
PEGylation of microbead surfaces reduces unspecific antibody binding in glycan-based suspension array

Suh, J.; Choy, K-Leong.; Lai, S.K.; Suk, J.Soo.; Tang, B.C.; Prabhu, S.; Hanes, J., 2008:
PEGylation of nanoparticles improves their cytoplasmic transport

Kotsokechagia, T.; Zaki, N.M.; Syres, K.; de Leonardis, P.; Thomas, A.; Cellesi, F.; Tirelli, N., 2012:
PEGylation of nanosubstrates (titania) with multifunctional reagents: at the crossroads between nanoparticles and nanocomposites

Saito-Yabe, M.; Kasuya, Y.; Yoshigae, Y.; Yamamura, N.; Suzuki, Y.; Fukuda, N.; Honma, M.; Yano, K.; Mochizuki, S-Ichi.; Okada, F.; Okada, A.; Nagayama, Y.; Tsuda, E.; Fischer, T.; Höpner, U.; Zaja, S.; Mueller, J.; Okada, J.; Kurihara, A.; Ikeda, T.; Okazaki, O., 2010:
PEGylation of osteoprotegerin/osteoclastogenesis inhibitory factor (OPG/OCIF) results in decreased uptake into rats and human liver

Nilsson, C.; Østergaard, J.; Larsen, S.Weng.; Larsen, C.; Urtti, A.; Yaghmur, A., 2015:
PEGylation of phytantriol-based lyotropic liquid crystalline particles--the effect of lipid composition, PEG chain length, and temperature on the internal nanostructure

Wang, C.; Pan, S-Rong.; Wu, H-Mei.; Wen, Y-Ting.; Zeng, X.; Feng, M., 2012:
PEGylation of polyamidoamine dendrimer and the properties for gene vectors

Kaminskas, L.M.; Kota, J.; McLeod, V.M.; Kelly, B.D.; Karellas, P.; Porter, C.Jh., 2010:
PEGylation of polylysine dendrimers improves absorption and lymphatic targeting following SC administration in rats

Britcher, L.; Barnes, T.J.; Griesser, H.J.; Prestidge, C.A., 2008:
PEGylation of porous silicon using click chemistry

Li, S.; Jiang, J.; Zou, J.; Qiao, J.; Xue, S.; Wei, L.; Long, R.; Wang, L.; Castiblanco, A.; White, N.; Ngo, J.; Mao, H.; Liu, Z-Ren.; Yang, J.J., 2012:
PEGylation of protein-based MRI contrast agents improves relaxivities and biocompatibilities

Milla, P.; Dosio, F.; Cattel, L., 2012:
PEGylation of proteins and liposomes: a powerful and flexible strategy to improve the drug delivery

Peng, F.; Wang, Y.; Sun, L.; Liu, Y.; Hu, T.; Zhang, G.; Ma, G.; Su, Z., 2013:
PEGylation of proteins in organic solution: a case study for interferon beta-1b

Jevsevar, S.; Kunstelj, M.; Porekar, V.Gaberc., 2010:
PEGylation of therapeutic proteins

Meng, F.; Tsai, A.G.; Intaglietta, M.; Acharya, S.A., 2016:
PEGylation of αα-Hb using succinimidyl propionic acid PEG 5K: Conjugation chemistry and PEG shell structure dictate respectively the oxygen affinity and resuscitation fluid like properties of PEG αα-Hbs

Noberini, R.; Mitra, S.; Salvucci, O.; Valencia, F.; Duggineni, S.; Prigozhina, N.; Wei, K.; Tosato, G.; Huang, Z.; Pasquale, E.B., 2012:
PEGylation potentiates the effectiveness of an antagonistic peptide that targets the EphB4 receptor with nanomolar affinity

Greco, C.A.; Maurer-Spurej, E.; Scott, M.D.; Kalab, M.; Nakane, N.; Ramírez-Arcos, S.M., 2011:
PEGylation prevents bacteria-induced platelet activation and biofilm formation in platelet concentrates

Caccia, D.; Ronda, L.; Frassi, R.; Perrella, M.; Del Favero, E.; Bruno, S.; Pioselli, B.; Abbruzzetti, S.; Viappiani, C.; Mozzarelli, A., 2009:
PEGylation promotes hemoglobin tetramer dissociation

Liu, C-Ying.; Li, X.; Chen, W-Yih.; Chang, L-Chiao.; Chen, Y-Fan.; Chen, H-Lung.; Sun, Y-Sen.; Lai, H-Yun.; Huang, E-Wen., 2015:
PEGylation site-dependent structural heterogeneity study of monoPEGylated human parathyroid hormone fragment hPTH(1-34)

Betancourt, T.; Byrne, J.D.; Sunaryo, N.; Crowder, S.W.; Kadapakkam, M.; Patel, S.; Casciato, S.; Brannon-Peppas, L., 2008:
PEGylation strategies for active targeting of PLA/PLGA nanoparticles

González-González, M.; Mayolo-Deloisa, K.; Rito-Palomares, M., 2012:
PEGylation, detection and chromatographic purification of site-specific PEGylated CD133-Biotin antibody in route to stem cell separation

Zündorf, I.; Dingermann, T., 2014:
PEGylation--a well-proven strategy for the improvement of recombinant drugs

Jain, A.; Jain, S.K., 2008:
PEGylation: an approach for drug delivery. A review

Caraballo, R.Horacio.; Pozo, A.Norma.; Gomez, Mía.; Semprino, M., 2011:
PEHO syndrome: a study of five Argentinian patients

Gajewski, J.B., 2009:
PEI 2010: Save the date!

Alexis, F.; Zeng, J.; Shu, W., 2006:
PEI Nanoparticles for Targeted Gene Delivery

Lynas, K., 2013 :
PEI PharmaCheck program

Glauser, W., 2014:
PEI asks residents how to improve health

Birchard, K., 2013:
PEI government announces catastrophic drug plan

Lynas, K., 2013:
PEI government signs new services agreement with PEI Pharmacists Association

Zhang, L.; Hu, C-Hua.; Cheng, S-Xue.; Zhuo, R-Xi., 2010:
PEI grafted hyperbranched polymers with polyglycerol as a core for gene delivery

Lynas, K., 2013:
PEI moves to lower generic drug prices

Gong, P.; Shi, B.; Zheng, M.; Wang, B.; Zhang, P.; Hu, D.; Gao, D.; Sheng, Z.; Zheng, C.; Ma, Y.; Cai, L., 2012:
PEI protected aptamer molecular probes for contrast-enhanced in vivo cancer imaging

Park, K., 2009:
PEI-DNA complexes with higher transfection efficiency and lower cytotoxicity

Kievit, F.M.; Veiseh, O.; Bhattarai, N.; Fang, C.; Gunn, J.W.; Lee, D.; Ellenbogen, R.G.; Olson, J.M.; Zhang, M., 2010:
PEI-PEG-Chitosan Copolymer Coated Iron Oxide Nanoparticles for Safe Gene Delivery: synthesis, complexation, and transfection

Patnaik, S.; Arif, M.; Pathak, A.; Singh, N.; Gupta, K.C., 2010:
PEI-alginate nanocomposites: efficient non-viral vectors for nucleic acids

Thomas, M.; Lange-Grünweller, K.; Dayyoub, E.; Bakowsky, U.; Weirauch, U.; Aigner, A.; Hartmann, R.K.; Grünweller, A., 2013:
PEI-complexed LNA antiseeds as miRNA inhibitors

Shi, J.; Zhang, H.; Wang, L.; Li, L.; Wang, H.; Wang, Z.; Li, Z.; Chen, C.; Hou, L.; Zhang, C.; Zhang, Z., 2013:
PEI-derivatized fullerene drug delivery using folate as a homing device targeting to tumor

Ungaro, F.; De Stefano, D.; Giovino, C.; Masuccio, A.; Miro, A.; Sorrentino, R.; Carnuccio, R.; Quaglia, F., 2013:
PEI-engineered respirable particles delivering a decoy oligonucleotide to NF-κB: inhibiting MUC2 expression in LPS-stimulated airway epithelial cells

Kim, J.; Kim, S.Wan.; Kim, W.Jong., 2011:
PEI-g-PEG-RGD/small interference RNA polyplex-mediated silencing of vascular endothelial growth factor receptor and its potential as an anti-angiogenic tumor therapeutic strategy

Zhang, S.; Bao, A.; Sun, T.; Wang, E.; Wang, J., 2015:
PEI/Zr⁴⁺-coated nanopore for selective and sensitive detection of ATP in combination with single-walled carbon nanotubes

Cheung, K.Lung.; Khor, T.Oo.; Yu, S.; Kong, A-Ng.Tony., 2008:
PEITC induces G1 cell cycle arrest on HT-29 cells through the activation of p38 MAPK signaling pathway

Tang, T.; Song, X.; Liu, Y-Fen.; Wang, W-Yue., 2014:
PEITC reverse multi-drug resistance of human gastric cancer SGC7901/DDP cell line

Carbone, A.; Gloghini, A., 2008:
PEL and HHV8-unrelated effusion lymphomas: classification and diagnosis

Richetta, A.; Amoruso, G.F.; Ascoli, V.; Natale, M.E.; Carboni, V.; Carlomagno, V.; Pezza, M.; Cimillo, M.; Maiani, E.; Mattozzi, C.; Calvieri, S., 2007:
PEL, Kaposi's sarcoma HHV8+ and idiopathic T-lymphocitopenia CD4+

Sindhi, R.; Soltys, K.; Bond, G.; Marcos, A.; Mazariegos, G. , 2007:
PELD allocation and acute liver/graft failure

Kuznetsov, N.A.; Milov, A.D.; Isaev, N.P.; Vorobjev, Y.N.; Koval, V.V.; Dzuba, S.A.; Fedorova, O.S.; Tsvetkov, Y.D., 2012:
PELDOR analysis of enzyme-induced structural changes in damaged DNA duplexes

Milov, A.D.; Samoilova, R.I.; Tsvetkov, Y.D.; De Zotti, M.; Toniolo, C.; Raap, J., 2008:
PELDOR conformational analysis of bis-labeled alamethicin aggregated in phospholipid vesicles

Giannoulis, A.; Ward, R.; Branigan, E.; Naismith, J.H.; Bode, B.E., 2014:
PELDOR in rotationally symmetric homo-oligomers

Bode, B.E.; Plackmeyer, Jörn.; Prisner, T.F.; Schiemann, O., 2008:
PELDOR measurements on a nitroxide-labeled Cu(II) porphyrin: orientation selection, spin-density distribution, and conformational flexibility

Hagelueken, G.; Ingledew, W.John.; Huang, H.; Petrovic-Stojanovska, B.; Whitfield, C.; ElMkami, H.; Schiemann, O.; Naismith, J.H., 2009:
PELDOR spectroscopy distance fingerprinting of the octameric outer-membrane protein Wza from Escherichia coli

Krstić, I.; Frolow, O.; Sezer, D.; Endeward, B.; Weigand, J.E.; Suess, B.; Engels, J.W.; Prisner, T.F., 2010:
PELDOR spectroscopy reveals preorganization of the neomycin-responsive riboswitch tertiary structure

Seyedsayamdost, M.R.; Chan, C.T.Y.; Mugnaini, V.; Stubbe, J.; Bennati, M., 2007:
PELDOR spectroscopy with DOPA-beta2 and NH2Y-alpha2s: distance measurements between residues involved in the radical propagation pathway of E. coli ribonucleotide reductase

Kuznetsov, N.A.; Milov, A.D.; Koval, V.V.; Samoilova, R.I.; Grishin, Y.A.; Knorre, D.G.; Tsvetkov, Y.D.; Fedorova, O.S.; Dzuba, S.A., 2009:
PELDOR study of conformations of double-spin-labeled single- and double-stranded DNA with non-nucleotide inserts

Madadkar-Sobhani, A.; Guallar, V., 2013:
PELE web server: atomistic study of biomolecular systems at your fingertips

van Bragt, S.; van den Bemt, L.; Kievits, R.; Merkus, P.; van Weel, C.; Schermer, T., 2015:
PELICAN: a cluster-randomized controlled trial in Dutch general practices to assess a self-management support intervention based on individual goals for children with asthma

Anonymous, 1946:
PELLAGRA and corn

Gillespie, A.T., 1940:
PELLAGRA: (With Report of a Case)

Leteurtre, Séphane.; Duhamel, A.; Salleron, J.; Grandbastien, B.; Lacroix, J.; Leclerc, F., 2013:
PELOD-2: an update of the PEdiatric logistic organ dysfunction score

Mann, M.; Cortez, V.; Vadlamudi, R., 2013:
PELP1 oncogenic functions involve CARM1 regulation

Mann, M.; Zou, Y.; Chen, Y.; Brann, D.; Vadlamudi, R., 2014:
PELP1 oncogenic functions involve alternative splicing via PRMT6

Cortez, V.; Samayoa, C.; Zamora, A.; Martinez, L.; Tekmal, R.R.; Vadlamudi, R.K., 2015:
PELP1 overexpression in the mouse mammary gland results in the development of hyperplasia and carcinoma

Ning, Z.; Zhang, Y.; Chen, H.; Wu, J.; Song, T.; Wu, Q.; Liu, F., 2015:
PELP1 suppression inhibits colorectal cancer through c-Src downregulation

Brann, D.W.; Zhang, Q-Guang.; Wang, R-Min.; Mahesh, V.B.; Vadlamudi, R.K., 2008:
PELP1--a novel estrogen receptor-interacting protein

Wan, J.; Li, X., 2013:
PELP1/MNAR suppression inhibits proliferation and metastasis of endometrial carcinoma cells

Wang, L.; Zhao, L.; Sun, H-Li., 2012:
PELP1/MNAR: a newly discovered nuclear receptor co-regulator

Chakravarty, D.; Tekmal, R.Rao.; Vadlamudi, R.K., 2010:
PELP1: A novel therapeutic target for hormonal cancers

Girard, B.J.; Daniel, A.R.; Lange, C.A.; Ostrander, J.H., 2014:
PELP1: a review of PELP1 interactions, signaling, and biology

Rashid, A.; Deyholos, M.K., 2011:
PELPK1 (At5g09530) contains a unique pentapeptide repeat and is a positive regulator of germination in Arabidopsis thaliana

Henderson, D.N., 1939:
PELVIC ENDOMETRIOSIS : (Report of 40 Cases)

Anonymous, 2011:
PELVIC fitting hip control

Frade, F.; Kadlub, N.; Soupre, V.; Cassier, S.; Audry, G.; Vazquez, M-P.; Picard, A., 2012:
PELVIS or LUMBAR syndrome: the same entity. Two case reports

Bourrat, E.; Lemarchand-Venencie, F.; Jacquemont, M-L.; El Ghoneimi, A.; Wassef, M.; Leger, J.; Morel, P., 2009:
PELVIS/SACRAL syndrome with livedoid haemangioma and amniotic band

Russell, I.C., 1903:

Marie, Hélène.; Barrere, Aélie.; Schoenstein, F.; Schoentstein, Fédérique.; Chavanne, M-Hélène.; Grosgogeat, B.; Mora, L., 2013:
PEM anchorage on titanium using catechol grafting

Rujirakul, K.; So-In, C.; Arnonkijpanich, B., 2015:
PEM-PCA: a parallel expectation-maximization PCA face recognition architecture

Rijal, K.; Mutharasan, R., 2007:
PEMC-based method of measuring DNA hybridization at femtomolar concentration directly in human serum and in the presence of copious noncomplementary strands

Baptista, Aão.Fontes.; Goes, B.Teixeira.; Menezes, D.; Gomes, Fávia.Carvalho.Alcantara.; Zugaib, Jão.; Stipursky, J.; Gomes, J.R.S.; Oliveira, Júlia.Teixeira.; Vannier-Santos, M.André.; Martinez, A.Maria.Blanco., 2010:
PEMF fails to enhance nerve regeneration after sciatic nerve crush lesion

Soboleva, T.; Malek, K.; Xie, Z.; Navessin, T.; Holdcroft, S., 2011:
PEMFC catalyst layers: the role of micropores and mesopores on water sorption and fuel cell activity

Billström, R., 2010:
PEMS syndrome--peculiar but not fictitious. A rare plasma cell disease with multiple organ system dysfunction

Korbel, J.O.; Abyzov, A.; Mu, X.Jasmine.; Carriero, N.; Cayting, P.; Zhang, Z.; Snyder, M.; Gerstein, M.B., 2010:
PEMer: a computational framework with simulation-based error models for inferring genomic structural variants from massive paired-end sequencing data

Horimoto, Aéa.R.V.Russo.; Onodera, Márcio.T.; Otto, P.A., 2011:
PENCALC: A program for penetrance estimation in autosomal dominant diseases

Sriyudthsak, K.; Iwata, M.; Hirai, M.Yokota.; Shiraishi, F., 2015:
PENDISC: a simple method for constructing a mathematical model from time-series data of metabolite concentrations

Merk, R.; Kröger, H.; Edelhäuser-Hornung, L.; Hoffmann, B., 2014:
PENELOPE-2008 Monte Carlo simulation of gamma exposure induced by ⁶⁰Co and NORM-radionuclides in closed geometries

Heuer, G.J.; Pratt, G.P.; Mason, V.R., 1920:

Joslyn, D.A., 1944:
PENICILLIN ASSAY Outline of Four-Hour Turbidimetric Method

Parry, T.G.; Laszlo, G.C.; Penistan, J.L., 1945:
PENICILLIN IN OPHTHALMOLOGY With special reference to its application in treatment outside hospital

Sorsby, A., 1945:

Anonymous, 2010:
PENICILLIN and its derivatives

Anonymous, 2014:
PENICILLIN and its use in the treatment of mastitis

Anonymous, 1947:
PENICILLIN and streptomycin solutions

Anonymous, 2010:
PENICILLIN and sulfonamides

Anonymous, 2010:
PENICILLIN and syphilis

Anonymous, 2010 :

Anonymous, 2011:
PENICILLIN by inhalation; strong nebulized solution effective in upper respiratory tract infections

Anonymous, 2014:
PENICILLIN for veterinary use

Anonymous, 1946:
PENICILLIN in infectious diseases of childhood

Anonymous, 2014:
PENICILLIN in mastitis of cows

Anonymous, 2011:
PENICILLIN in neurosyphilis

Anonymous, 2012:
PENICILLIN in plenty

Anonymous, 1946:
PENICILLIN in subacute bacterial endocarditis

Anonymous, 2014:
PENICILLIN in syphilis and gonorrhea

Anonymous, 1947:
PENICILLIN in syphilis: a review of factors concerned

Anonymous, 2014:
PENICILLIN in the treatment of venereal diseases; a review

Anonymous, 1946:
PENICILLIN preparations of the British Pharmacopoeia

Anonymous, 2012:
PENICILLIN production

Anonymous, 2014:
PENICILLIN prophylaxis of gonorrhea

Anonymous, 2010:
PENICILLIN supply and demand

Anonymous, 1947:
PENICILLIN therapy for diseases of the eye

Anonymous, 2011:
PENICILLIN therapy for peritonitis

Anonymous, 1948:
PENICILLIN treatment of primary, secondary and early latent syphilis

Anonymous, 2010:
PENICILLIN: is it on the skids?

Anonymous, 2011:
PENICILLIN; a second brief review

Anonymous, 2011:
PENICILLIN; administration and dosage

Shaw, L.M., 2007:
PENN biomarker core of the Alzheimer's disease Neuroimaging Initiative

Trojanowski, J.Q., 2007:
PENN neurodegenerative disease research - in the spirit of Benjamin Franklin

Anonymous, 2012:
PENNSYLVANIA, summary of vital statistics, 1945

Anonymous, 1947:
PENROSE Tumor Clinic

Tadini, G.; Restano, L.; Happle, R.; Itin, P., 2012:
PENS syndrome: a new neurocutaneous phenotype

Anonymous, 1921:
PENSIONS ADMINISTRATION: Departmental Committee's Report

Welch, S.; Sharland, M.; Lyall, E.G.Hermione.; Tudor-Williams, G.; Niehues, T.; Wintergerst, U.; Bunupuradah, T.; Hainaut, M.; Della Negra, M.; Pena, M.José.Mellado.; Amador, Jé.Tomas.Ramos.; Gattinara, G.Castelli.; Compagnucci, A.; Faye, A.; Giaquinto, C.; Gibb, D.M.; Gandhi, K.; Forcat, S.; Buckberry, K.; Harper, L.; Königs, C.; Patel, D.; Bastiaans, D.; Aboulker, J-P.; Babiker, A.; Bohlin, A-B.; Butler, K.; Castelli-Gattinara, G.; Clayden, P.; Compagnucci, A.; Darbyshire, J.N.; Debré, M.;, 2010:
PENTA 2009 guidelines for the use of antiretroviral therapy in paediatric HIV-1 infection

Anonymous, 2016:
PENTACRESOL: a virucidal antiseptic

Anonymous, 2014:
PENTOTHAL anesthesia in urology

Anonymous, 1947:

Anonymous, 2014:
PENTOTHAL sodium anesthesia in vaginal delivery

Anonymous, 1946:
PENTOTHAL sodium; review of recent literature

Anonymous, 2014:
PENTOTHAL-PROCAINE obstetrical analgesia

Sadtler, Véronique.; Rondon-Gonzalez, M.; Acrement, A.; Choplin, L.; Marie, E., 2011:
PEO-Covered Nanoparticles by Emulsion Inversion Point (EIP) Method

Gau-Racine, J.; Lal, J.; Zeghal, M.; Auvray, Lïc., 2007:
PEO-PPO block copolymer vectors do not interact directly with DNA but with lipid membranes

Alvarez-Lorenzo, C.; Sosnik, A.; Concheiro, A., 2012:
PEO-PPO block copolymers for passive micellar targeting and overcoming multidrug resistance in cancer therapy

da Silva, L.Henrique.M.; da Silva, M.C.Hespanhol.; Francisco, K.R.; Cardoso, M.V.C.; Minim, L.A.; Coimbra, J.S.R., 2008:
PEO-[M(CN)5NO](x-) (M = Fe, Mn, or Cr) interaction as a driving force in the partitioning of the pentacyanonitrosylmetallate anion in ATPS: strong effect of the central atom

Anonymous, 2014:
PEOPLE and planning

Jansen, E.J.P.; Pieper, J.; Gijbels, M.J.J.; Guldemond, N.A.; Riesle, J.; Van Rhijn, L.W.; Bulstra, S.K.; Kuijer, R., 2008:
PEOT/PBT based scaffolds with low mechanical properties improve cartilage repair tissue formation in osteochondral defects

Kurzawa, L.; Pellerano, M.; Morris, M.C., 2010:
PEP and CADY-mediated delivery of fluorescent peptides and proteins into living cells

Casale, J.A., 2009:
PEP for bat exposure?

El Amari, E.Boffi.; Iten, A.; Sacroug, T.; Hirschel, B., 2008 :
PEP or no PEP? The rational of initiating postexposure prophylaxis

Tang, Y.; Li, R.; Lin, G.; Li, L., 2015:
PEP search in MyCompoundID: detection and identification of dipeptides and tripeptides using dimethyl labeling and hydrophilic interaction liquid chromatography tandem mass spectrometry

Zhang, L.; Dong, X-Wei.; Wang, J-Ning.; Tang, J-Ming.; Yang, J-Ye.; Guo, L-Yun.; Zheng, F.; Kong, X.; Huang, Y-Zhang.; Chen, S-You., 2013:
PEP-1-CAT-transduced mesenchymal stem cells acquire an enhanced viability and promote ischemia-induced angiogenesis

Youn, J.Kyu.; Kim, D.Won.; Kim, S.Tae.; Park, S.Yeon.; Yeo, E.Ji.; Choi, Y.Joo.; Lee, H-Ran.; Kim, D-Soo.; Cho, S-Woo.; Han, K.Hyung.; Park, J.; Eum, W.Sik.; Hwang, H.Sook.; Choi, S.Young., 2015:
PEP-1-HO-1 prevents MPTP-induced degeneration of dopaminergic neurons in a Parkinson's disease mouse model

Ahn, E.Hee.; Kim, D.Won.; Shin, M.Jea.; Kim, H.Ri.; Kim, S.Mi.; Woo, S.Jung.; Eom, S.Ae.; Jo, H.Sang.; Kim, D-Soo.; Cho, S-Woo.; Park, J.; Eum, W.Sik.; Choi, S.Young., 2014:
PEP-1-PEA-15 protects against toxin-induced neuronal damage in a mouse model of Parkinson's disease

Kim, M.Jin.; Jeong, H.Jae.; Kim, D.Won.; Sohn, E.Jeong.; Jo, H.Sang.; Kim, D-Soo.; Kim, H.Ah.; Park, E.Young.; Park, J.Hoon.; Son, O.; Han, K.Hyung.; Park, J.; Eum, W.Sik.; Choi, S.Young., 2014:
PEP-1-PON1 protein regulates inflammatory response in raw 264.7 macrophages and ameliorates inflammation in a TPA-induced animal model

Kim, M.Jin.; Kim, D.Won.; Park, J.Hwan.; Kim, S.Jin.; Lee, C.Hern.; Yong, J.In.; Ryu, E.Ji.; Cho, S.Bin.; Yeo, H.Ji.; Hyeon, J.; Cho, S-Woo.; Kim, D-Soo.; Son, O.; Park, J.; Han, K.Hyung.; Cho, Y.Shin.; Eum, W.Sik.; Choi, S.Young., 2013:
PEP-1-SIRT2 inhibits inflammatory response and oxidative stress-induced cell death via expression of antioxidant enzymes in murine macrophages

Zhang, Y-En.; Fu, S-Zhi.; Li, X-Quan.; Chen, P.; Wang, J-Liang.; Che, J.; Tang, J-Ming.; Chen, S-You.; Wang, J-Ning., 2011:
PEP-1-SOD1 protects brain from ischemic insult following asphyxial cardiac arrest in rats

Kim, D-Soo.; Sohn, E.Jeong.; Kim, D.Won.; Kim, Y.Nam.; Eom, S.Ae.; Yoon, G.Hyeon.; Cho, S-Woo.; Lee, S-Hyun.; Hwang, H.Sook.; Cho, Y.Shin.; Park, J.; Eum, W.Sik.; Choi, S.Young., 2013:
PEP-1-p18 prevents neuronal cell death by inhibiting oxidative stress and Bax expression

Kleerekoper, Q.K.; Putkey, J.A., 2009:
PEP-19, an intrinsically disordered regulator of calmodulin signaling

Maupetit, J.; Derreumaux, P.; Tuffery, P., 2009:
PEP-FOLD: an online resource for de novo peptide structure prediction

Thévenet, P.; Shen, Y.; Maupetit, J.; Guyon, Fédéric.; Derreumaux, P.; Tufféry, P., 2012:
PEP-FOLD: an updated de novo structure prediction server for both linear and disulfide bonded cyclic peptides

Saladin, A.; Rey, J.; Thévenet, P.; Zacharias, M.; Moroy, G.; Tufféry, P., 2014:
PEP-SiteFinder: a tool for the blind identification of peptide binding sites on protein surfaces

Siller, G.; Rosen, R.; Freeman, M.; Welburn, P.; Katsamas, J.; Ogbourne, S.M., 2011:
PEP005 (ingenol mebutate) gel for the topical treatment of superficial basal cell carcinoma: results of a randomized phase IIa trial

Siller, G.; Gebauer, K.; Welburn, P.; Katsamas, J.; Ogbourne, S.M., 2009:
PEP005 (ingenol mebutate) gel, a novel agent for the treatment of actinic keratosis: results of a randomized, double-blind, vehicle-controlled, multicentre, phase IIa study

Albani, M.C.; Castaings, L.; Wötzel, S.; Mateos, J.L.; Wunder, Jörg.; Wang, R.; Reymond, M.; Coupland, G., 2013:
PEP1 of Arabis alpina is encoded by two overlapping genes that contribute to natural genetic variation in perennial flowering

Gebhard-Achilles, W., 2014:
PEP: patient-supported esthetic protocol

Prior, D.; Paardekooper, C.; Waight, C.; Jackson, P., 2010:
PEPA: bridging the gap in palliative care

Hugl, B.; Nevelsteen, A.; Daenens, K.; Perez, M.Alonso.; Heider, P.; Railo, M.; Schelzig, H.; Gluecklich, B.; Balzer, K.; Vermassen, F.; De Smit, P.; Fraedrich, G., 2009:
PEPE II--a multicenter study with an end-point heparin-bonded expanded polytetrafluoroethylene vascular graft for above and below knee bypass surgery: determinants of patency

Shelton, J.D., 2012:
PEPFAR and adult mortality

Emanuel, E.J., 2012:
PEPFAR and maximizing the effects of global health assistance

Anonymous, 2007:
PEPFAR and the fight against HIV/AIDS

Katz, I.T.; Bassett, I.V.; Wright, A.A., 2013:
PEPFAR in transition--implications for HIV care in South Africa

Traynor, K., 2010:
PEPFAR pharmacist thrives on unusual challenges

Kruk, M.E.; Jakubowski, A.; Rabkin, M.; Elul, B.; Friedman, M.; El-Sadr, W., 2012:
PEPFAR programs linked to more deliveries in health facilities by African women who are not infected with HIV

Krauss, K., 2007:
PEPFAR reauthorization: can US aid keep up with the AIDS pandemic?

Anonymous, 2008:
PEPFAR renewal repeals HIV travel ban

Abrams, E.J.; Simonds, R.J.; Modi, S.; Rivadeneira, E.; Vaz, P.; Kankasa, C.; Tindyebwa, D.; Phelps, B.Ryan.; Bowsky, S.; Teasdale, C.A.; Koumans, E.; Ruff, A.J., 2012:
PEPFAR scale-up of pediatric HIV services: innovations, achievements, and challenges

Howard, A.A.; Gasana, M.; Getahun, H.; Harries, A.; Lawn, S.D.; Miller, B.; Nelson, L.; Sitienei, J.; Coggin, W.L., 2012:
PEPFAR support for the scaling up of collaborative TB/HIV activities

Gostin, L.O., 2013:
PEPFAR's antiprostitution pledge: spending power and free speech in tension

Gostin, L.O., 2013:
PEPFAR's antiprostitution "loyalty oath": Politicizing Public Health

Navario, P., 2009:
PEPFAR's biggest success is also its largest liability

Goosby, E., 2015:
PEPFAR's commitment to country ownership and achieving an AIDS-free generation

Needle, R.; Fu, J.; Beyrer, C.; Loo, V.; Abdul-Quader, A.S.; McIntyre, J.A.; Li, Z.; Mbwambo, J.K.K.; Muthui, M.; Pick, B., 2012:
PEPFAR's evolving HIV prevention approaches for key populations--people who inject drugs, men who have sex with men, and sex workers: progress, challenges, and opportunities

Morris, A., 2014:
PEPFAR's new leader faces challenges as program enters second decade

Holmes, C.B.; Blandford, J.M.; Sangrujee, N.; Stewart, S.R.; DuBois, A.; Smith, T.R.; Martin, J.C.; Gavaghan, A.; Ryan, C.A.; Goosby, E.P., 2012:
PEPFAR's past and future efforts to cut costs, improve efficiency, and increase the impact of global HIV programs

Bryant, M.; Beard, J.; Sabin, L.; Brooks, M.I.; Scott, N.; Larson, B.A.; Biemba, G.; Miller, C.; Simon, J., 2012:
PEPFAR's support for orphans and vulnerable children: some beneficial effects, but too little data, and programs spread thin

Palen, J.; El-Sadr, W.; Phoya, A.; Imtiaz, R.; Einterz, R.; Quain, E.; Blandford, J.; Bouey, P.; Lion, A., 2012:
PEPFAR, health system strengthening, and promoting sustainability and country ownership

von Zinkernagel, D., 2015:
PEPFAR: bringing research and practice together for children by predicting long-term outcomes for children affected by AIDS

Anonymous, 2011:
PEPPER can help you focus on likely RAC targets

Kulus, J., 2014:
PEPPER gives corporate compliance guidance

Anonymous, 1948:
PEPPERMINT and spearmint

Zhou, A.; Zhang, F.; Chen, J.Y., 2011:
PEPPI: a peptidomic database of human protein isoforms for proteomics experiments

Canseco-Gonzalez, D.; Gniewek, A.; Szulmanowicz, M.; Müller-Bunz, H.; Trzeciak, A.M.; Albrecht, M., 2012:
PEPPSI-type palladium complexes containing basic 1,2,3-triazolylidene ligands and their role in Suzuki-Miyaura catalysis

Yamaguchi, Y.; Huffaker, A.; Bryan, A.C.; Tax, F.E.; Ryan, C.A., 2010:
PEPR2 is a second receptor for the Pep1 and Pep2 peptides and contributes to defense responses in Arabidopsis

Zimmer, R., 2014:
PEPSE and coke: should we be increasing awareness of HIV post-exposure prophylaxis for consensual risk exposures?

Zhang, Q.; Liu, Q.; Wu, J.; Wang, C.; Peng, J.; Ma, X.; Liu, K., 2009:
PEPT1 involved in the uptake and transepithelial transport of cefditoren in vivo and in vitro

Wang, L.; Wang, C.; Liu, Q.; Meng, Q.; Huo, X.; Sun, P.; Yang, X.; Sun, H.; Zhen, Y.; Peng, J.; Ma, X.; Liu, K., 2015:
PEPT1- and OAT1/3-mediated drug-drug interactions between bestatin and cefixime in vivo and in vitro in rats, and in vitro in human

Anonymous, 1948:
PEPTIC ulcer; its causes and therapy

Litake, G.M.; Ghole, V.S.; Niphadkar, K.B.; Joshi, S.G., 2009:
PER-1-type extended-spectrum beta-lactamase-producing Acinetobacter baumannii clinical isolates from India

Girlich, D.; Poirel, L.; Nordmann, P., 2010:
PER-6, an extended-spectrum beta-lactamase from Aeromonas allosaccharophila

Sanders, B.P.; Edo-Matas, D.; Custers, J.H.H.V.; Koldijk, M.H.; Klaren, V.; Turk, M.; Luitjens, A.; Bakker, W.A.M.; Uytdehaag, F.; Goudsmit, J.; Lewis, J.A.; Schuitemaker, H., 2013:
PER.C6(®) cells as a serum-free suspension cell platform for the production of high titer poliovirus: a potential low cost of goods option for world supply of inactivated poliovirus vaccine

Hsu, C-Ming.; Lin, P-Mei.; Lai, C-Chih.; Lin, H-Ching.; Lin, S-Fung.; Yang, M-Yu., 2015:
PER1 and CLOCK: potential circulating biomarkers for head and neck squamous cell carcinoma

Balakrishnan, A.; Stearns, A.T.; Ashley, S.W.; Rhoads, D.B.; Tavakkolizadeh, A., 2012:
PER1 modulates SGLT1 transcription in vitro independent of E-box status

Liu, Z.; Huang, M.; Wu, X.; Shi, G.; Xing, L.; Dong, Z.; Qu, Z.; Yan, J.; Yang, L.; Panda, S.; Xu, Y., 2015:
PER1 phosphorylation specifies feeding rhythm in mice

Grimaldi, B.; Bellet, M.Maria.; Katada, S.; Astarita, G.; Hirayama, J.; Amin, R.H.; Granneman, J.G.; Piomelli, D.; Leff, T.; Sassone-Corsi, P., 2011:
PER2 controls lipid metabolism by direct regulation of PPARγ

Zani, F.; Breasson, L.; Becattini, B.; Vukolic, A.; Montani, J-Pierre.; Albrecht, U.; Provenzani, A.; Ripperger, J.A.; Solinas, G., 2013:
PER2 promotes glucose storage to liver glycogen during feeding and acute fasting by inducing Gys2 PTG and G L expression

Ramanathan, C.; Stowie, A.; Smale, L.; Nunez, A., 2010:
PER2 rhythms in the amygdala and bed nucleus of the stria terminalis of the diurnal grass rat (Arvicanthis niloticus)

Forbes, E.E.; Dahl, R.E.; Almeida, J.R.C.; Ferrell, R.E.; Nimgaonkar, V.L.; Mansour, H.; Sciarrillo, S.R.; Holm, S.M.; Rodriguez, E.E.; Phillips, M.L., 2012:
PER2 rs2304672 polymorphism moderates circadian-relevant reward circuitry activity in adolescents

Santos, B.; Marques, T.; Malta, Mísa.; Gameleira, F.; Secolin, R.; Andrade, T.; Gitaí, Lívia.; Gitaí, D., 2015:
PER2 rs2304672, CLOCK rs1801260, and PER3 rs57875989 polymorphisms are not associated with juvenile myoclonic epilepsy

Lavebratt, C.; Sjöholm, L.K.; Partonen, T.; Schalling, M.; Forsell, Y., 2010:
PER2 variantion is associated with depression vulnerability

Lee, H-Jeong.; Kim, L.; Kang, S-Gul.; Yoon, H-Kyoung.; Choi, J-Eun.; Park, Y-Min.; Kim, S.Ju.; Kripke, D.F., 2011:
PER2 variation is associated with diurnal preference in a Korean young population

Viola, A.U.; James, L.M.; Archer, S.N.; Dijk, D-Jan., 2008:
PER3 polymorphism and cardiac autonomic control: effects of sleep debt and circadian phase

Brower, K.J.; Wojnar, M.; Sliwerska, E.; Armitage, R.; Burmeister, M., 2012:
PER3 polymorphism and insomnia severity in alcohol dependence

Goel, N.; Banks, S.; Mignot, E.; Dinges, D.F., 2009:
PER3 polymorphism predicts cumulative sleep homeostatic but not neurobehavioral changes to chronic partial sleep deprivation

Hong, Z.; Feng, Z.; Sai, Z.; Tao, S., 2015:
PER3, a novel target of miR-103, plays a suppressive role in colorectal cancer in vitro

Madsen, T.E., 2010:
PERC bleeding risk calculation and resultant test threshold may be inappropriate

Ganz, A.; Gandhi, S.Rajan.; Schafer, J.; Singh, T.; Puleo, E.; Mullett, G.; Wilson, C., 2012:
PERCEPT: indoor navigation for the blind and visually impaired

Lehtonen, L.; Rautava, L.; Korvenranta, E.; Korvenranta, H.; Peltola, M.; Häkkinen, U., 2011:
PERFECT preterm infant study

Häkkinen, U.; Malmivaara, A.; Sund, R., 2011:
PERFECT--conclusions and future developments

Bortolotti, V.; Fantazzini, P.; Gombia, M.; Greco, D.; Rinaldin, G.; Sykora, S., 2011:
PERFIDI filters to suppress and/or quantify relaxation time components in multi-component systems: an example for fat-water systems

Sykora, S.; Bortollotti, V.; Fantazzini, P., 2007:
PERFIDI: parametrically enabled relaxation filters with double and multiple inversion

Ross, A.; Letourneau, C., 1939:
PERFORATED PEPTIC ULCERS : (Analysis of a Series of 228 Consecutive Cases)

Anonymous, 1945:
PERFORATED peptic ulcer

Maxted, G., 1920:
PERFORATING WOUNDS OF THE EYE: An investigation of 106 cases occurring in Soldiers at a Military Ophthalmic Centre in London

Everett, W., 1925:

Caravita, S.; Faini, A.; Carolino D'Araujo, S.; Dewachter, Céline.; Chomette, L.; Bondue, A.; Naeije, R.; Parati, G.; Vachiéry, J-Luc., 2018:
Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: Role of the pre-capillary component

Tzallas, A.T.; Tsipouras, M.G.; Rigas, G.; Tsalikakis, D.G.; Karvounis, E.C.; Chondrogiorgi, M.; Psomadellis, F.; Cancela, J.; Pastorino, M.; Waldmeyer, Mía.Teresa.Arredondo.; Konitsiotis, S.; Fotiadis, D.I., 2015:
PERFORM: a system for monitoring, assessment and management of patients with Parkinson's disease

Anonymous, 2014:
PERFUMES in medicine

Paull, R., 1947:

Bannatyne, G.A., 1898:

Beller, M.; Bulankina, A.V.; Hsiao, H-Hsuan.; Urlaub, H.; Jäckle, H.; Kühnlein, R.P., 2011:
PERILIPIN-dependent control of lipid droplet structure and fat storage in Drosophila

Lang, B.T., 1920:
PERIMETRY: The Methods, Means, and Manner of Determining the Size of a Field or Scotoma

Day, R.V., 1923:

Sato, F.; Wu, Y.; Bhawal, U.Kumar.; Liu, Y.; Imaizumi, T.; Morohashi, S.; Kato, Y.; Kijima, H., 2011:
PERIOD1 (PER1) has anti-apoptotic effects, and PER3 has pro-apoptotic effects during cisplatin (CDDP) treatment in human gingival cancer CA9-22 cells

Rawashdeh, O.; Jilg, A.; Jedlicka, P.; Slawska, J.; Thomas, L.; Saade, A.; Schwarzacher, S.W.; Stehle, Jörg.H., 2015:
PERIOD1 coordinates hippocampal rhythms and memory processing with daytime

Sato, F.; Nagata, C.; Liu, Y.; Suzuki, T.; Kondo, J.; Morohashi, S.; Imaizumi, T.; Kato, Y.; Kijima, H., 2010:
PERIOD1 is an anti-apoptotic factor in human pancreatic and hepatic cancer cells

Garaulet, M.; Corbalán-Tutau, M.Dolores.; Madrid, J.A.; Baraza, J.C.; Parnell, L.D.; Lee, Y-Chi.; Ordovas, J.M., 2010:
PERIOD2 variants are associated with abdominal obesity, psycho-behavioral factors, and attrition in the dietary treatment of obesity

Dijk, D-Jan.; Archer, S.N., 2010:
PERIOD3, circadian phenotypes, and sleep homeostasis

Anonymous, 2010:
PERIODICITY of influenza

Romanos, G.E.; Asnani, K.P.; Hingorani, D.; Deshmukh, V.L., 2013:
PERIOSTIN: role in formation and maintenance of dental tissues

Johnson, H.H., 1922:

Cho, M.; Aaker, G.; DʼAmico, D.J.; Kiss, Sárd., 2011:

Komiyama, N., 2012:
PERISCOPE (Pioglitazone Effect on Regression of Intravascular Sonographic Coronary Obstruction Prospective Evaluation) trial

Launay, D.; Montani, D.; Hassoun, P.M.; Cottin, V.; Le Pavec, Jérôme.; Clerson, P.; Sitbon, O.; Jaïs, X.; Savale, L.; Weatherald, J.; Sobanski, V.; Mathai, S.C.; Shafiq, M.; Cordier, J-François.; Hachulla, E.; Simonneau, Gérald.; Humbert, M., 2018:
Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis

Marx, N., 2008:
PERISCOPE and the effect of pioglitazone on the progression of coronary artery disease in patients with diabetes

Canet, J.; Hardman, J.; Sabaté, S.; Langeron, O.; Abreu, M.Gama.de.; Gallart, L.; Belda, J.; Markstaller, K.; Pelosi, P.; Mazo, V., 2012:
PERISCOPE study: predicting post-operative pulmonary complications in Europe

Anonymous, 2008:
PERISCOPE: pioglitazone offers the right cluster of effects to confer benefit in type 2 diabetes

Anonymous, 1948:

Gupta, S.; McGrath, B.; Cavener, D.R., 2010:
PERK (EIF2AK3) regulates proinsulin trafficking and quality control in the secretory pathway

Moore, C.E.; Omikorede, O.; Gomez, E.; Willars, G.B.; Herbert, T.P., 2011:
PERK activation at low glucose concentration is mediated by SERCA pump inhibition and confers preemptive cytoprotection to pancreatic β-cells

Lin, Y.; Huang, G.; Jamison, S.; Li, J.; Harding, H.P.; Ron, D.; Lin, W., 2014:
PERK activation preserves the viability and function of remyelinating oligodendrocytes in immune-mediated demyelinating diseases

Cavener, D.R.; Gupta, S.; McGrath, B.C., 2011:
PERK in beta cell biology and insulin biogenesis

Avivar-Valderas, A.; Salas, E.; Bobrovnikova-Marjon, E.; Diehl, J.Alan.; Nagi, C.; Debnath, J.; Aguirre-Ghiso, J.A., 2011:
PERK integrates autophagy and oxidative stress responses to promote survival during extracellular matrix detachment

Gao, Y.; Sartori, D.J.; Li, C.; Yu, Q-Chun.; Kushner, J.A.; Simon, M.Celeste.; Diehl, J.Alan., 2013:
PERK is required in the adult pancreas and is essential for maintenance of glucose homeostasis

Devi, L.; Ohno, M., 2015:
PERK mediates eIF2α phosphorylation responsible for BACE1 elevation, CREB dysfunction and neurodegeneration in a mouse model of Alzheimer's disease

Zhang, X.; Fu, Y.; Xu, X.; Li, M.; Du, L.; Han, Y.; Ge, Y., 2015:
PERK pathway are involved in NO-induced apoptosis in endothelial cells cocultured with RPE under high glucose conditions

Gupta, S.; McGrath, B.; Cavener, D.R., 2010:
PERK regulates the proliferation and development of insulin-secreting beta-cell tumors in the endocrine pancreas of mice

Humphrey, T.V.; Haasen, K.E.; Aldea-Brydges, M.Grace.; Sun, H.; Zayed, Y.; Indriolo, E.; Goring, D.R., 2016:
PERK-KIPK-KCBP signalling negatively regulates root growth in Arabidopsis thaliana

Meares, G.P.; Liu, Y.; Rajbhandari, R.; Qin, H.; Nozell, S.E.; Mobley, J.A.; Corbett, J.A.; Benveniste, E.N., 2014:
PERK-dependent activation of JAK1 and STAT3 contributes to endoplasmic reticulum stress-induced inflammation

Park, M.A.; Yacoub, A.; Sarkar, D.; Emdad, L.; Rahmani, M.; Spiegel, S.; Koumenis, C.; Graf, M.; Curiel, D.T.; Grant, S.; Fisher, P.B.; Dent, P., 2008:
PERK-dependent regulation of MDA-7/IL-24-induced autophagy in primary human glioma cells

Yacoub, A.; Hamed, H.A.; Allegood, J.; Mitchell, C.; Spiegel, S.; Lesniak, M.S.; Ogretmen, B.; Dash, R.; Sarkar, D.; Broaddus, W.C.; Grant, S.; Curiel, D.T.; Fisher, P.B.; Dent, P., 2010:
PERK-dependent regulation of ceramide synthase 6 and thioredoxin play a key role in mda-7/IL-24-induced killing of primary human glioblastoma multiforme cells

Bobrovnikova-Marjon, E.; Hatzivassiliou, G.; Grigoriadou, C.; Romero, M.; Cavener, D.R.; Thompson, C.B.; Diehl, J.Alan., 2008:
PERK-dependent regulation of lipogenesis during mouse mammary gland development and adipocyte differentiation

Masuda, M.; Miyazaki-Anzai, S.; Levi, M.; Ting, T.C.; Miyazaki, M., 2014:
PERK-eIF2α-ATF4-CHOP signaling contributes to TNFα-induced vascular calcification

Dey, S.; Tameire, F.; Koumenis, C., 2013:
PERK-ing up autophagy during MYC-induced tumorigenesis

Rouschop, K.M.; Dubois, L.J.; Keulers, T.G.; van den Beucken, T.; Lambin, P.; Bussink, J.; van der Kogel, A.J.; Koritzinsky, M.; Wouters, B.G., 2013:
PERK/eIF2α signaling protects therapy resistant hypoxic cells through induction of glutathione synthesis and protection against ROS

Ma, T.; Klann, E., 2014:
PERK: a novel therapeutic target for neurodegenerative diseases?

Pagani, C.; Jacalan-Baras, J., 2009:
PERL of wisdom: a tool to help bedside nurses remember available evidence-based resources

Slavin, S.J.; Schindler, D.; Chibnall, J.T.; Fendell, G.; Shoss, M., 2013:
PERMA: a model for institutional leadership and culture change

Rougeron, V.; Waleckx, E.; Hide, M.; DE Meeûs, T.; Arevalo, J.; Llanos-Cuentas, A.; Bañuls, A.L., 2008:
PERMANENT GENETIC RESOURCES: A set of 12 microsatellite loci for genetic studies of Leishmania braziliensis

Zhou, X.; Wang, Y.; Chen, X.; Lin, Q.; Fang, W.; Wei, D., 2008:
PERMANENT GENETIC RESOURCES: A set of primer pairs for amplifying the complete mitochondrial DNA of endangered Chinese egret (Aves, Ardeidae, Egretta eulophotes)

Dias, I.M.G.; Amato, G.; Carvalho, M.R.S.; Cunha, H.M.; Paglia, A.P.; Desalle, R.; Fonseca, C.G., 2008:
PERMANENT GENETIC RESOURCES: Characterization of eight microsatellite loci in the woolly mouse opossum, Micoureus paraguayanus, isolated from Micoureus demerarae

Hanson, T.R.; Brunsfeld, S.J.; Finegan, B.; Waits, L.P., 2008:
PERMANENT GENETIC RESOURCES: Characterization of microsatellite markers for the almendro (Dipteryx panamensis), a tetraploid rainforest tree

Dubey, S.; Brown, G.P.; Madsen, T.; Shine, R., 2008:
PERMANENT GENETIC RESOURCES: Characterization of tri- and tetranucleotide microsatellite loci for the slatey-grey snake (Stegonotus cucullatus, Colubridae)

Trung, L.Quang.; VAN Puyvelde, K.; Triest, L., 2008:
PERMANENT GENETIC RESOURCES: Consensus primers of cyp73 genes discriminate willow species and hybrids (Salix, Salicaceae)

Donaldson, F.R.; Vercoe, P.E., 2008:
PERMANENT GENETIC RESOURCES: Cross-family amplification: microsatellites isolated from Macropodidae are polymorphic in Potoroidae

Zhang, J.; Yao, X.; Wei, X.; Chen, L.; Jiang, M., 2008:
PERMANENT GENETIC RESOURCES: Development and characterization of 14 polymorphic microsatellite loci in the endangered tree Euptelea pleiospermum (Eupteleaceae)

Escribano, P.; Viruel, M.A.; Hormaza, J.I., 2008:
PERMANENT GENETIC RESOURCES: Development of 52 new polymorphic SSR markers from cherimoya (Annona cherimola Mill.): transferability to related taxa and selection of a reduced set for DNA fingerprinting and diversity studies

Guzinski, J.; Saint, K.M.; Gardner, M.G.; Donnellan, S.C.; Bull, C.Michael., 2008:
PERMANENT GENETIC RESOURCES: Development of microsatellite markers and analysis of their inheritance in the Australian reptile tick, Bothriocroton hydrosauri

Pérez, M.; Guiñez, R.; Llavona, A.; Toro, J.E.; Astorga, M.; Presa, P., 2008:
PERMANENT GENETIC RESOURCES: Development of microsatellite markers for the ecosystem bioengineer mussel Perumytilus purpuratus and cross-priming testing in six Mytilinae genera

Zhong, S.; Yang, B.; Alfenas, A.Couto., 2008:
PERMANENT GENETIC RESOURCES: Development of microsatellite markers for the guava rust fungus, Puccinia psidii

Geng, Q.F.; Lian, C.L.; Tao, J.M.; Hogetsu, T., 2008:
PERMANENT GENETIC RESOURCES: Development of microsatellite markers for two nonviviparous mangrove species, Acanthus ilicifolius and Lumnitzera racemosa

Ducarme, V.; Risterucci, A.M.; Wesselingh, R.A., 2008:
PERMANENT GENETIC RESOURCES: Development of microsatellite markers in Rhinanthus angustifolius and cross-species amplification

Iwata, Y.; Lian, C.L.; Sakurai, Y., 2008:
PERMANENT GENETIC RESOURCES: Development of microsatellite markers in the Japanese common squid Todarodes pacificus (Ommastrephidae)

Cibrián-Jaramillo, Aélica.; Hahn, W.J.; Desalle, R., 2008:
PERMANENT GENETIC RESOURCES: Development of microsatellite markers of the Mexican understorey palm Chamaedorea elegans, cross-species genotyping, and amplification in congeners

Piaggio, A.J.; Johnston, J.J.; Perkins, S.L., 2008:
PERMANENT GENETIC RESOURCES: Development of polymorphic microsatellite loci for the common vampire bat, Desmodus rotundus (Chiroptera: Phylostomidae)

Anderson, C.M.; Sarver, S.K., 2008:
PERMANENT GENETIC RESOURCES: Development of polymorphic microsatellite loci for the endangered Topeka shiner, Notropis topeka

Kikuchi, S.; Shibata, M., 2008:
PERMANENT GENETIC RESOURCES: Development of polymorphic microsatellite markers in Acer mono Maxim

Tringali, M.D.; Seyoum, S.; Carney, S.L.; Davis, M.C.; Rodriguez-Lopez, M.A.; Reynolds Iii, J.E.; Haubold, E., 2008:
PERMANENT GENETIC RESOURCES: Eighteen new polymorphic microsatellite markers for the endangered Florida manatee, Trichechus manatus latirostris

Crawford, N.G.; Hagen, C.; Sahli, H.F.; Stacy, E.A.; Glenn, T.C., 2008:
PERMANENT GENETIC RESOURCES: Fifteen polymorphic microsatellite DNA loci from Hawaii's Metrosideros polymorpha (Myrtaceae: Myrtales), a model species for ecology and evolution

Kirchoff, V.S.; Peacock, M.M.; Teglas, M.B., 2008:
PERMANENT GENETIC RESOURCES: Identification and characterization of 14 polymorphic microsatellite loci in the argasid tick Ornithodoros coriaceus

Hamilton, P.B.; Tyler, C.R., 2008:
PERMANENT GENETIC RESOURCES: Identification of microsatellite loci for parentage analysis in roach Rutilus rutilus and eight other cyprinid fish by cross-species amplification, and a novel test for detecting hybrids between roach and other cyprinids

Stearns, F.; Boles, S.; Hurston, H.; Vo, T.; Butler, D.; Shuham, W.; Juenger, T.E., 2008:
PERMANENT GENETIC RESOURCES: Identification of nuclear microsatellite loci for Ipomopsis aggregata and the distribution of pairwise relatedness in a natural population

Sellas, A.B.; Feldheim, K.A.; Bowie, R.C.K., 2008:
PERMANENT GENETIC RESOURCES: Isolation and characterization of 10 tetranucleotide microsatellite loci in an enigmatic East African bird, the spot-throat (Modulatrix stictigula)

Vila, M.; Robles, H.; Ciudad, C.; Olea, P.P.; Baglione, V., 2008:
PERMANENT GENETIC RESOURCES: Isolation and characterization of 12 microsatellite markers in the middle-spotted woodpecker (Dendrocopos medius)

Shao, C.W.; Liao, X.; Chen, S.L., 2008:
PERMANENT GENETIC RESOURCES: Isolation and characterization of microsatellite DNA loci from the southern flounder, Paralichthys lethostigma

Ramey, A.; Graziano, S.L.; Nielsen, J.L., 2008:
PERMANENT GENETIC RESOURCES: Isolation and characterization of microsatellite loci from the Arctic cisco (Coregonus autumnalis)

Kim, K.Seok.; Coates, B.S.; Hellmich, R.L.; Sumerford, D.V.; Sappington, T.W., 2008:
PERMANENT GENETIC RESOURCES: Isolation and characterization of microsatellite loci from the European corn borer, Ostrinia nubilalis (Hübner) (Insecta: Lepidoptera: Crambidae)

Marino, I.A.M.; Barbisan, F.; Gennari, M.; Bisol, P.Maria.; Zane, L., 2008:
PERMANENT GENETIC RESOURCES: Isolation and characterization of microsatellite loci in the Mediterranean shore crab Carcinus aestuarii (Decapoda, Portunidae)

Jensen, T.; Nutt, K.J.; Seal, B.S.; Fernandes, L.B.; Durrant, B., 2008:
PERMANENT GENETIC RESOURCES: Isolation and characterization of microsatellite loci in the North Island brown kiwi, Apteryx mantelli

Maeda, K.; Takeshima, H.; Mizoiri, S.; Okada, N.; Nishida, M.; Tachida, H., 2008:
PERMANENT GENETIC RESOURCES: Isolation and characterization of microsatellite loci in the cichlid fish in Lake Victoria, Haplochromis chilotes

Muniz, L.; Vigilant, L., 2008:
PERMANENT GENETIC RESOURCES: Isolation and characterization of microsatellite markers in the white-faced capuchin monkey (Cebus capucinus) and cross-species amplification in other New World monkeys

Yagishita, N.; Kobayashi, T., 2008:
PERMANENT GENETIC RESOURCES: Isolation and characterization of nine microsatellite loci from the chub mackerel, Scomber japonicus (Perciformes, Scombridae)

Larson, E.L.; Bogdanowicz, S.M.; Agrawal, A.A.; Johnson, M.T.J.; Harrison, R.G., 2008:
PERMANENT GENETIC RESOURCES: Isolation and characterization of polymorphic microsatellite loci in common evening primrose (Oenothera biennis)

Kokita, T.; Takahashi, S., 2008:
PERMANENT GENETIC RESOURCES: Isolation and characterization of polymorphic trinucleotide and dinucleotide microsatellite loci for the ice goby, Leucopsarison petersii

Giraud, T.; Yockteng, R.; Marthey, S.; Chiapello, H.; Jonot, O.; Lopez-Villavicencio, M.; DE Vienne, D.M.; Hood, M.E.; Refregier, G.; Gendrault-Jacquemard, A.; Wincker, P.; Dossat, C., 2008:
PERMANENT GENETIC RESOURCES: Isolation of 60 polymorphic microsatellite loci in EST libraries of four sibling species of the phytopathogenic fungal complex Microbotryum

McGlaughlin, M.E.; Wallace, L.E.; Helenurm, K., 2008:
PERMANENT GENETIC RESOURCES: Isolation of microsatellite loci from the endangered plant Sibara filifolia (Brassicaceae)

Engel, C.R.; Guillemin, M-L.; Jacob, A-M.; Valero, M.; Viard, F., 2008:
PERMANENT GENETIC RESOURCES: Isolation of microsatellite loci from the kelp, Saccorhiza polyschides (Heterokontophyta, incertae sedis)

Edwards, C.E.; Soltis, D.E.; Soltis, P.S., 2008:
PERMANENT GENETIC RESOURCES: Isolation, characterization and cross-species amplifications of microsatellite loci from Conradina (Lamiaceae)

Mayer, C.; Schiegg, K.; Pasinelli, G., 2008:
PERMANENT GENETIC RESOURCES: Isolation, characterization and multiplex genotyping of 11 autosomal and four sex-linked microsatellite loci in the reed bunting, Emberiza schoeniclus (Emberizidae, Aves)

Switzer, J.F.; Welsh, S.A.; King, T.L., 2008:
PERMANENT GENETIC RESOURCES: Microsatellite DNA primers for the candy darter, Etheostoma osburni and variegate darter, Etheostoma variatum, and cross-species amplification in other darters (Percidae)

Liu, H-P.; Hershler, R., 2008:
PERMANENT GENETIC RESOURCES: Microsatellite markers for the threatened Bliss Rapids snail (Taylorconcha serpenticola) and cross-amplification in its congener, T. insperata

Karlsson, S.; Renshaw, M.A.; Rexroad Iii, C.E.; Gold, J.R., 2008:
PERMANENT GENETIC RESOURCES: PCR primers for 100 microsatellites in red drum (Sciaenops ocellatus)

Garnier, S.; Verduijn, M.; Preuss, S.; Wolff, K.; Stone, G.N., 2008:
PERMANENT GENETIC RESOURCES: Polymorphic microsatellite loci and interspecific cross-amplification in the parasitoid wasps Megastigmus stigmatizans and Megastigmus dorsalis

Forbes, A.A.; Powell, T.H.Q.; Lobo, N.F.; Noor, M.A.F.; Feder, J.L., 2008:
PERMANENT GENETIC RESOURCES: Polymorphic microsatellite loci for Diachasma alloeum (Hymenoptera: Braconidae)

Hoffman, J.I.; Dasmahapatra, K.K.; Nichols, H.J., 2008:
PERMANENT GENETIC RESOURCES: Ten novel polymorphic dinucleotide microsatellite loci cloned from the Antarctic fur seal Arctocephalus gazella

Estes-Zumpf, W.A.; Rachlow, J.L.; Waits, L.P., 2008:
PERMANENT GENETIC RESOURCES: Ten polymorphic microsatellite markers for the pygmy rabbit (Brachylagus idahoensis)

Gao, H.; Kong, J.; Yan, B.; Yu, F.; Luan, S.; Cai, S., 2008:
PERMANENT GENETIC RESOURCES: Twelve new microsatellite markers for the Chinese shrimp Fenneropenaeus chinensis

Seyoum, S.; Wallace, E.M.; Tringali, M.D., 2008:
PERMANENT GENETIC RESOURCES: Twelve polymorphic microsatellite markers for the bonefish, Albula vulpes and two congeners

Anonymous, 1881:

Steiß, V.; Letschert, T.; Schäfer, H.; Pahl, R., 2012:
PERMORY-MPI: a program for high-speed parallel permutation testing in genome-wide association studies

Pahl, R.; Schäfer, H., 2010:
PERMORY: an LD-exploiting permutation test algorithm for powerful genome-wide association testing

Piney, A., 1924:
PERNICIOUS ANAEMIA: Some Morphological and Etiological Considerations

Chen, K.; Luo, Z.; Li, Z.; Liu, Y.; Zhao, Q., 2013:
PERP gene therapy attenuates lung cancer xenograft via inducing apoptosis and suppressing VEGF

Jheon, A.H.; Mostowfi, P.; Snead, M.L.; Ihrie, R.A.; Sone, E.; Pramparo, T.; Attardi, L.D.; Klein, O.D., 2011:
PERP regulates enamel formation via effects on cell-cell adhesion and gene expression

Jiménez-Fernández, S.; Araujo-Pinto, A.; Cobo-Sánchez de Rojas, A.; del Pozo-Guerrero, F.; Nieto-Taladriz, O.; de Toledo-Heras, P.; Moya-Fernández, Jé.Manuel., 2007:
PERSEIA: a biomedical wireless sensor network to support healthcare delivery for the elderly and chronically ill

Mah, F.; Milner, M.; Yiu, S.; Donnenfeld, E.; Conway, T.M.; Hollander, D.A., 2012:
PERSIST: Physician's Evaluation of Restasis(®) Satisfaction in Second Trial of topical cyclosporine ophthalmic emulsion 0.05% for dry eye: a retrospective review

Ozturk, H.; Eroglu, M.; Ozturk, H.; Uzunlar, A.Kemal.; Okur, H., 2007:
PERSISTENT Müllerian duct syndrome associated with transverse testicular ectopia: report of two cases

Weinhold, B., 2010:
PERSISTENT ORGANIC POLLUTANTS: melting glaciers release frozen toxicants

Stiles, P.G., 1911:
PERSONAL HYGIENE NOTES: Dreams as Tokens of Condition

Schaller, W.F., 1922:
PERSONAL OBSERVATIONS ON UNUSUAL FORMS OF ACUTE POLIOMYELITIC PARALYSIS: With Remarks on Clinically Related Types of Epidemic Encephalitis and Landry's Paralysis

Anonymous, 2011:

Anonymous, 2012:
PERSONNEL of museums

Anonymous, 1947:
PERSONNEL research

Anonymous, 2008:
PERSOONIAL Reflections

Anonymous, 2010:
PERSOONIAL Reflections

Anonymous, 2010:
PERSOONIAL Reflections

Anonymous, 2011:
PERSOONIAL Reflections

Duarte-Silva, D.; Figueiras, A.; Herdeiro, M.T.; Teixeira Rodrigues, Aónio.; Silva Branco, Fábio.; Polónia, J.; Figueiredo, I.V., 2014:
PERSYVE - Design and validation of a questionnaire about adverse effects of antihypertensive drugs

Qiao, W.; Quon, G.; Csaszar, E.; Yu, M.; Morris, Q.; Zandstra, P.W., 2013:
PERT: a method for expression deconvolution of human blood samples from varied microenvironmental and developmental conditions

Anonymous, 1947:
PERTAINING to penicillin

Gore, S.M.; Lamberty, B.George.H., 2012:
PERTHESE implant-identical cohesive-gel sizers in breast augmentation: a prospective report on 200 consecutive cases and implications for treatment of breast asymmetry

Kaski, J.Carlos.; Consuegra-Sanchez, L., 2013:
PERTINENT (a substudy of the EUROPA trial): a persistent legacy

Anonymous, 2014:
PERTUSSIS immunization

Anonymous, 2010:

Lee, C.; Chen, R.; Lee, H-Min., 2010:
PERpetual motion of the circadian negative feedback loop

Deboer, T., 2010:
PERsonalizing sleep

Ripperger, Jürgen.A.; Schmutz, I.; Albrecht, U., 2011:
PERsuading nuclear receptors to dance the circadian rhythm

Li, J.; Zhuang, Q.; Lan, X.; Zeng, G.; Jiang, X.; Huang, Z., 2014:
PES1 differentially regulates the expression of ERα and ERβ in ovarian cancer

Cheng, L.; Li, J.; Han, Y.; Lin, J.; Niu, C.; Zhou, Z.; Yuan, B.; Huang, K.; Li, J.; Jiang, K.; Zhang, H.; Ding, L.; Xu, X.; Ye, Q., 2012:
PES1 promotes breast cancer by differentially regulating ERα and ERβ

Barbosa-Silva, A.; Fontaine, J-Fred.; Donnard, E.R.; Stussi, F.; Ortega, J.Miguel.; Andrade-Navarro, M.A., 2012:
PESCADOR, a web-based tool to assist text-mining of biointeractions extracted from PubMed queries

Das, S.; Krein, M.P.; Breneman, C.M., 2010:
PESDserv: a server for high-throughput comparison of protein binding site surfaces

Lindner, S.; Michler, C.; Wängler, Börn.; Bartenstein, P.; Fischer, G.; Schirrmacher, R.; Wängler, C., 2014:
PESIN multimerization improves receptor avidities and in vivo tumor targeting properties to GRPR-overexpressing tumors

Veillette, Aé.; Rhee, I.; Souza, C.Martins.; Davidson, D., 2009:
PEST family phosphatases in immunity, autoimmunity, and autoinflammatory disorders

Ramakrishna, S.; Suresh, B.; Lim, K-Hwan.; Cha, B-Hyun.; Lee, S-Hong.; Kim, K-Soo.; Baek, K-Hyun., 2011:
PEST motif sequence regulating human NANOG for proteasomal degradation

Xing, H.; Hong, Y.; Sarge, K.D., 2010:
PEST sequences mediate heat shock factor 2 turnover by interacting with the Cul3 subunit of the Cul3-RING ubiquitin ligase

Obiri, D.D.; Flink, N.; Maier, J.V.; Neeb, A.; Maddalo, D.; Thiele, W.; Menon, A.; Stassen, M.; Kulkarni, R.A.; Garabedian, M.J.; Barrios, A.M.; Cato, A.C.B., 2012:
PEST-domain-enriched tyrosine phosphatase and glucocorticoids as regulators of anaphylaxis in mice

Nam, S-Hyeuk.; Kim, D-Won.; Jung, T-Sung.; Choi, Y-Sang.; Kim, D-Wook.; Choi, H-Suk.; Choi, S-Haeng.; Park, H-Seog., 2009:
PESTAS: a web server for EST analysis and sequence mining

Burton, A., 2009:
PESTICIDES: toward DDT-free malaria control

Spanoudaki, V.C.; Ziegler, S.I., 2008:
PET & SPECT instrumentation

Tanaka, K.; Fukase, K., 2008:
PET (positron emission tomography) imaging of biomolecules using metal-DOTA complexes: a new collaborative challenge by chemists, biologists, and physicians for future diagnostics and exploration of in vivo dynamics

Eberling, J.L.; Bankiewicz, K.S.; O'Neil, J.P.; Jagust, W.J., 2008:
PET 6-[F]fluoro-L-m-tyrosine Studies of Dopaminergic Function in Human and Nonhuman Primates

Wu, K.; Ung, Y.C.; Hornby, J.; Freeman, M.; Hwang, D.; Tsao, M.S.; Dahele, M.; Darling, G.; Maziak, D.E.; Tirona, R.; Mah, K.; Wong, C.Shun., 2010:
PET CT thresholds for radiotherapy target definition in non-small-cell lung cancer: how close are we to the pathologic findings?